data_2mi9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mi9 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.815 0.341 . . . . 73.329999999999998 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.8 mm 63.54 110.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 73.140000000000001 111.1 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.72 160.62 7.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 111.099 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -50.83 120.34 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 65.120000000000005 110.857 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.79 35.63 19.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.941 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.2 166.21 23.14 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.78 -0.724 . . . . 62.420000000000002 112.466 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 152.31 44.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 74.329999999999998 110.91 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 149.74 40.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 75.319999999999993 110.911 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -73.01 -35.38 66.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 74.420000000000002 110.875 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.14 -69.37 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 51.299999999999997 112.481 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -25.96 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.337 . . . . 75.450000000000003 111.118 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.27 95.04 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 70.109999999999999 111.125 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -88.32 9.51 23.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 74.430000000000007 110.848 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.3 69.61 6.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 64.510000000000005 110.947 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.5 t -99.46 104.75 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 71.209999999999994 110.882 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -53.24 -64.61 0.77 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 75.400000000000006 110.853 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -131.86 161.83 60.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.723 . . . . 73.319999999999993 110.845 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.78 -49.55 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.213 0 C-N-CA 122.653 -1.811 . . . . 71.140000000000001 112.364 0.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -127.85 -92.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 74.400000000000006 110.927 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.47 160.36 35.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 72.030000000000001 110.936 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -88.83 126.04 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 110.891 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 94.5 m -145.99 135.31 11.39 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 64.400000000000006 111.136 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.79 170.41 58.74 Favored 'Cis proline' 0 C--N 1.341 0.147 0 C-N-CA 122.758 -1.767 . . . . 74.239999999999995 112.313 0.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -6.47 18.68 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.702 2.268 . . . . 73.099999999999994 112.32 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 mt -92.98 -69.58 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 72.120000000000005 111.1 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -152.92 119.67 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 75.25 111.172 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.63 -141.85 3.8 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 72.329999999999998 112.468 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -130.69 141.19 50.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 74.310000000000002 110.893 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.9 t -74.52 128.85 36.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 72.209999999999994 110.893 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.9 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.796 0.331 . . . . 73.409999999999997 110.901 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.5 mm 63.45 109.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 74.200000000000003 111.136 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.49 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 70.140000000000001 111.124 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -50.85 120.34 4.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 71.129999999999995 110.862 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.85 35.63 19.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 74.099999999999994 110.949 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.44 166.79 23.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 64.510000000000005 112.478 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 152.1 44.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.352 . . . . 74.420000000000002 110.893 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 149.67 40.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 71.049999999999997 110.889 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.09 -34.57 68.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 61.0 110.869 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.66 -69.68 0.31 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 73.040000000000006 112.493 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -25.97 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 72.120000000000005 111.147 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -96.35 97.32 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.25 111.105 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -89.29 9.97 24.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 64.439999999999998 110.879 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.13 69.94 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.937 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.6 t -101.71 105.24 16.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 62.119999999999997 110.884 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.2 m -54.15 -64.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 61.549999999999997 110.903 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -129.98 161.79 57.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.589 0.709 . . . . 54.219999999999999 110.875 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.74 -49.64 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 -1.788 . . . . 75.019999999999996 112.306 0.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.88 -91.6 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 74.040000000000006 110.907 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.45 160.24 34.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 65.120000000000005 110.884 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -88.48 125.12 34.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 71.150000000000006 110.874 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.524 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 94.8 m -147.96 136.24 11.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.572 0.701 . . . . 74.109999999999999 111.113 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.6 Cg_endo -69.71 168.08 68.6 Favored 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.691 -1.796 . . . . 74.219999999999999 112.334 -0.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.29 23.21 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.628 2.218 . . . . 74.319999999999993 112.355 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 pt -116.56 83.72 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 74.439999999999998 111.106 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 61.07 103.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 111.097 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.01 -151.99 7.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 74.109999999999999 112.446 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -124.05 137.55 54.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 75.400000000000006 110.893 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.0 t -77.54 129.72 36.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 53.219999999999999 110.906 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 72.310000000000002 110.912 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.819 0.343 . . . . 73.420000000000002 110.881 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.5 mm 63.42 109.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 75.439999999999998 111.129 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.84 160.64 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 74.530000000000001 111.07 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -50.92 120.43 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 73.420000000000002 110.824 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.76 35.49 19.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 74.400000000000006 110.932 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.32 166.73 23.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.686 -0.769 . . . . 73.310000000000002 112.468 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.17 152.2 44.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 74.420000000000002 110.873 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 149.85 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.25 -28.96 61.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 74.510000000000005 110.913 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 -69.41 0.22 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 71.239999999999995 112.439 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.05 -25.46 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 70.230000000000004 111.142 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.26 96.43 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.329999999999998 111.126 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -88.82 9.86 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 64.450000000000003 110.855 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -80.21 69.67 6.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 74.109999999999999 110.903 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -101.56 104.98 15.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.94 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.8 m -54.6 -64.62 0.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.420000000000002 110.884 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -129.95 161.79 57.63 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 74.510000000000005 110.861 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.76 -49.44 0.23 Allowed 'Cis proline' 0 C--N 1.341 0.157 0 C-N-CA 122.695 -1.794 . . . . 73.209999999999994 112.349 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -127.72 -91.7 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 71.530000000000001 110.947 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.59 160.37 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.319999999999993 110.92 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.2 m -87.73 125.27 34.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 72.129999999999995 110.908 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.521 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 96.0 m -148.85 136.48 11.1 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.543 0.687 . . . . 64.430000000000007 111.133 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.74 167.6 70.4 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 -1.798 . . . . 74.409999999999997 112.342 -0.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -9.45 26.14 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.676 2.251 . . . . 64.420000000000002 112.375 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 pt -112.91 79.71 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 75.510000000000005 111.14 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 61.42 104.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 111.122 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -164.72 -146.51 4.79 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 71.230000000000004 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.21 137.49 52.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 75.209999999999994 110.843 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.4 t -77.45 129.56 35.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 74.209999999999994 110.88 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 110.969 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.793 0.33 . . . . 72.329999999999998 110.881 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.0 mm 63.47 110.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 64.209999999999994 111.138 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.69 160.65 7.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 72.030000000000001 111.103 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -50.77 120.46 4.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 63.340000000000003 110.82 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.87 35.68 19.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.540000000000006 110.958 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.46 165.03 23.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 61.439999999999998 112.438 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 152.23 44.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.343 . . . . 64.450000000000003 110.92 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 150.4 39.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 74.230000000000004 110.86 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -73.64 -29.92 62.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 110.871 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.82 -69.68 0.25 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 70.420000000000002 112.511 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.64 -26.04 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 72.019999999999996 111.132 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.82 95.12 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.200000000000003 111.16 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -89.34 9.77 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 71.310000000000002 110.879 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -80.24 69.91 6.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 73.530000000000001 110.899 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.6 t -101.57 105.37 16.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.909 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.4 m -53.83 -64.76 0.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 110.848 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.1 m-20 -131.0 161.82 59.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.581 0.705 . . . . 65.310000000000002 110.866 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.69 -49.75 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.694 -1.794 . . . . 62.439999999999998 112.397 -0.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.57 -92.19 0.49 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 71.099999999999994 110.961 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.61 160.35 34.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 71.329999999999998 110.871 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.79 117.46 29.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 74.519999999999996 110.871 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.532 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -139.74 139.24 21.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.608 0.718 . . . . 73.129999999999995 111.122 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.73 169.47 63.05 Favored 'Cis proline' 0 C--O 1.232 0.185 0 C-N-CA 122.66 -1.808 . . . . 72.439999999999998 112.377 -0.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -7.98 22.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.655 2.237 . . . . 71.439999999999998 112.35 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.05 80.98 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 73.420000000000002 111.13 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp 60.6 100.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 71.219999999999999 111.1 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.74 -146.2 4.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 71.239999999999995 112.502 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -130.39 138.4 50.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.379 . . . . 71.109999999999999 110.85 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 t -76.8 128.97 35.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 74.540000000000006 110.879 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 110.905 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.813 0.339 . . . . 75.439999999999998 110.901 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.2 mm 63.77 118.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 111.131 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.38 159.82 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 74.010000000000005 111.064 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -51.28 118.24 3.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 74.219999999999999 110.866 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 60.44 35.83 20.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 75.400000000000006 110.941 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.72 167.06 31.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 35.32 112.489 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 152.64 43.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 71.549999999999997 110.943 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.07 154.88 31.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 70.140000000000001 110.865 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -72.91 -35.12 67.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.13 -69.57 0.29 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.759 -0.734 . . . . 72.25 112.514 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -26.04 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.759 0.314 . . . . 74.420000000000002 111.14 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mt -97.16 98.51 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 63.119999999999997 111.174 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -89.59 9.83 25.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 74.510000000000005 110.89 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.11 69.94 6.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 74.430000000000007 110.916 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.9 t -100.0 106.29 18.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 64.120000000000005 110.909 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.7 m -52.62 -64.91 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 110.873 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.492 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -132.66 161.43 63.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.565 0.697 . . . . 72.310000000000002 110.904 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.77 -49.83 0.21 Allowed 'Cis proline' 0 C--N 1.341 0.166 0 C-N-CA 122.685 -1.798 . . . . 74.019999999999996 112.365 0.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.31 -92.07 0.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 110.954 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.45 160.37 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.873 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -90.26 118.64 29.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 70.439999999999998 110.859 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.531 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -140.35 138.96 19.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 74.230000000000004 111.121 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.78 169.42 63.52 Favored 'Cis proline' 0 C--N 1.342 0.22 0 C-N-CA 122.665 -1.806 . . . . 70.530000000000001 112.356 -0.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -7.83 22.05 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.676 2.251 . . . . 74.129999999999995 112.351 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -115.14 80.93 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 73.400000000000006 111.145 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 60.4 100.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 74.310000000000002 111.108 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.69 -146.29 4.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 73.219999999999999 112.486 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -130.16 137.93 50.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 70.439999999999998 110.875 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.21 131.78 38.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 75.519999999999996 110.89 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 72.349999999999994 110.911 179.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.79 0.329 . . . . 74.219999999999999 110.871 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.5 mm 63.37 109.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 74.420000000000002 111.104 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.67 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 74.239999999999995 111.085 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -50.78 120.35 4.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.847 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.88 35.62 19.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 73.450000000000003 110.863 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.09 165.94 23.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 71.450000000000003 112.499 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 152.39 44.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.861 0.362 . . . . 74.140000000000001 110.893 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.92 149.89 40.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 60.119999999999997 110.852 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -76.39 -35.41 58.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 74.019999999999996 110.845 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.04 -69.22 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 72.129999999999995 112.531 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.72 -25.88 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.34 . . . . 75.219999999999999 111.129 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.9 mp -97.3 93.33 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 74.409999999999997 111.16 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -88.16 9.5 22.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 71.209999999999994 110.926 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -80.29 69.6 6.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 71.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.5 t -99.53 104.74 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 53.109999999999999 110.871 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.0 m -54.69 -64.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 73.349999999999994 110.897 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -130.64 161.63 59.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 72.150000000000006 110.848 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.76 -49.52 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.673 -1.803 . . . . 73.040000000000006 112.314 0.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.64 -92.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 75.299999999999997 110.887 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.09 160.12 35.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.340000000000003 110.882 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.57 126.16 35.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 64.230000000000004 110.892 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 96.0 m -145.48 135.39 11.72 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.147 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.79 170.34 59.09 Favored 'Cis proline' 0 C--N 1.341 0.153 0 C-N-CA 122.648 -1.813 . . . . 75.519999999999996 112.354 -0.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -6.67 19.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 50.409999999999997 112.333 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.95 -69.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 75.150000000000006 111.147 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -152.87 120.09 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 73.140000000000001 111.145 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.13 -141.91 3.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 65.349999999999994 112.462 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -130.73 141.24 50.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.391 . . . . 75.319999999999993 110.865 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.7 t -74.4 128.66 36.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 73.230000000000004 110.9 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 74.040000000000006 110.896 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.845 0.355 . . . . 71.239999999999995 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.6 mm 63.43 109.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 111.11 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.93 160.51 7.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 72.319999999999993 111.093 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -50.8 120.4 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 73.430000000000007 110.862 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.79 35.58 19.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.961 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.21 166.69 23.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.732 -0.747 . . . . 70.120000000000005 112.451 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 152.19 44.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.795 0.331 . . . . 74.400000000000006 110.925 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.17 149.85 40.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.898 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.27 -35.16 61.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 74.120000000000005 110.84 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.2 -70.01 0.37 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 75.209999999999994 112.502 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -25.36 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 73.120000000000005 111.117 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.3 mt -94.66 93.75 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 75.109999999999999 111.105 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.16 9.08 24.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 75.209999999999994 110.845 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -80.86 69.46 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 73.450000000000003 110.929 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 t -99.56 104.6 16.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 72.319999999999993 110.904 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.8 m -54.62 -64.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 75.409999999999997 110.882 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -131.81 161.72 60.78 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.601 0.715 . . . . 72.409999999999997 110.888 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.79 -49.64 0.22 Allowed 'Cis proline' 0 C--O 1.232 0.179 0 C-N-CA 122.695 -1.794 . . . . 72.340000000000003 112.28 0.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.64 -92.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 71.319999999999993 110.945 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.02 160.22 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 71.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.49 126.28 35.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.872 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 95.5 m -145.4 135.48 11.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.561 0.696 . . . . 73.310000000000002 111.182 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.73 170.23 59.33 Favored 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.685 -1.798 . . . . 74.219999999999999 112.359 -0.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.83 19.53 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.705 2.27 . . . . 74.129999999999995 112.323 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 mt -92.68 -69.34 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 74.219999999999999 111.133 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -152.8 119.58 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 70.530000000000001 111.113 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.68 -142.2 3.94 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.775 -0.726 . . . . 74.040000000000006 112.501 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -130.79 141.4 50.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 71.219999999999999 110.867 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.5 t -74.06 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 74.25 110.902 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 75.209999999999994 110.879 179.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.776 0.322 . . . . 71.040000000000006 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.0 mm 63.67 110.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 111.112 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.72 160.7 7.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 71.299999999999997 111.095 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -50.81 120.35 4.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 110.879 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 60.81 35.6 19.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.241 -0.436 . . . . 72.340000000000003 110.946 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.51 165.78 23.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.738 -0.744 . . . . 73.349999999999994 112.466 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 152.22 44.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 72.530000000000001 110.931 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 149.82 40.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 70.530000000000001 110.878 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.42 -33.49 67.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 73.409999999999997 110.868 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.37 -73.19 0.33 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.738 -0.744 . . . . 75.120000000000005 112.506 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -25.93 32.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.833 0.349 . . . . 64.450000000000003 111.134 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.2 mt -90.7 93.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 71.439999999999998 111.159 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -88.06 9.12 23.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 64.450000000000003 110.847 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.79 69.71 7.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.340000000000003 110.947 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -102.03 104.8 15.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.209999999999994 110.868 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.9 m -54.81 -64.54 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 73.239999999999995 110.855 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -131.21 160.97 64.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.601 0.715 . . . . 73.319999999999993 110.882 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.8 -49.72 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.701 -1.791 . . . . 72.109999999999999 112.327 0.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -128.53 -93.02 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 73.510000000000005 110.909 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.4 160.35 35.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 72.400000000000006 110.907 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.8 m -88.28 125.96 34.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.877 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 93.9 m -146.15 135.38 11.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.575 0.703 . . . . 73.319999999999993 111.144 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.79 170.34 59.08 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.687 -1.797 . . . . 70.430000000000007 112.331 -0.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -6.64 19.11 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.704 2.269 . . . . 72.230000000000004 112.32 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.5 mt -92.58 -69.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 71.219999999999999 111.108 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -153.04 119.72 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.146 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.99 -141.93 3.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.773 -0.727 . . . . 52.049999999999997 112.479 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -130.65 141.52 50.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 72.549999999999997 110.883 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.0 t -74.17 128.33 35.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 74.239999999999995 110.874 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 71.450000000000003 110.896 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.788 0.327 . . . . 70.0 110.869 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.9 mm 63.57 112.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 70.040000000000006 111.109 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.35 161.31 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 61.420000000000002 111.147 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -50.14 120.41 4.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 54.329999999999998 110.852 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.8 35.25 19.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.981 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.68 155.55 19.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.697 -0.763 . . . . 74.120000000000005 112.499 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.36 150.26 46.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 70.140000000000001 110.849 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.28 161.79 19.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.299999999999997 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.72 -32.68 73.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.409999999999997 110.856 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.13 -69.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 73.420000000000002 112.486 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -25.82 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 72.120000000000005 111.121 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -89.95 97.13 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.430000000000007 111.149 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.84 9.85 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 73.099999999999994 110.866 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -80.14 69.73 6.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 71.310000000000002 110.857 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.2 t -102.22 104.85 15.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.439999999999998 110.846 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.2 m -53.98 -64.78 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 71.409999999999997 110.871 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -131.63 161.63 61.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 63.32 110.837 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.85 -49.57 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.713 -1.786 . . . . 73.409999999999997 112.328 0.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -129.67 -91.39 0.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 72.239999999999995 110.925 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.18 160.2 34.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 73.010000000000005 110.946 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.19 119.81 32.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 110.854 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.528 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -139.25 139.56 23.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.576 0.703 . . . . 63.409999999999997 111.166 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.528 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.79 169.71 62.15 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.793 . . . . 73.230000000000004 112.359 -0.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -7.87 22.16 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 74.340000000000003 112.369 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.1 pt -114.91 83.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 71.400000000000006 111.125 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 61.28 86.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 74.120000000000005 111.114 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.39 -157.48 7.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 73.439999999999998 112.525 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.23 138.36 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.395 . . . . 75.519999999999996 110.817 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.04 129.4 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 75.25 110.874 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.885 -180.0 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.826 0.346 . . . . 74.150000000000006 110.889 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.3 mm 63.79 111.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 75.409999999999997 111.127 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.87 161.01 6.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 74.430000000000007 111.097 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -50.71 120.46 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 75.140000000000001 110.873 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.84 35.11 19.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 74.409999999999997 110.913 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.41 161.69 18.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 72.329999999999998 112.488 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 150.3 46.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.851 0.358 . . . . 73.319999999999993 110.899 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -119.53 160.84 21.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.409999999999997 110.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -69.06 -34.96 76.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 74.450000000000003 110.866 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.79 -69.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.71 -0.757 . . . . 64.109999999999999 112.493 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -25.72 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 73.329999999999998 111.19 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.5 mt -90.12 100.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 72.129999999999995 111.144 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.41 9.13 21.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 74.430000000000007 110.924 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -80.63 69.66 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 75.340000000000003 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.1 t -102.82 104.78 15.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 72.530000000000001 110.813 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.0 m -55.32 -64.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.109999999999999 110.86 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -132.83 161.46 63.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 73.219999999999999 110.864 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.75 -49.68 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 -1.805 . . . . 75.310000000000002 112.342 0.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -128.08 -91.96 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.099999999999994 110.895 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.67 160.61 33.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 72.530000000000001 110.924 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.0 t -89.94 119.46 30.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 73.219999999999999 110.843 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.535 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -141.11 138.87 18.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.56 0.695 . . . . 72.340000000000003 111.184 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.69 169.29 63.77 Favored 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.678 -1.801 . . . . 73.400000000000006 112.354 -0.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.09 22.73 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.637 2.225 . . . . 74.329999999999998 112.346 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.73 80.29 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 71.340000000000003 111.127 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 60.97 101.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 73.25 111.104 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.79 -145.75 4.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 72.099999999999994 112.467 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -130.14 137.97 50.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.946 0.403 . . . . 75.310000000000002 110.865 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.13 129.3 35.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 75.120000000000005 110.879 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 74.040000000000006 110.935 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.812 0.339 . . . . 64.040000000000006 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.6 mm 63.37 110.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 111.175 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.59 7.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 74.010000000000005 111.108 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -50.85 120.29 4.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 72.420000000000002 110.896 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.81 35.59 19.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.9 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.63 166.0 23.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 72.030000000000001 112.532 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 152.03 44.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 74.420000000000002 110.928 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.23 149.77 40.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 73.510000000000005 110.84 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -74.48 -34.9 63.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 73.400000000000006 110.848 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.42 -70.19 0.37 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 71.129999999999995 112.525 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.43 -25.43 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 75.409999999999997 111.185 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 mt -94.1 93.26 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.123 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -88.0 8.99 23.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 75.209999999999994 110.908 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -80.94 69.52 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.92 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 t -100.57 104.75 16.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 74.030000000000001 110.84 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 m -54.98 -64.43 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 110.848 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -131.54 161.37 62.59 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 55.310000000000002 110.862 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.78 -49.74 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.225 0 C-N-CA 122.674 -1.803 . . . . 72.120000000000005 112.307 0.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -128.97 -92.56 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.882 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.0 160.45 34.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 74.230000000000004 110.908 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.82 125.3 35.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.893 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -144.2 136.36 13.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.574 0.702 . . . . 71.400000000000006 111.159 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.83 170.99 56.09 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.648 -1.813 . . . . 75.129999999999995 112.346 -0.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -5.68 16.74 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 75.120000000000005 112.362 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 mt -93.68 -69.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 73.439999999999998 111.157 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.5 mp -153.09 115.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 74.129999999999995 111.098 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.1 -143.08 3.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 64.329999999999998 112.466 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -130.68 141.59 50.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.877 0.37 . . . . 74.5 110.911 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.2 t -73.99 128.22 34.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 73.239999999999995 110.864 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 62.229999999999997 110.953 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 13.6 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 73.209999999999994 110.878 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.5 mm 62.5 109.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 74.319999999999993 111.155 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.31 160.05 11.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 61.350000000000001 111.052 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.66 120.92 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 110.85 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 61.12 36.15 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 75.129999999999995 110.893 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.25 169.63 29.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.783 -0.723 . . . . 72.310000000000002 112.462 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 154.93 41.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.342 . . . . 73.549999999999997 110.884 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -116.06 149.75 38.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 63.229999999999997 110.89 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.55 -32.27 69.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.837 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.22 -79.38 0.29 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.737 -0.744 . . . . 75.510000000000005 112.483 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -25.11 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 70.019999999999996 111.075 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.71 101.0 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 75.340000000000003 111.145 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -86.01 9.51 16.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 75.349999999999994 110.864 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -79.83 69.56 6.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 110.925 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.12 105.44 17.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 64.230000000000004 110.841 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -50.7 -72.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 71.510000000000005 110.887 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.493 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -135.31 159.5 71.54 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.578 0.704 . . . . 74.030000000000001 110.896 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.78 -49.43 0.23 Allowed 'Cis proline' 0 C--O 1.232 0.179 0 C-N-CA 122.717 -1.784 . . . . 75.310000000000002 112.33 0.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -130.42 -91.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.879 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.59 160.27 34.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 74.239999999999995 110.935 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 23.7 p -95.42 126.44 40.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 75.400000000000006 110.848 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -136.87 140.89 33.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.569 0.7 . . . . 64.349999999999994 111.109 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.74 170.41 58.53 Favored 'Cis proline' 0 C--N 1.342 0.199 0 C-N-CA 122.694 -1.794 . . . . 63.039999999999999 112.35 -0.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -5.14 15.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.652 2.235 . . . . 74.109999999999999 112.382 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.7 mt -108.52 73.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 111.131 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 mp 62.13 98.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 73.230000000000004 111.167 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.05 -143.63 3.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 63.229999999999997 112.54 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -130.77 139.52 50.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.377 . . . . 64.5 110.846 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -76.27 128.71 35.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 61.310000000000002 110.887 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 72.540000000000006 110.895 179.963 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.808 0.337 . . . . 72.150000000000006 110.876 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.3 mm 63.43 110.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 71.340000000000003 111.162 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.65 160.92 6.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 111.109 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.58 120.23 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 110.857 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.75 35.44 19.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 110.91 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.09 164.71 23.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 72.430000000000007 112.47 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 152.33 44.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.341 . . . . 75.310000000000002 110.925 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 149.84 40.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 42.240000000000002 110.882 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -74.6 -35.16 62.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 72.519999999999996 110.864 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.35 -69.36 0.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 73.319999999999993 112.446 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.86 -25.92 30.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.784 0.326 . . . . 74.430000000000007 111.091 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -96.85 93.58 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.13 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -88.22 9.44 22.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 110.903 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -80.29 69.6 6.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 71.019999999999996 110.909 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.6 t -100.39 104.82 16.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 73.420000000000002 110.871 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.3 m -54.44 -64.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 110.875 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -130.53 161.74 58.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.602 0.715 . . . . 64.019999999999996 110.879 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.71 -49.53 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.15 0 C-N-CA 122.737 -1.776 . . . . 62.329999999999998 112.34 -0.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.49 -93.04 0.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.540000000000006 110.925 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.63 160.14 36.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 71.230000000000004 110.883 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.77 126.1 35.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 110.866 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.517 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 94.4 m -146.07 135.79 11.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.608 0.718 . . . . 75.200000000000003 111.132 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.73 170.44 58.33 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.684 -1.799 . . . . 72.25 112.345 -0.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -7.62 21.52 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 75.209999999999994 112.329 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.5 mt -93.4 -58.89 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 74.439999999999998 111.164 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -163.22 130.67 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 73.439999999999998 111.102 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.71 -139.33 4.99 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.751 -0.738 . . . . 71.239999999999995 112.508 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -131.33 140.72 49.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 74.150000000000006 110.88 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.1 t -75.29 128.51 35.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 71.230000000000004 110.875 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 74.349999999999994 110.914 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.772 0.32 . . . . 75.010000000000005 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.2 mm 63.36 110.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 73.519999999999996 111.106 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.66 160.69 6.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 75.319999999999993 111.059 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -50.62 120.42 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 75.329999999999998 110.82 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.83 35.6 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 72.450000000000003 110.922 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.27 165.23 23.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 75.25 112.498 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 152.47 44.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 74.349999999999994 110.899 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.87 149.89 40.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.888 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.12 -33.92 38.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.867 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.51 -69.26 0.39 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 70.310000000000002 112.433 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -25.88 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 75.439999999999998 111.126 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.55 90.44 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 111.127 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -88.03 9.4 22.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 73.450000000000003 110.881 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -80.33 69.61 6.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 110.942 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.9 t -99.92 104.67 16.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.857 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -54.49 -64.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 110.863 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -129.94 161.63 58.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 75.140000000000001 110.87 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.67 -49.54 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.671 -1.804 . . . . 71.349999999999994 112.373 -0.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -129.16 -91.88 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.937 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.83 160.23 35.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 63.229999999999997 110.934 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 m -91.94 125.54 36.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.9 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.526 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -142.41 137.35 15.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.612 0.72 . . . . 72.409999999999997 111.122 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.71 171.02 55.4 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.712 -1.786 . . . . 70.049999999999997 112.369 -0.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -7.02 20.01 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.695 2.264 . . . . 71.409999999999997 112.353 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.6 mt -94.89 -56.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 111.101 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -164.93 129.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 74.319999999999993 111.144 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.97 -140.76 5.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 71.230000000000004 112.485 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -131.15 140.98 50.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 75.519999999999996 110.878 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -74.56 128.95 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 62.299999999999997 110.861 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 73.040000000000006 110.956 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.83 0.348 . . . . 73.450000000000003 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.7 mm 63.26 109.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 72.140000000000001 111.122 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 161.07 11.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 71.5 111.089 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -50.13 120.46 4.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 71.540000000000006 110.871 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 60.8 36.01 19.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 73.219999999999999 110.906 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.07 164.64 20.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 74.109999999999999 112.49 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 154.35 41.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 73.219999999999999 110.874 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.37 149.57 39.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 75.140000000000001 110.886 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.43 -22.25 51.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.319999999999993 110.877 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.07 -77.33 0.22 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 73.340000000000003 112.509 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -25.08 29.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 63.450000000000003 111.107 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 39.4 mt -89.59 97.53 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.329999999999998 111.117 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.93 7.48 27.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 70.439999999999998 110.886 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -80.02 69.35 6.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 72.310000000000002 110.899 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.37 106.62 18.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 73.219999999999999 110.893 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -49.67 -72.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 62.530000000000001 110.865 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -135.27 160.7 67.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 71.439999999999998 110.878 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.73 -49.8 0.21 Allowed 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.716 -1.785 . . . . 74.450000000000003 112.352 -0.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -130.51 -91.53 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 75.140000000000001 110.917 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.9 160.65 33.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 73.109999999999999 110.983 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 24.4 p -94.4 126.81 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.87 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.535 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -136.34 140.96 34.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.605 0.717 . . . . 75.140000000000001 111.107 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.0 Cg_endo -69.82 170.61 57.91 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 -1.802 . . . . 71.219999999999999 112.291 -0.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -3.75 12.61 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.667 2.245 . . . . 71.329999999999998 112.365 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.3 mt -109.85 72.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 75.109999999999999 111.139 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp 62.65 99.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 63.329999999999998 111.116 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.46 -143.21 3.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.702 -0.761 . . . . 54.340000000000003 112.458 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -130.52 139.74 50.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.928 0.394 . . . . 73.510000000000005 110.886 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -76.1 129.05 36.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.86 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 110.978 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.863 0.363 . . . . 65.439999999999998 110.924 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.2 mm 63.52 111.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 111.087 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.73 160.48 7.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 75.450000000000003 111.061 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -50.98 120.26 4.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.813 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.71 35.6 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 72.329999999999998 110.909 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.52 166.37 24.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 71.430000000000007 112.518 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 152.41 44.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 74.129999999999995 110.915 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 149.96 40.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.857 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.62 -22.75 66.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 75.310000000000002 110.836 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.24 -87.84 0.42 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.671 -0.776 . . . . 71.450000000000003 112.48 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -25.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 75.140000000000001 111.12 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.54 93.52 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 74.329999999999998 111.18 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -100.51 19.69 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 74.219999999999999 110.889 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.27 70.38 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 74.299999999999997 110.9 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 p -107.53 111.0 23.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 70.25 110.865 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.2 m -39.58 -63.56 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 72.340000000000003 110.879 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.485 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.2 m-20 -128.1 162.56 49.34 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.623 0.725 . . . . 74.310000000000002 110.803 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.5 Cg_endo -69.78 -50.92 0.17 OUTLIER 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.712 -1.787 . . . . 73.0 112.312 0.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -130.47 -93.8 0.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.923 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.88 161.34 28.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 75.400000000000006 110.897 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.1 m -85.63 125.97 33.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 52.130000000000003 110.891 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.528 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -153.2 138.23 11.35 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.586 0.707 . . . . 73.439999999999998 111.18 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.528 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.72 169.38 63.47 Favored 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 -1.79 . . . . 71.140000000000001 112.331 -0.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -8.4 23.52 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 61.310000000000002 112.34 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.18 92.18 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 75.540000000000006 111.132 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 50.19 85.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.299999999999997 111.109 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.51 -152.24 5.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.741 -0.742 . . . . 75.409999999999997 112.481 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -130.88 140.72 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 73.519999999999996 110.861 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 4.1 t -74.1 126.47 30.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 74.310000000000002 110.876 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 110.904 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.852 0.358 . . . . 63.329999999999998 110.935 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.8 mm 63.45 110.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 63.439999999999998 111.153 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.59 7.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 72.439999999999998 111.081 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -50.93 120.28 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 110.843 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.85 35.69 19.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.914 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.18 166.58 23.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 74.230000000000004 112.492 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 151.92 44.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.773 0.32 . . . . 73.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 149.71 40.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 71.349999999999994 110.857 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -74.02 -35.42 64.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.0 110.87 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.02 -69.38 0.34 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 73.200000000000003 112.478 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -25.86 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 73.319999999999993 111.168 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.67 94.78 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 74.25 111.108 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -88.16 9.45 22.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 71.030000000000001 110.899 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -80.4 69.56 6.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 75.400000000000006 110.888 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.5 t -101.2 104.82 15.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 73.340000000000003 110.884 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.9 m -53.39 -64.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 72.140000000000001 110.845 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.486 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -131.89 161.71 60.93 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.602 0.715 . . . . 73.140000000000001 110.867 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.84 -49.52 0.23 Allowed 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 -1.805 . . . . 72.420000000000002 112.331 0.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -128.23 -92.93 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 75.299999999999997 110.884 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.51 160.45 35.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 71.549999999999997 110.863 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.4 m -90.13 125.18 35.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 71.040000000000006 110.877 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.517 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -143.33 136.64 14.03 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.594 0.712 . . . . 54.229999999999997 111.128 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.8 170.63 57.71 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.617 -1.826 . . . . 74.099999999999994 112.352 -0.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 2.32 3.66 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.703 2.269 . . . . 72.430000000000007 112.314 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -107.65 -65.56 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 71.439999999999998 111.099 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.2 mp -148.36 123.93 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 111.141 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.409 ' HA3' ' HD2' ' A' ' 23' ' ' PRO . . . 176.93 -147.08 8.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 72.230000000000004 112.487 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -130.94 142.19 50.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 73.200000000000003 110.922 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.8 t -73.15 128.27 34.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 55.210000000000001 110.909 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 75.239999999999995 110.88 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.845 0.355 . . . . 72.209999999999994 110.883 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.2 mm 65.01 115.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 111.075 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.73 7.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 74.219999999999999 111.071 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.81 120.3 4.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 73.010000000000005 110.86 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.74 35.26 19.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 74.450000000000003 110.914 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.42 170.19 24.28 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 73.049999999999997 112.508 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.92 152.85 44.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 72.530000000000001 110.924 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.1 156.73 28.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 62.450000000000003 110.888 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.24 -28.55 38.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 75.099999999999994 110.894 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.19 -69.58 0.21 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 74.409999999999997 112.487 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -26.09 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 74.109999999999999 111.156 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.89 99.97 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 71.230000000000004 111.148 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -89.01 9.65 24.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 63.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -80.24 69.83 6.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 73.140000000000001 110.947 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.0 t -103.97 103.51 13.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 71.430000000000007 110.862 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 p -49.75 -62.17 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 71.349999999999994 110.841 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.497 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -136.34 160.94 64.94 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.573 0.701 . . . . 71.25 110.893 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.77 -50.23 0.2 OUTLIER 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.662 -1.807 . . . . 74.049999999999997 112.388 0.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -130.6 -93.81 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 110.952 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.84 160.94 35.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 72.549999999999997 110.926 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.8 m -84.0 125.65 32.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 71.239999999999995 110.861 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.534 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 95.9 m -145.94 136.86 12.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.573 0.701 . . . . 64.200000000000003 111.131 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.72 162.31 84.27 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.792 . . . . 71.010000000000005 112.337 -0.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 54.59 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.241 . . . . 73.010000000000005 112.351 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -172.39 86.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 75.239999999999995 111.127 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp 50.34 83.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 73.5 111.125 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -145.7 -140.22 3.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 75.129999999999995 112.487 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -130.82 137.59 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 73.140000000000001 110.867 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 t -77.29 128.43 34.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 74.510000000000005 110.876 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 73.299999999999997 110.895 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.756 0.312 . . . . 75.140000000000001 110.868 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.5 mm 64.62 114.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 74.310000000000002 111.157 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.84 160.51 7.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 41.030000000000001 111.107 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -50.79 120.48 4.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 75.230000000000004 110.835 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.85 35.63 19.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 110.905 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.53 167.1 24.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 74.239999999999995 112.45 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 152.01 44.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 72.120000000000005 110.877 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 149.9 40.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 73.040000000000006 110.827 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -72.59 -35.17 67.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 70.230000000000004 110.885 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.32 -69.88 0.37 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 74.230000000000004 112.505 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -26.67 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.78 0.324 . . . . 71.540000000000006 111.145 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.1 mt -94.71 92.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 74.219999999999999 111.135 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -88.1 8.83 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 110.874 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.84 69.55 7.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 75.450000000000003 110.925 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.5 t -99.25 103.48 15.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 64.450000000000003 110.878 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 p -50.09 -61.49 2.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 71.310000000000002 110.895 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -135.75 161.26 63.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.57 0.7 . . . . 73.129999999999995 110.911 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.76 -49.66 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.193 0 C-N-CA 122.676 -1.802 . . . . 73.129999999999995 112.35 0.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.9 -93.0 0.45 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 73.5 110.909 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.51 160.72 34.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 75.349999999999994 110.923 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.5 m -90.06 125.01 35.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 71.519999999999996 110.893 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.519 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -142.94 136.09 13.94 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.591 0.71 . . . . 73.209999999999994 111.116 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.78 171.08 55.46 Favored 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.689 -1.796 . . . . 64.5 112.324 -0.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -5.56 16.46 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.681 2.254 . . . . 74.209999999999994 112.337 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 mt -93.8 -69.37 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 63.130000000000003 111.169 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -153.05 115.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 111.14 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.27 -142.85 3.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 61.020000000000003 112.495 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -130.57 141.66 50.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 74.340000000000003 110.858 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.9 t -74.32 128.98 36.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 110.898 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 110.918 -179.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.813 0.34 . . . . 75.409999999999997 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm 63.83 112.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 65.310000000000002 111.155 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.49 160.78 6.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 73.129999999999995 111.088 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.62 120.24 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 73.010000000000005 110.831 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.73 35.37 19.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.904 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.63 162.92 25.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 72.230000000000004 112.473 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 151.0 45.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 74.129999999999995 110.838 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.32 149.93 40.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 65.209999999999994 110.892 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.28 -27.69 56.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 75.239999999999995 110.884 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.45 -74.65 0.37 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.739 . . . . 63.409999999999997 112.515 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -13.91 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 71.019999999999996 111.149 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.4 tt -88.5 85.69 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 72.209999999999994 111.086 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -85.6 6.71 26.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 110.898 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.06 69.27 9.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 110.907 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.8 t -106.96 103.41 12.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 50.439999999999998 110.89 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.8 m -56.03 -64.31 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 62.439999999999998 110.872 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -131.37 160.94 64.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.559 0.695 . . . . 63.140000000000001 110.878 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.71 -49.47 0.23 Allowed 'Cis proline' 0 C--O 1.231 0.155 0 C-N-CA 122.696 -1.793 . . . . 63.149999999999999 112.354 0.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.65 -93.8 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 74.129999999999995 110.937 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.18 160.73 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 75.129999999999995 110.885 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -87.32 125.3 34.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 74.209999999999994 110.861 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.512 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -143.41 137.29 14.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.581 0.705 . . . . 74.409999999999997 111.123 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.79 171.18 55.04 Favored 'Cis proline' 0 C--O 1.232 0.195 0 C-N-CA 122.691 -1.795 . . . . 73.150000000000006 112.362 -0.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -6.47 18.68 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.651 2.234 . . . . 74.430000000000007 112.33 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mt -95.37 -56.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 111.123 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -165.47 131.03 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 74.239999999999995 111.115 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.26 -139.09 4.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.752 -0.737 . . . . 74.140000000000001 112.531 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -131.64 141.39 49.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 74.519999999999996 110.851 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.3 t -74.11 128.57 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 73.120000000000005 110.863 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.477 . . . . 74.109999999999999 110.936 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.815 0.341 . . . . 73.329999999999998 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.8 mm 63.54 110.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 73.140000000000001 111.1 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.72 160.62 7.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 111.099 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -50.83 120.34 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 65.120000000000005 110.857 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.79 35.63 19.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.941 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.2 166.21 23.14 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.78 -0.724 . . . . 62.420000000000002 112.466 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 152.31 44.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 74.329999999999998 110.91 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 149.74 40.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 75.319999999999993 110.911 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -73.01 -35.38 66.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 74.420000000000002 110.875 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.14 -69.37 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 51.299999999999997 112.481 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -25.96 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.337 . . . . 75.450000000000003 111.118 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.27 95.04 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 70.109999999999999 111.125 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -88.32 9.51 23.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 74.430000000000007 110.848 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.3 69.61 6.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 64.510000000000005 110.947 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.5 t -99.46 104.75 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 71.209999999999994 110.882 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -53.24 -64.61 0.77 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 75.400000000000006 110.853 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -131.86 161.83 60.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.723 . . . . 73.319999999999993 110.845 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.78 -49.55 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.213 0 C-N-CA 122.653 -1.811 . . . . 71.140000000000001 112.364 0.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -127.85 -92.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 74.400000000000006 110.927 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.47 160.36 35.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 72.030000000000001 110.936 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -88.83 126.04 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 110.891 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 94.5 m -145.99 135.31 11.39 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 64.400000000000006 111.136 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.79 170.41 58.74 Favored 'Cis proline' 0 C--N 1.341 0.147 0 C-N-CA 122.758 -1.767 . . . . 74.239999999999995 112.313 0.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -6.47 18.68 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.702 2.268 . . . . 73.099999999999994 112.32 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 mt -92.98 -69.58 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 72.120000000000005 111.1 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -152.92 119.67 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 75.25 111.172 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.63 -141.85 3.8 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 72.329999999999998 112.468 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -130.69 141.19 50.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 74.310000000000002 110.893 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.9 t -74.52 128.85 36.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 72.209999999999994 110.893 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.9 179.983 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.796 0.331 . . . . 73.409999999999997 110.901 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.5 mm 63.45 109.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 74.200000000000003 111.136 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.49 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 70.140000000000001 111.124 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -50.85 120.34 4.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 71.129999999999995 110.862 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.85 35.63 19.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 74.099999999999994 110.949 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.44 166.79 23.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 64.510000000000005 112.478 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 152.1 44.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.352 . . . . 74.420000000000002 110.893 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 149.67 40.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 71.049999999999997 110.889 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.09 -34.57 68.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 61.0 110.869 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.66 -69.68 0.31 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 73.040000000000006 112.493 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -25.97 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 72.120000000000005 111.147 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -96.35 97.32 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.25 111.105 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -89.29 9.97 24.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 64.439999999999998 110.879 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.13 69.94 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.937 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.6 t -101.71 105.24 16.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 62.119999999999997 110.884 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.2 m -54.15 -64.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 61.549999999999997 110.903 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -129.98 161.79 57.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.589 0.709 . . . . 54.219999999999999 110.875 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.74 -49.64 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 -1.788 . . . . 75.019999999999996 112.306 0.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.88 -91.6 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 74.040000000000006 110.907 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.45 160.24 34.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 65.120000000000005 110.884 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -88.48 125.12 34.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 71.150000000000006 110.874 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.524 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 94.8 m -147.96 136.24 11.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.572 0.701 . . . . 74.109999999999999 111.113 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.6 Cg_endo -69.71 168.08 68.6 Favored 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.691 -1.796 . . . . 74.219999999999999 112.334 -0.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.29 23.21 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.628 2.218 . . . . 74.319999999999993 112.355 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 pt -116.56 83.72 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 74.439999999999998 111.106 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 61.07 103.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 111.097 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.01 -151.99 7.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 74.109999999999999 112.446 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -124.05 137.55 54.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 75.400000000000006 110.893 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.0 t -77.54 129.72 36.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 53.219999999999999 110.906 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 72.310000000000002 110.912 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.819 0.343 . . . . 73.420000000000002 110.881 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.5 mm 63.42 109.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 75.439999999999998 111.129 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.84 160.64 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 74.530000000000001 111.07 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -50.92 120.43 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 73.420000000000002 110.824 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.76 35.49 19.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 74.400000000000006 110.932 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.32 166.73 23.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.686 -0.769 . . . . 73.310000000000002 112.468 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.17 152.2 44.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 74.420000000000002 110.873 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 149.85 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.25 -28.96 61.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 74.510000000000005 110.913 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 -69.41 0.22 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 71.239999999999995 112.439 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.05 -25.46 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 70.230000000000004 111.142 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.26 96.43 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 74.329999999999998 111.126 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -88.82 9.86 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 64.450000000000003 110.855 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -80.21 69.67 6.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 74.109999999999999 110.903 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -101.56 104.98 15.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.94 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.8 m -54.6 -64.62 0.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.420000000000002 110.884 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -129.95 161.79 57.63 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 74.510000000000005 110.861 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.76 -49.44 0.23 Allowed 'Cis proline' 0 C--N 1.341 0.157 0 C-N-CA 122.695 -1.794 . . . . 73.209999999999994 112.349 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -127.72 -91.7 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 71.530000000000001 110.947 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.59 160.37 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.319999999999993 110.92 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.2 m -87.73 125.27 34.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 72.129999999999995 110.908 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.521 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 96.0 m -148.85 136.48 11.1 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.543 0.687 . . . . 64.430000000000007 111.133 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.74 167.6 70.4 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 -1.798 . . . . 74.409999999999997 112.342 -0.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -9.45 26.14 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.676 2.251 . . . . 64.420000000000002 112.375 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 4.3 pt -112.91 79.71 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 75.510000000000005 111.14 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 61.42 104.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 111.122 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -164.72 -146.51 4.79 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 71.230000000000004 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.21 137.49 52.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 75.209999999999994 110.843 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.4 t -77.45 129.56 35.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 74.209999999999994 110.88 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 74.239999999999995 110.969 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.793 0.33 . . . . 72.329999999999998 110.881 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.0 mm 63.47 110.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 64.209999999999994 111.138 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.69 160.65 7.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 72.030000000000001 111.103 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -50.77 120.46 4.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 63.340000000000003 110.82 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.87 35.68 19.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.540000000000006 110.958 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.46 165.03 23.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 61.439999999999998 112.438 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 152.23 44.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.343 . . . . 64.450000000000003 110.92 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 150.4 39.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 74.230000000000004 110.86 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -73.64 -29.92 62.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.144 -0.48 . . . . 73.239999999999995 110.871 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.82 -69.68 0.25 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 70.420000000000002 112.511 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.64 -26.04 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 72.019999999999996 111.132 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mp -95.82 95.12 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.200000000000003 111.16 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -89.34 9.77 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 71.310000000000002 110.879 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -80.24 69.91 6.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 73.530000000000001 110.899 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.6 t -101.57 105.37 16.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.909 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.4 m -53.83 -64.76 0.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 110.848 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.1 m-20 -131.0 161.82 59.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.581 0.705 . . . . 65.310000000000002 110.866 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.69 -49.75 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.694 -1.794 . . . . 62.439999999999998 112.397 -0.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.57 -92.19 0.49 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 71.099999999999994 110.961 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.61 160.35 34.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 71.329999999999998 110.871 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.79 117.46 29.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 74.519999999999996 110.871 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.532 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -139.74 139.24 21.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.608 0.718 . . . . 73.129999999999995 111.122 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.73 169.47 63.05 Favored 'Cis proline' 0 C--O 1.232 0.185 0 C-N-CA 122.66 -1.808 . . . . 72.439999999999998 112.377 -0.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -7.98 22.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.655 2.237 . . . . 71.439999999999998 112.35 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 66.3 mt -115.05 80.98 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 73.420000000000002 111.13 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp 60.6 100.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 71.219999999999999 111.1 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.74 -146.2 4.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 71.239999999999995 112.502 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -130.39 138.4 50.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.379 . . . . 71.109999999999999 110.85 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 t -76.8 128.97 35.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 74.540000000000006 110.879 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 110.905 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.813 0.339 . . . . 75.439999999999998 110.901 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.2 mm 63.77 118.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 111.131 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.38 159.82 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 74.010000000000005 111.064 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -51.28 118.24 3.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 74.219999999999999 110.866 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 60.44 35.83 20.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 75.400000000000006 110.941 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.72 167.06 31.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 35.32 112.489 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 152.64 43.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 71.549999999999997 110.943 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.07 154.88 31.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 70.140000000000001 110.865 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -72.91 -35.12 67.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.13 -69.57 0.29 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.759 -0.734 . . . . 72.25 112.514 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -26.04 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.759 0.314 . . . . 74.420000000000002 111.14 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mt -97.16 98.51 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 63.119999999999997 111.174 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -89.59 9.83 25.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 74.510000000000005 110.89 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.11 69.94 6.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 74.430000000000007 110.916 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.9 t -100.0 106.29 18.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 64.120000000000005 110.909 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.7 m -52.62 -64.91 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 110.873 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.492 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -132.66 161.43 63.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.565 0.697 . . . . 72.310000000000002 110.904 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.77 -49.83 0.21 Allowed 'Cis proline' 0 C--N 1.341 0.166 0 C-N-CA 122.685 -1.798 . . . . 74.019999999999996 112.365 0.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.31 -92.07 0.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 110.954 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.45 160.37 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.873 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -90.26 118.64 29.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 70.439999999999998 110.859 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.531 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -140.35 138.96 19.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 74.230000000000004 111.121 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.78 169.42 63.52 Favored 'Cis proline' 0 C--N 1.342 0.22 0 C-N-CA 122.665 -1.806 . . . . 70.530000000000001 112.356 -0.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -7.83 22.05 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.676 2.251 . . . . 74.129999999999995 112.351 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -115.14 80.93 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 73.400000000000006 111.145 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 60.4 100.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 74.310000000000002 111.108 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.69 -146.29 4.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 73.219999999999999 112.486 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -130.16 137.93 50.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 70.439999999999998 110.875 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.21 131.78 38.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 75.519999999999996 110.89 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 72.349999999999994 110.911 179.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.79 0.329 . . . . 74.219999999999999 110.871 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.5 mm 63.37 109.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 74.420000000000002 111.104 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.67 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 74.239999999999995 111.085 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -50.78 120.35 4.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.847 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.88 35.62 19.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 73.450000000000003 110.863 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.09 165.94 23.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 71.450000000000003 112.499 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.26 152.39 44.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.861 0.362 . . . . 74.140000000000001 110.893 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.92 149.89 40.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 60.119999999999997 110.852 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -76.39 -35.41 58.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 74.019999999999996 110.845 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.04 -69.22 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 72.129999999999995 112.531 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.72 -25.88 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.34 . . . . 75.219999999999999 111.129 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.9 mp -97.3 93.33 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 74.409999999999997 111.16 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -88.16 9.5 22.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 71.209999999999994 110.926 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -80.29 69.6 6.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 71.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.5 t -99.53 104.74 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 53.109999999999999 110.871 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.0 m -54.69 -64.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 73.349999999999994 110.897 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -130.64 161.63 59.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 72.150000000000006 110.848 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.76 -49.52 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.673 -1.803 . . . . 73.040000000000006 112.314 0.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.64 -92.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 75.299999999999997 110.887 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.09 160.12 35.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.340000000000003 110.882 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.57 126.16 35.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 64.230000000000004 110.892 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 96.0 m -145.48 135.39 11.72 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.147 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.79 170.34 59.09 Favored 'Cis proline' 0 C--N 1.341 0.153 0 C-N-CA 122.648 -1.813 . . . . 75.519999999999996 112.354 -0.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -6.67 19.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 50.409999999999997 112.333 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.9 mt -92.95 -69.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 75.150000000000006 111.147 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -152.87 120.09 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 73.140000000000001 111.145 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.13 -141.91 3.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 65.349999999999994 112.462 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -130.73 141.24 50.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.391 . . . . 75.319999999999993 110.865 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.7 t -74.4 128.66 36.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 73.230000000000004 110.9 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 74.040000000000006 110.896 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.845 0.355 . . . . 71.239999999999995 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.6 mm 63.43 109.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 111.11 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.93 160.51 7.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 72.319999999999993 111.093 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -50.8 120.4 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 73.430000000000007 110.862 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.79 35.58 19.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.961 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.21 166.69 23.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.732 -0.747 . . . . 70.120000000000005 112.451 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 152.19 44.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.795 0.331 . . . . 74.400000000000006 110.925 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.17 149.85 40.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 72.530000000000001 110.898 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.27 -35.16 61.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 74.120000000000005 110.84 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.2 -70.01 0.37 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 75.209999999999994 112.502 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -25.36 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 73.120000000000005 111.117 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.3 mt -94.66 93.75 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 75.109999999999999 111.105 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.16 9.08 24.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 75.209999999999994 110.845 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -80.86 69.46 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 73.450000000000003 110.929 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 t -99.56 104.6 16.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 72.319999999999993 110.904 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.8 m -54.62 -64.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 75.409999999999997 110.882 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -131.81 161.72 60.78 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.601 0.715 . . . . 72.409999999999997 110.888 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.79 -49.64 0.22 Allowed 'Cis proline' 0 C--O 1.232 0.179 0 C-N-CA 122.695 -1.794 . . . . 72.340000000000003 112.28 0.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.64 -92.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 71.319999999999993 110.945 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.02 160.22 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 71.0 110.902 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.49 126.28 35.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.872 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 95.5 m -145.4 135.48 11.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.561 0.696 . . . . 73.310000000000002 111.182 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.73 170.23 59.33 Favored 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.685 -1.798 . . . . 74.219999999999999 112.359 -0.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.83 19.53 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.705 2.27 . . . . 74.129999999999995 112.323 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 mt -92.68 -69.34 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 74.219999999999999 111.133 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.7 mp -152.8 119.58 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 70.530000000000001 111.113 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.68 -142.2 3.94 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.775 -0.726 . . . . 74.040000000000006 112.501 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -130.79 141.4 50.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 71.219999999999999 110.867 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.5 t -74.06 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 74.25 110.902 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 75.209999999999994 110.879 179.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.776 0.322 . . . . 71.040000000000006 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.0 mm 63.67 110.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 111.112 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.72 160.7 7.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 71.299999999999997 111.095 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -50.81 120.35 4.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 110.879 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 60.81 35.6 19.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.241 -0.436 . . . . 72.340000000000003 110.946 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.51 165.78 23.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.738 -0.744 . . . . 73.349999999999994 112.466 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 152.22 44.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 72.530000000000001 110.931 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 149.82 40.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 70.530000000000001 110.878 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.42 -33.49 67.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 73.409999999999997 110.868 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.37 -73.19 0.33 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.738 -0.744 . . . . 75.120000000000005 112.506 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -25.93 32.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.833 0.349 . . . . 64.450000000000003 111.134 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.2 mt -90.7 93.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 71.439999999999998 111.159 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -88.06 9.12 23.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 64.450000000000003 110.847 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.79 69.71 7.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.340000000000003 110.947 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -102.03 104.8 15.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.209999999999994 110.868 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.9 m -54.81 -64.54 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 73.239999999999995 110.855 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -131.21 160.97 64.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.601 0.715 . . . . 73.319999999999993 110.882 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.8 -49.72 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.701 -1.791 . . . . 72.109999999999999 112.327 0.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -128.53 -93.02 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 73.510000000000005 110.909 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.4 160.35 35.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 72.400000000000006 110.907 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.8 m -88.28 125.96 34.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.877 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 93.9 m -146.15 135.38 11.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.575 0.703 . . . . 73.319999999999993 111.144 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.79 170.34 59.08 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.687 -1.797 . . . . 70.430000000000007 112.331 -0.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -6.64 19.11 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.704 2.269 . . . . 72.230000000000004 112.32 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.5 mt -92.58 -69.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 71.219999999999999 111.108 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -153.04 119.72 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.146 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.99 -141.93 3.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.773 -0.727 . . . . 52.049999999999997 112.479 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -130.65 141.52 50.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 72.549999999999997 110.883 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.0 t -74.17 128.33 35.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 74.239999999999995 110.874 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 71.450000000000003 110.896 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.788 0.327 . . . . 70.0 110.869 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 51.9 mm 63.57 112.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 70.040000000000006 111.109 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.35 161.31 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 61.420000000000002 111.147 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -50.14 120.41 4.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 54.329999999999998 110.852 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.8 35.25 19.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.981 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.68 155.55 19.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.697 -0.763 . . . . 74.120000000000005 112.499 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.36 150.26 46.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 70.140000000000001 110.849 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.28 161.79 19.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.299999999999997 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -67.72 -32.68 73.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.409999999999997 110.856 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.13 -69.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 73.420000000000002 112.486 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -25.82 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 72.120000000000005 111.121 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -89.95 97.13 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.430000000000007 111.149 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.84 9.85 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 73.099999999999994 110.866 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -80.14 69.73 6.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 71.310000000000002 110.857 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.2 t -102.22 104.85 15.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.439999999999998 110.846 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.2 m -53.98 -64.78 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 71.409999999999997 110.871 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -131.63 161.63 61.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 63.32 110.837 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.85 -49.57 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.713 -1.786 . . . . 73.409999999999997 112.328 0.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -129.67 -91.39 0.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 72.239999999999995 110.925 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.18 160.2 34.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 73.010000000000005 110.946 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.19 119.81 32.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 110.854 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.528 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -139.25 139.56 23.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.576 0.703 . . . . 63.409999999999997 111.166 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.528 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.79 169.71 62.15 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.793 . . . . 73.230000000000004 112.359 -0.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -7.87 22.16 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 74.340000000000003 112.369 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.1 pt -114.91 83.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 71.400000000000006 111.125 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 61.28 86.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 74.120000000000005 111.114 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.39 -157.48 7.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 73.439999999999998 112.525 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.23 138.36 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.395 . . . . 75.519999999999996 110.817 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.04 129.4 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 75.25 110.874 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.885 -180.0 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.826 0.346 . . . . 74.150000000000006 110.889 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.3 mm 63.79 111.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 75.409999999999997 111.127 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.87 161.01 6.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 74.430000000000007 111.097 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -50.71 120.46 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 75.140000000000001 110.873 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.84 35.11 19.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 74.409999999999997 110.913 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.41 161.69 18.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 72.329999999999998 112.488 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 150.3 46.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.851 0.358 . . . . 73.319999999999993 110.899 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -119.53 160.84 21.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.409999999999997 110.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -69.06 -34.96 76.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 74.450000000000003 110.866 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.79 -69.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.71 -0.757 . . . . 64.109999999999999 112.493 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -25.72 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 73.329999999999998 111.19 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.5 mt -90.12 100.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 72.129999999999995 111.144 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.41 9.13 21.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 74.430000000000007 110.924 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -80.63 69.66 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 75.340000000000003 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.1 t -102.82 104.78 15.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 72.530000000000001 110.813 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.0 m -55.32 -64.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.109999999999999 110.86 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -132.83 161.46 63.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 73.219999999999999 110.864 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.75 -49.68 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 -1.805 . . . . 75.310000000000002 112.342 0.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -128.08 -91.96 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.099999999999994 110.895 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.67 160.61 33.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 72.530000000000001 110.924 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.0 t -89.94 119.46 30.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 73.219999999999999 110.843 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.535 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -141.11 138.87 18.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.56 0.695 . . . . 72.340000000000003 111.184 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.69 169.29 63.77 Favored 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.678 -1.801 . . . . 73.400000000000006 112.354 -0.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.09 22.73 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.637 2.225 . . . . 74.329999999999998 112.346 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.73 80.29 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 71.340000000000003 111.127 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 60.97 101.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 73.25 111.104 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.79 -145.75 4.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 72.099999999999994 112.467 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -130.14 137.97 50.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.946 0.403 . . . . 75.310000000000002 110.865 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.13 129.3 35.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 75.120000000000005 110.879 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 74.040000000000006 110.935 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.812 0.339 . . . . 64.040000000000006 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.6 mm 63.37 110.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 111.175 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.59 7.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 74.010000000000005 111.108 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -50.85 120.29 4.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 72.420000000000002 110.896 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.81 35.59 19.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.9 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.63 166.0 23.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 72.030000000000001 112.532 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 152.03 44.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 74.420000000000002 110.928 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.23 149.77 40.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 73.510000000000005 110.84 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -74.48 -34.9 63.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 73.400000000000006 110.848 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.42 -70.19 0.37 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 71.129999999999995 112.525 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.43 -25.43 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 75.409999999999997 111.185 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 mt -94.1 93.26 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.123 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -88.0 8.99 23.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 75.209999999999994 110.908 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -80.94 69.52 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.92 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 t -100.57 104.75 16.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 74.030000000000001 110.84 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 m -54.98 -64.43 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 110.848 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -131.54 161.37 62.59 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 55.310000000000002 110.862 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.78 -49.74 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.225 0 C-N-CA 122.674 -1.803 . . . . 72.120000000000005 112.307 0.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -128.97 -92.56 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.882 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.0 160.45 34.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 74.230000000000004 110.908 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.82 125.3 35.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.409999999999997 110.893 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -144.2 136.36 13.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.574 0.702 . . . . 71.400000000000006 111.159 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.83 170.99 56.09 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.648 -1.813 . . . . 75.129999999999995 112.346 -0.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -5.68 16.74 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 75.120000000000005 112.362 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.4 mt -93.68 -69.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 73.439999999999998 111.157 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.5 mp -153.09 115.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 74.129999999999995 111.098 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.1 -143.08 3.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 64.329999999999998 112.466 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -130.68 141.59 50.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.877 0.37 . . . . 74.5 110.911 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.2 t -73.99 128.22 34.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 73.239999999999995 110.864 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 62.229999999999997 110.953 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 13.6 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 73.209999999999994 110.878 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.5 mm 62.5 109.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 74.319999999999993 111.155 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.31 160.05 11.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 61.350000000000001 111.052 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.66 120.92 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 110.85 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 61.12 36.15 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 75.129999999999995 110.893 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.25 169.63 29.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.783 -0.723 . . . . 72.310000000000002 112.462 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 154.93 41.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.342 . . . . 73.549999999999997 110.884 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -116.06 149.75 38.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 63.229999999999997 110.89 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.55 -32.27 69.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.837 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.22 -79.38 0.29 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.737 -0.744 . . . . 75.510000000000005 112.483 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -25.11 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 70.019999999999996 111.075 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.71 101.0 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 75.340000000000003 111.145 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -86.01 9.51 16.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 75.349999999999994 110.864 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -79.83 69.56 6.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 110.925 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.12 105.44 17.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 64.230000000000004 110.841 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -50.7 -72.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 71.510000000000005 110.887 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.493 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -135.31 159.5 71.54 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.578 0.704 . . . . 74.030000000000001 110.896 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.78 -49.43 0.23 Allowed 'Cis proline' 0 C--O 1.232 0.179 0 C-N-CA 122.717 -1.784 . . . . 75.310000000000002 112.33 0.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -130.42 -91.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.879 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.59 160.27 34.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 74.239999999999995 110.935 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 23.7 p -95.42 126.44 40.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 75.400000000000006 110.848 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -136.87 140.89 33.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.569 0.7 . . . . 64.349999999999994 111.109 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.74 170.41 58.53 Favored 'Cis proline' 0 C--N 1.342 0.199 0 C-N-CA 122.694 -1.794 . . . . 63.039999999999999 112.35 -0.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -5.14 15.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.652 2.235 . . . . 74.109999999999999 112.382 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.7 mt -108.52 73.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 111.131 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.4 mp 62.13 98.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 73.230000000000004 111.167 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.05 -143.63 3.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 63.229999999999997 112.54 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -130.77 139.52 50.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.377 . . . . 64.5 110.846 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -76.27 128.71 35.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 61.310000000000002 110.887 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 72.540000000000006 110.895 179.963 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.808 0.337 . . . . 72.150000000000006 110.876 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.3 mm 63.43 110.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 71.340000000000003 111.162 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.65 160.92 6.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 111.109 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.58 120.23 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 110.857 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.75 35.44 19.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 110.91 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.09 164.71 23.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 72.430000000000007 112.47 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.3 152.33 44.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.341 . . . . 75.310000000000002 110.925 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 149.84 40.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 42.240000000000002 110.882 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -74.6 -35.16 62.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 72.519999999999996 110.864 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.35 -69.36 0.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 73.319999999999993 112.446 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.86 -25.92 30.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.784 0.326 . . . . 74.430000000000007 111.091 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -96.85 93.58 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.13 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -88.22 9.44 22.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 73.439999999999998 110.903 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -80.29 69.6 6.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 71.019999999999996 110.909 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.6 t -100.39 104.82 16.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 73.420000000000002 110.871 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.3 m -54.44 -64.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 110.875 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -130.53 161.74 58.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.602 0.715 . . . . 64.019999999999996 110.879 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.71 -49.53 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.15 0 C-N-CA 122.737 -1.776 . . . . 62.329999999999998 112.34 -0.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.49 -93.04 0.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.540000000000006 110.925 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.63 160.14 36.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 71.230000000000004 110.883 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.77 126.1 35.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 110.866 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.517 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 94.4 m -146.07 135.79 11.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.608 0.718 . . . . 75.200000000000003 111.132 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.73 170.44 58.33 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.684 -1.799 . . . . 72.25 112.345 -0.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -7.62 21.52 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 75.209999999999994 112.329 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.5 mt -93.4 -58.89 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 74.439999999999998 111.164 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -163.22 130.67 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 73.439999999999998 111.102 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.71 -139.33 4.99 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.751 -0.738 . . . . 71.239999999999995 112.508 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -131.33 140.72 49.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 74.150000000000006 110.88 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.1 t -75.29 128.51 35.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 71.230000000000004 110.875 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 74.349999999999994 110.914 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.772 0.32 . . . . 75.010000000000005 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.2 mm 63.36 110.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 73.519999999999996 111.106 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.66 160.69 6.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 75.319999999999993 111.059 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -50.62 120.42 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 75.329999999999998 110.82 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.83 35.6 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 72.450000000000003 110.922 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.27 165.23 23.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 75.25 112.498 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 152.47 44.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 74.349999999999994 110.899 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.87 149.89 40.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.888 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.12 -33.92 38.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.867 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.51 -69.26 0.39 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 70.310000000000002 112.433 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -25.88 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 75.439999999999998 111.126 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.55 90.44 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 111.127 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -88.03 9.4 22.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 73.450000000000003 110.881 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -80.33 69.61 6.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 110.942 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.9 t -99.92 104.67 16.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.857 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -54.49 -64.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 110.863 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -129.94 161.63 58.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 75.140000000000001 110.87 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.67 -49.54 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.671 -1.804 . . . . 71.349999999999994 112.373 -0.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -129.16 -91.88 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.937 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.83 160.23 35.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 63.229999999999997 110.934 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 m -91.94 125.54 36.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.9 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.526 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -142.41 137.35 15.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.612 0.72 . . . . 72.409999999999997 111.122 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.71 171.02 55.4 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.712 -1.786 . . . . 70.049999999999997 112.369 -0.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -7.02 20.01 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.695 2.264 . . . . 71.409999999999997 112.353 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.6 mt -94.89 -56.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 111.101 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -164.93 129.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 74.319999999999993 111.144 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.97 -140.76 5.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 71.230000000000004 112.485 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -131.15 140.98 50.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 75.519999999999996 110.878 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -74.56 128.95 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 62.299999999999997 110.861 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 73.040000000000006 110.956 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.83 0.348 . . . . 73.450000000000003 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.7 mm 63.26 109.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 72.140000000000001 111.122 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 161.07 11.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 71.5 111.089 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -50.13 120.46 4.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 71.540000000000006 110.871 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 60.8 36.01 19.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 73.219999999999999 110.906 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.07 164.64 20.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 74.109999999999999 112.49 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.86 154.35 41.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 73.219999999999999 110.874 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.37 149.57 39.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 75.140000000000001 110.886 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.43 -22.25 51.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.319999999999993 110.877 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.07 -77.33 0.22 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 73.340000000000003 112.509 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -25.08 29.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 63.450000000000003 111.107 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 39.4 mt -89.59 97.53 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.329999999999998 111.117 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.93 7.48 27.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 70.439999999999998 110.886 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -80.02 69.35 6.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 72.310000000000002 110.899 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.37 106.62 18.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 73.219999999999999 110.893 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -49.67 -72.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 62.530000000000001 110.865 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -135.27 160.7 67.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 71.439999999999998 110.878 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.73 -49.8 0.21 Allowed 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.716 -1.785 . . . . 74.450000000000003 112.352 -0.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -130.51 -91.53 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 75.140000000000001 110.917 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.9 160.65 33.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 73.109999999999999 110.983 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 24.4 p -94.4 126.81 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.87 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.535 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -136.34 140.96 34.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.605 0.717 . . . . 75.140000000000001 111.107 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.0 Cg_endo -69.82 170.61 57.91 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 -1.802 . . . . 71.219999999999999 112.291 -0.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -3.75 12.61 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.667 2.245 . . . . 71.329999999999998 112.365 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.3 mt -109.85 72.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 75.109999999999999 111.139 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.2 mp 62.65 99.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 63.329999999999998 111.116 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.46 -143.21 3.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.702 -0.761 . . . . 54.340000000000003 112.458 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -130.52 139.74 50.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.928 0.394 . . . . 73.510000000000005 110.886 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -76.1 129.05 36.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.86 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 71.140000000000001 110.978 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.863 0.363 . . . . 65.439999999999998 110.924 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.2 mm 63.52 111.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 111.087 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.73 160.48 7.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 75.450000000000003 111.061 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -50.98 120.26 4.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.813 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.71 35.6 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 72.329999999999998 110.909 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.52 166.37 24.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 71.430000000000007 112.518 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 152.41 44.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 74.129999999999995 110.915 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 149.96 40.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.857 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.62 -22.75 66.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 75.310000000000002 110.836 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.24 -87.84 0.42 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.671 -0.776 . . . . 71.450000000000003 112.48 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -25.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 75.140000000000001 111.12 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.54 93.52 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 74.329999999999998 111.18 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -100.51 19.69 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 74.219999999999999 110.889 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.27 70.38 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 74.299999999999997 110.9 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 p -107.53 111.0 23.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 70.25 110.865 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.2 m -39.58 -63.56 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 72.340000000000003 110.879 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.485 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.2 m-20 -128.1 162.56 49.34 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.623 0.725 . . . . 74.310000000000002 110.803 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.5 Cg_endo -69.78 -50.92 0.17 OUTLIER 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.712 -1.787 . . . . 73.0 112.312 0.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -130.47 -93.8 0.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.923 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.88 161.34 28.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 75.400000000000006 110.897 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.1 m -85.63 125.97 33.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 52.130000000000003 110.891 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.528 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -153.2 138.23 11.35 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.586 0.707 . . . . 73.439999999999998 111.18 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.528 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.72 169.38 63.47 Favored 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 -1.79 . . . . 71.140000000000001 112.331 -0.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -8.4 23.52 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 61.310000000000002 112.34 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.18 92.18 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 75.540000000000006 111.132 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 50.19 85.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.299999999999997 111.109 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.51 -152.24 5.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.741 -0.742 . . . . 75.409999999999997 112.481 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -130.88 140.72 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 73.519999999999996 110.861 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 4.1 t -74.1 126.47 30.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 74.310000000000002 110.876 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 110.904 179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.852 0.358 . . . . 63.329999999999998 110.935 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 39.8 mm 63.45 110.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 63.439999999999998 111.153 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.59 7.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 72.439999999999998 111.081 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -50.93 120.28 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 110.843 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.85 35.69 19.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.914 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.18 166.58 23.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 74.230000000000004 112.492 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 151.92 44.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.773 0.32 . . . . 73.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 149.71 40.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 71.349999999999994 110.857 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -74.02 -35.42 64.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.0 110.87 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.02 -69.38 0.34 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 73.200000000000003 112.478 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -25.86 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 73.319999999999993 111.168 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.67 94.78 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 74.25 111.108 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -88.16 9.45 22.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 71.030000000000001 110.899 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -80.4 69.56 6.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 75.400000000000006 110.888 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.5 t -101.2 104.82 15.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 73.340000000000003 110.884 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.9 m -53.39 -64.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 72.140000000000001 110.845 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.486 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -131.89 161.71 60.93 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.602 0.715 . . . . 73.140000000000001 110.867 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.84 -49.52 0.23 Allowed 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 -1.805 . . . . 72.420000000000002 112.331 0.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -128.23 -92.93 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 75.299999999999997 110.884 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.51 160.45 35.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 71.549999999999997 110.863 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.4 m -90.13 125.18 35.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 71.040000000000006 110.877 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.517 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -143.33 136.64 14.03 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.594 0.712 . . . . 54.229999999999997 111.128 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.8 170.63 57.71 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.617 -1.826 . . . . 74.099999999999994 112.352 -0.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 2.32 3.66 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.703 2.269 . . . . 72.430000000000007 112.314 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -107.65 -65.56 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 71.439999999999998 111.099 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.2 mp -148.36 123.93 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 111.141 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.409 ' HA3' ' HD2' ' A' ' 23' ' ' PRO . . . 176.93 -147.08 8.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 72.230000000000004 112.487 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -130.94 142.19 50.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 73.200000000000003 110.922 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.8 t -73.15 128.27 34.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 55.210000000000001 110.909 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 75.239999999999995 110.88 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.845 0.355 . . . . 72.209999999999994 110.883 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.2 mm 65.01 115.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 111.075 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.73 7.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 74.219999999999999 111.071 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.81 120.3 4.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 73.010000000000005 110.86 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.74 35.26 19.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 74.450000000000003 110.914 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.42 170.19 24.28 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 73.049999999999997 112.508 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.92 152.85 44.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 72.530000000000001 110.924 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.1 156.73 28.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 62.450000000000003 110.888 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.24 -28.55 38.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 75.099999999999994 110.894 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.19 -69.58 0.21 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 74.409999999999997 112.487 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -26.09 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 74.109999999999999 111.156 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.89 99.97 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 71.230000000000004 111.148 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -89.01 9.65 24.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 63.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -80.24 69.83 6.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 73.140000000000001 110.947 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.0 t -103.97 103.51 13.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 71.430000000000007 110.862 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 p -49.75 -62.17 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 71.349999999999994 110.841 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.497 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -136.34 160.94 64.94 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.573 0.701 . . . . 71.25 110.893 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.77 -50.23 0.2 OUTLIER 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.662 -1.807 . . . . 74.049999999999997 112.388 0.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -130.6 -93.81 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 110.952 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.84 160.94 35.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 72.549999999999997 110.926 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.8 m -84.0 125.65 32.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 71.239999999999995 110.861 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.534 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 95.9 m -145.94 136.86 12.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.573 0.701 . . . . 64.200000000000003 111.131 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.534 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.72 162.31 84.27 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.792 . . . . 71.010000000000005 112.337 -0.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 54.59 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.241 . . . . 73.010000000000005 112.351 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -172.39 86.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 75.239999999999995 111.127 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp 50.34 83.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 73.5 111.125 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -145.7 -140.22 3.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 75.129999999999995 112.487 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -130.82 137.59 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 73.140000000000001 110.867 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 t -77.29 128.43 34.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 74.510000000000005 110.876 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 73.299999999999997 110.895 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.756 0.312 . . . . 75.140000000000001 110.868 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.5 mm 64.62 114.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 74.310000000000002 111.157 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.84 160.51 7.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 41.030000000000001 111.107 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -50.79 120.48 4.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 75.230000000000004 110.835 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.85 35.63 19.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 110.905 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.53 167.1 24.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 74.239999999999995 112.45 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 152.01 44.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 72.120000000000005 110.877 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 149.9 40.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 73.040000000000006 110.827 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -72.59 -35.17 67.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 70.230000000000004 110.885 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.32 -69.88 0.37 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 74.230000000000004 112.505 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -26.67 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.78 0.324 . . . . 71.540000000000006 111.145 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.1 mt -94.71 92.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 74.219999999999999 111.135 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -88.1 8.83 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 110.874 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.84 69.55 7.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 75.450000000000003 110.925 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.5 t -99.25 103.48 15.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 64.450000000000003 110.878 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 p -50.09 -61.49 2.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 71.310000000000002 110.895 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -135.75 161.26 63.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.57 0.7 . . . . 73.129999999999995 110.911 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.76 -49.66 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.193 0 C-N-CA 122.676 -1.802 . . . . 73.129999999999995 112.35 0.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.9 -93.0 0.45 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 73.5 110.909 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.51 160.72 34.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 75.349999999999994 110.923 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.5 m -90.06 125.01 35.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 71.519999999999996 110.893 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.519 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -142.94 136.09 13.94 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.591 0.71 . . . . 73.209999999999994 111.116 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.78 171.08 55.46 Favored 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.689 -1.796 . . . . 64.5 112.324 -0.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -5.56 16.46 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.681 2.254 . . . . 74.209999999999994 112.337 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 mt -93.8 -69.37 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 63.130000000000003 111.169 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.6 mp -153.05 115.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 111.14 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.27 -142.85 3.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 61.020000000000003 112.495 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -130.57 141.66 50.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 74.340000000000003 110.858 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.9 t -74.32 128.98 36.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 110.898 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.230000000000004 110.918 -179.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.813 0.34 . . . . 75.409999999999997 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm 63.83 112.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 65.310000000000002 111.155 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.49 160.78 6.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 73.129999999999995 111.088 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.62 120.24 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 73.010000000000005 110.831 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.73 35.37 19.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.904 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.63 162.92 25.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 72.230000000000004 112.473 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 151.0 45.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 74.129999999999995 110.838 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.32 149.93 40.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 65.209999999999994 110.892 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.28 -27.69 56.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 75.239999999999995 110.884 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.45 -74.65 0.37 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.739 . . . . 63.409999999999997 112.515 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -13.91 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 71.019999999999996 111.149 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.4 tt -88.5 85.69 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 72.209999999999994 111.086 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -85.6 6.71 26.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 110.898 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.06 69.27 9.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 110.907 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.8 t -106.96 103.41 12.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 50.439999999999998 110.89 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.8 m -56.03 -64.31 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 62.439999999999998 110.872 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -131.37 160.94 64.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.559 0.695 . . . . 63.140000000000001 110.878 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.71 -49.47 0.23 Allowed 'Cis proline' 0 C--O 1.231 0.155 0 C-N-CA 122.696 -1.793 . . . . 63.149999999999999 112.354 0.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.65 -93.8 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 74.129999999999995 110.937 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.18 160.73 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 75.129999999999995 110.885 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -87.32 125.3 34.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 74.209999999999994 110.861 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.512 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -143.41 137.29 14.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.581 0.705 . . . . 74.409999999999997 111.123 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.79 171.18 55.04 Favored 'Cis proline' 0 C--O 1.232 0.195 0 C-N-CA 122.691 -1.795 . . . . 73.150000000000006 112.362 -0.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -6.47 18.68 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.651 2.234 . . . . 74.430000000000007 112.33 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mt -95.37 -56.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 111.123 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -165.47 131.03 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 74.239999999999995 111.115 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.26 -139.09 4.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.752 -0.737 . . . . 74.140000000000001 112.531 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -131.64 141.39 49.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 74.519999999999996 110.851 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.3 t -74.11 128.57 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 73.120000000000005 110.863 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.477 . . . . 74.109999999999999 110.936 179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.815 0.341 . . . . 73.329999999999998 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 7' ' ' LYS . 40.8 mm 63.54 110.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 51.140000000000001 111.1 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.72 160.62 7.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 111.099 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -50.83 120.34 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 65.120000000000005 110.857 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.79 35.63 19.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.941 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.2 166.21 23.14 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.78 -0.724 . . . . 31.550000000000001 112.466 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.468 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.21 152.31 44.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 74.329999999999998 110.91 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 149.74 40.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.310000000000002 110.911 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -73.01 -35.38 66.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 74.409999999999997 110.875 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.14 -69.37 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 51.299999999999997 112.481 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -25.96 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.337 . . . . 60.140000000000001 111.118 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.27 95.04 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 70.109999999999999 111.125 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -88.32 9.51 23.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 74.430000000000007 110.848 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.3 69.61 6.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 34.119999999999997 110.947 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.5 t -99.46 104.75 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 54.119999999999997 110.882 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -53.24 -64.61 0.77 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 60.43 110.853 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -131.86 161.83 60.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.723 . . . . 73.319999999999993 110.845 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.78 -49.55 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.213 0 C-N-CA 122.653 -1.811 . . . . 71.140000000000001 112.364 0.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -127.85 -92.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 72.230000000000004 110.927 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.47 160.36 35.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 72.030000000000001 110.936 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -88.83 126.04 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 64.340000000000003 110.891 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.568 HG23 ' HA ' ' A' ' 23' ' ' PRO . 94.5 m -145.99 135.31 11.39 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 64.400000000000006 111.136 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.79 170.41 58.74 Favored 'Cis proline' 0 C--N 1.341 0.147 0 C-N-CA 122.758 -1.767 . . . . 74.239999999999995 112.313 0.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -6.47 18.68 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.702 2.268 . . . . 61.439999999999998 112.32 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 1.042 HG22 HD12 ' A' ' 26' ' ' ILE . 14.7 mt -92.98 -69.58 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 51.409999999999997 111.1 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.042 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -152.92 119.67 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.129999999999995 111.172 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.63 -141.85 3.8 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 72.329999999999998 112.468 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -130.69 141.19 50.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 73.439999999999998 110.893 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.9 t -74.52 128.85 36.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 72.209999999999994 110.893 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.5 pp . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.9 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.796 0.331 . . . . 73.409999999999997 110.901 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 7' ' ' LYS . 44.5 mm 63.45 109.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 52.25 111.136 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.49 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 70.140000000000001 111.124 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -50.85 120.34 4.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 71.129999999999995 110.862 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.85 35.63 19.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 74.099999999999994 110.949 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.44 166.79 23.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 54.130000000000003 112.478 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.1 152.1 44.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.352 . . . . 65.299999999999997 110.893 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 149.67 40.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 71.049999999999997 110.889 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.09 -34.57 68.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 52.439999999999998 110.869 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.66 -69.68 0.31 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 73.040000000000006 112.493 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -25.97 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 72.120000000000005 111.147 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -96.35 97.32 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 63.5 111.105 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -89.29 9.97 24.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 64.439999999999998 110.879 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.13 69.94 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.937 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.6 t -101.71 105.24 16.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 62.119999999999997 110.884 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.2 m -54.15 -64.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 54.030000000000001 110.903 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -129.98 161.79 57.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.589 0.709 . . . . 52.140000000000001 110.875 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.74 -49.64 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 -1.788 . . . . 74.129999999999995 112.306 0.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.88 -91.6 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 65.140000000000001 110.907 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -130.45 160.24 34.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 54.030000000000001 110.884 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -88.48 125.12 34.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 64.239999999999995 110.874 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.585 HG23 ' HA ' ' A' ' 23' ' ' PRO . 94.8 m -147.96 136.24 11.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.572 0.701 . . . . 70.140000000000001 111.113 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.585 ' HA ' HG23 ' A' ' 22' ' ' THR . 54.6 Cg_endo -69.71 168.08 68.6 Favored 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.691 -1.796 . . . . 74.219999999999999 112.334 -0.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.29 23.21 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.628 2.218 . . . . 74.319999999999993 112.355 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 26' ' ' ILE . 3.3 pt -116.56 83.72 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 64.329999999999998 111.106 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.3 mp 61.07 103.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 111.097 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.01 -151.99 7.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 64.340000000000003 112.446 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.542 ' O ' HD12 ' A' ' 30' ' ' LEU . 88.5 m-85 -124.05 137.55 54.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 75.400000000000006 110.893 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.0 t -77.54 129.72 36.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 53.219999999999999 110.906 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 28' ' ' PHE . 4.6 mp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 72.310000000000002 110.912 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.819 0.343 . . . . 72.209999999999994 110.881 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 7' ' ' LYS . 41.5 mm 63.42 109.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 111.129 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.84 160.64 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 74.530000000000001 111.07 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -50.92 120.43 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 73.150000000000006 110.824 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.76 35.49 19.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 74.0 110.932 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.32 166.73 23.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.686 -0.769 . . . . 73.310000000000002 112.468 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.17 152.2 44.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 74.420000000000002 110.873 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 149.85 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 65.049999999999997 110.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.25 -28.96 61.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 110.913 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 -69.41 0.22 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 71.239999999999995 112.439 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.05 -25.46 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 63.409999999999997 111.142 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.26 96.43 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 71.129999999999995 111.126 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -88.82 9.86 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 60.020000000000003 110.855 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -80.21 69.67 6.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 74.109999999999999 110.903 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -101.56 104.98 15.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.94 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.8 m -54.6 -64.62 0.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.420000000000002 110.884 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -129.95 161.79 57.63 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 74.510000000000005 110.861 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.76 -49.44 0.23 Allowed 'Cis proline' 0 C--N 1.341 0.157 0 C-N-CA 122.695 -1.794 . . . . 63.240000000000002 112.349 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -127.72 -91.7 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 71.530000000000001 110.947 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -130.59 160.37 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.319999999999993 110.92 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.2 m -87.73 125.27 34.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 54.530000000000001 110.908 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.6 HG23 ' HA ' ' A' ' 23' ' ' PRO . 96.0 m -148.85 136.48 11.1 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.543 0.687 . . . . 63.43 111.133 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.6 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.74 167.6 70.4 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 -1.798 . . . . 74.409999999999997 112.342 -0.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -9.45 26.14 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.676 2.251 . . . . 54.119999999999997 112.375 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.458 ' C ' HD12 ' A' ' 26' ' ' ILE . 4.3 pt -112.91 79.71 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 75.510000000000005 111.14 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.3 mp 61.42 104.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 72.329999999999998 111.122 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -164.72 -146.51 4.79 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 61.140000000000001 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.21 137.49 52.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 75.209999999999994 110.843 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.4 t -77.45 129.56 35.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 74.209999999999994 110.88 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 74.099999999999994 110.969 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.793 0.33 . . . . 72.329999999999998 110.881 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 7' ' ' LYS . 47.0 mm 63.47 110.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 63.439999999999998 111.138 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.69 160.65 7.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 51.409999999999997 111.103 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -50.77 120.46 4.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 63.340000000000003 110.82 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.87 35.68 19.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.540000000000006 110.958 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.46 165.03 23.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 42.229999999999997 112.438 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.16 152.23 44.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.343 . . . . 64.450000000000003 110.92 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 150.4 39.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 74.230000000000004 110.86 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.499 ' HB3' HD12 ' A' ' 12' ' ' ILE . 26.1 t0 -73.64 -29.92 62.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.144 -0.48 . . . . 71.230000000000004 110.871 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.82 -69.68 0.25 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 70.420000000000002 112.511 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.64 -26.04 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 71.340000000000003 111.132 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.499 HD12 ' HB3' ' A' ' 9' ' ' ASP . 2.5 mp -95.82 95.12 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 111.16 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -89.34 9.77 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 71.310000000000002 110.879 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -80.24 69.91 6.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 73.530000000000001 110.899 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.6 t -101.57 105.37 16.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.909 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.4 m -53.83 -64.76 0.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 110.848 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.1 m-20 -131.0 161.82 59.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.581 0.705 . . . . 64.340000000000003 110.866 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.69 -49.75 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.694 -1.794 . . . . 52.119999999999997 112.397 -0.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.57 -92.19 0.49 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 71.099999999999994 110.961 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -130.61 160.35 34.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 71.329999999999998 110.871 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.79 117.46 29.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 74.519999999999996 110.871 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.539 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -139.74 139.24 21.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.608 0.718 . . . . 71.340000000000003 111.122 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.73 169.47 63.05 Favored 'Cis proline' 0 C--O 1.232 0.185 0 C-N-CA 122.66 -1.808 . . . . 72.439999999999998 112.377 -0.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -7.98 22.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.655 2.237 . . . . 71.439999999999998 112.35 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.403 ' C ' HD12 ' A' ' 26' ' ' ILE . 66.3 mt -115.05 80.98 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 61.109999999999999 111.13 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.2 mp 60.6 100.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 71.219999999999999 111.1 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.74 -146.2 4.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 71.239999999999995 112.502 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -130.39 138.4 50.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.379 . . . . 65.420000000000002 110.85 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 t -76.8 128.97 35.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 72.310000000000002 110.879 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 51.200000000000003 110.905 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.813 0.339 . . . . 75.439999999999998 110.901 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.2 mm 63.77 118.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 111.131 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.38 159.82 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 64.310000000000002 111.064 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -51.28 118.24 3.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 74.219999999999999 110.866 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 60.44 35.83 20.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 75.400000000000006 110.941 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.72 167.06 31.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 32.310000000000002 112.489 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 152.64 43.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 71.549999999999997 110.943 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.07 154.88 31.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 70.140000000000001 110.865 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -72.91 -35.12 67.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.13 -69.57 0.29 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.759 -0.734 . . . . 72.25 112.514 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -26.04 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.759 0.314 . . . . 54.299999999999997 111.14 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mt -97.16 98.51 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 63.119999999999997 111.174 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -89.59 9.83 25.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 63.229999999999997 110.89 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.11 69.94 6.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 73.340000000000003 110.916 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.9 t -100.0 106.29 18.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 61.130000000000003 110.909 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.7 m -52.62 -64.91 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 110.873 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.504 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -132.66 161.43 63.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.565 0.697 . . . . 72.310000000000002 110.904 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.77 -49.83 0.21 Allowed 'Cis proline' 0 C--N 1.341 0.166 0 C-N-CA 122.685 -1.798 . . . . 63.439999999999998 112.365 0.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.31 -92.07 0.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 73.049999999999997 110.954 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -130.45 160.37 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.873 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -90.26 118.64 29.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 70.439999999999998 110.859 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -140.35 138.96 19.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 64.239999999999995 111.121 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.78 169.42 63.52 Favored 'Cis proline' 0 C--N 1.342 0.22 0 C-N-CA 122.665 -1.806 . . . . 65.0 112.356 -0.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -7.83 22.05 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.676 2.251 . . . . 43.409999999999997 112.351 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -115.14 80.93 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 73.400000000000006 111.145 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 60.4 100.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.040000000000006 111.108 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.69 -146.29 4.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 73.219999999999999 112.486 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -130.16 137.93 50.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 70.439999999999998 110.875 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.21 131.78 38.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 75.519999999999996 110.89 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 30' ' ' LEU . 2.8 pp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 61.43 110.911 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.79 0.329 . . . . 72.239999999999995 110.871 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 7' ' ' LYS . 40.5 mm 63.37 109.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 73.510000000000005 111.104 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.67 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 74.239999999999995 111.085 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -50.78 120.35 4.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 54.43 110.847 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.88 35.62 19.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 73.450000000000003 110.863 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.09 165.94 23.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 43.310000000000002 112.499 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.26 152.39 44.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.861 0.362 . . . . 73.219999999999999 110.893 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.92 149.89 40.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 60.119999999999997 110.852 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -76.39 -35.41 58.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 74.019999999999996 110.845 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.04 -69.22 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 65.540000000000006 112.531 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.72 -25.88 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.34 . . . . 63.219999999999999 111.129 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.9 mp -97.3 93.33 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 74.409999999999997 111.16 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -88.16 9.5 22.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 70.239999999999995 110.926 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -80.29 69.6 6.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 71.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.5 t -99.53 104.74 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 43.140000000000001 110.871 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.0 m -54.69 -64.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 60.539999999999999 110.897 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -130.64 161.63 59.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 72.150000000000006 110.848 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.76 -49.52 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.673 -1.803 . . . . 62.25 112.314 0.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.64 -92.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 75.299999999999997 110.887 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.09 160.12 35.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.340000000000003 110.882 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.57 126.16 35.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 64.230000000000004 110.892 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 23' ' ' PRO . 96.0 m -145.48 135.39 11.72 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.147 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.575 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.79 170.34 59.09 Favored 'Cis proline' 0 C--N 1.341 0.153 0 C-N-CA 122.648 -1.813 . . . . 74.409999999999997 112.354 -0.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -6.67 19.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 50.409999999999997 112.333 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 1.066 HG22 HD12 ' A' ' 26' ' ' ILE . 12.9 mt -92.95 -69.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 73.140000000000001 111.147 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.066 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -152.87 120.09 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 41.299999999999997 111.145 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.13 -141.91 3.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 65.349999999999994 112.462 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -130.73 141.24 50.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.391 . . . . 62.210000000000001 110.865 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.7 t -74.4 128.66 36.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 73.230000000000004 110.9 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 64.120000000000005 110.896 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.845 0.355 . . . . 63.310000000000002 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 7' ' ' LYS . 39.6 mm 63.43 109.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 111.11 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.93 160.51 7.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 61.409999999999997 111.093 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -50.8 120.4 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 73.0 110.862 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.79 35.58 19.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 74.120000000000005 110.961 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.21 166.69 23.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.732 -0.747 . . . . 70.120000000000005 112.451 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.27 152.19 44.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.795 0.331 . . . . 74.400000000000006 110.925 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.17 149.85 40.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 110.898 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.479 ' OD2' HD12 ' A' ' 12' ' ' ILE . 7.2 m-20 -75.27 -35.16 61.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 74.120000000000005 110.84 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.2 -70.01 0.37 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 75.209999999999994 112.502 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -25.36 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 73.120000000000005 111.117 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.479 HD12 ' OD2' ' A' ' 9' ' ' ASP . 8.3 mt -94.66 93.75 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 65.219999999999999 111.105 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.16 9.08 24.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 75.209999999999994 110.845 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -80.86 69.46 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 71.409999999999997 110.929 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 t -99.56 104.6 16.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 72.319999999999993 110.904 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.8 m -54.62 -64.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 70.209999999999994 110.882 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -131.81 161.72 60.78 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.601 0.715 . . . . 72.319999999999993 110.888 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.79 -49.64 0.22 Allowed 'Cis proline' 0 C--O 1.232 0.179 0 C-N-CA 122.695 -1.794 . . . . 72.340000000000003 112.28 0.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.64 -92.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 71.319999999999993 110.945 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.02 160.22 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 54.420000000000002 110.902 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.49 126.28 35.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.872 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 23' ' ' PRO . 95.5 m -145.4 135.48 11.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.561 0.696 . . . . 73.310000000000002 111.182 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.73 170.23 59.33 Favored 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.685 -1.798 . . . . 74.219999999999999 112.359 -0.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.83 19.53 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.705 2.27 . . . . 54.539999999999999 112.323 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 1.07 HG22 HD12 ' A' ' 26' ' ' ILE . 11.9 mt -92.68 -69.34 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 74.219999999999999 111.133 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.07 HD12 HG22 ' A' ' 25' ' ' ILE . 2.7 mp -152.8 119.58 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 61.030000000000001 111.113 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.68 -142.2 3.94 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.775 -0.726 . . . . 74.040000000000006 112.501 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -130.79 141.4 50.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 70.219999999999999 110.867 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.5 t -74.06 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 73.310000000000002 110.902 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 30' ' ' LEU . 1.7 pt? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 75.209999999999994 110.879 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.776 0.322 . . . . 63.229999999999997 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 7' ' ' LYS . 48.0 mm 63.67 110.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 73.25 111.112 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.72 160.7 7.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 71.299999999999997 111.095 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -50.81 120.35 4.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 73.049999999999997 110.879 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 60.81 35.6 19.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.241 -0.436 . . . . 72.340000000000003 110.946 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.51 165.78 23.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.738 -0.744 . . . . 73.349999999999994 112.466 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.403 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.22 152.22 44.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 62.329999999999998 110.931 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 149.82 40.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 42.329999999999998 110.878 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.42 -33.49 67.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 70.420000000000002 110.868 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.37 -73.19 0.33 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.738 -0.744 . . . . 75.120000000000005 112.506 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -25.93 32.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.833 0.349 . . . . 64.450000000000003 111.134 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.2 mt -90.7 93.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 62.43 111.159 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -88.06 9.12 23.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 64.209999999999994 110.847 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.79 69.71 7.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.340000000000003 110.947 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -102.03 104.8 15.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.209999999999994 110.868 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.9 m -54.81 -64.54 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 51.420000000000002 110.855 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -131.21 160.97 64.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.601 0.715 . . . . 63.340000000000003 110.882 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.8 -49.72 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.701 -1.791 . . . . 72.109999999999999 112.327 0.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -128.53 -93.02 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 73.510000000000005 110.909 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.4 160.35 35.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 72.400000000000006 110.907 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.8 m -88.28 125.96 34.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.877 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 23' ' ' PRO . 93.9 m -146.15 135.38 11.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.575 0.703 . . . . 73.319999999999993 111.144 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.564 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.79 170.34 59.08 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.687 -1.797 . . . . 70.430000000000007 112.331 -0.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -6.64 19.11 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.704 2.269 . . . . 72.230000000000004 112.32 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 1.044 HG22 HD12 ' A' ' 26' ' ' ILE . 14.5 mt -92.58 -69.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 71.219999999999999 111.108 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.044 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -153.04 119.72 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.146 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.99 -141.93 3.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.773 -0.727 . . . . 32.299999999999997 112.479 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -130.65 141.52 50.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 71.219999999999999 110.883 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.0 t -74.17 128.33 35.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 74.239999999999995 110.874 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 71.450000000000003 110.896 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.788 0.327 . . . . 70.0 110.869 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 7' ' ' LYS . 51.9 mm 63.57 112.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 70.040000000000006 111.109 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.35 161.31 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 52.109999999999999 111.147 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -50.14 120.41 4.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 43.130000000000003 110.852 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.8 35.25 19.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 73.340000000000003 110.981 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.68 155.55 19.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.697 -0.763 . . . . 74.120000000000005 112.499 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' NZ ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -70.36 150.26 46.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 70.140000000000001 110.849 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.28 161.79 19.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.299999999999997 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.579 ' HB3' HD12 ' A' ' 12' ' ' ILE . 26.9 t70 -67.72 -32.68 73.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.409999999999997 110.856 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.13 -69.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 73.420000000000002 112.486 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -25.82 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 72.120000000000005 111.121 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 9' ' ' ASP . 2.7 mp -89.95 97.13 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.430000000000007 111.149 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -88.84 9.85 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 50.329999999999998 110.866 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -80.14 69.73 6.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 71.310000000000002 110.857 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.2 t -102.22 104.85 15.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.439999999999998 110.846 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.2 m -53.98 -64.78 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 71.409999999999997 110.871 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -131.63 161.63 61.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 63.32 110.837 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.85 -49.57 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.713 -1.786 . . . . 64.340000000000003 112.328 0.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -129.67 -91.39 0.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 72.239999999999995 110.925 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.18 160.2 34.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 61.5 110.946 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.19 119.81 32.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 61.420000000000002 110.854 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -139.25 139.56 23.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.576 0.703 . . . . 63.409999999999997 111.166 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.79 169.71 62.15 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.793 . . . . 70.450000000000003 112.359 -0.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -7.87 22.16 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 64.109999999999999 112.369 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.412 ' C ' HD12 ' A' ' 26' ' ' ILE . 6.1 pt -114.91 83.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 71.400000000000006 111.125 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.487 HG23 ' NZ ' ' A' ' 7' ' ' LYS . 5.3 mp 61.28 86.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 51.450000000000003 111.114 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.39 -157.48 7.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 53.340000000000003 112.525 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.23 138.36 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.395 . . . . 64.340000000000003 110.817 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.04 129.4 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 75.25 110.874 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.885 -180.0 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.826 0.346 . . . . 71.200000000000003 110.889 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 7' ' ' LYS . 49.3 mm 63.79 111.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 75.409999999999997 111.127 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.87 161.01 6.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 74.430000000000007 111.097 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -50.71 120.46 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 75.140000000000001 110.873 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.84 35.11 19.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 64.439999999999998 110.913 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.41 161.69 18.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 44.439999999999998 112.488 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.3 150.3 46.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.851 0.358 . . . . 64.219999999999999 110.899 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -119.53 160.84 21.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 52.210000000000001 110.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -69.06 -34.96 76.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 60.32 110.866 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.79 -69.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.71 -0.757 . . . . 64.109999999999999 112.493 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -25.72 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 70.099999999999994 111.19 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.5 mt -90.12 100.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 72.129999999999995 111.144 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.41 9.13 21.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 73.319999999999993 110.924 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -80.63 69.66 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 75.340000000000003 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.1 t -102.82 104.78 15.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 52.219999999999999 110.813 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.0 m -55.32 -64.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.109999999999999 110.86 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -132.83 161.46 63.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 73.219999999999999 110.864 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.75 -49.68 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 -1.805 . . . . 64.219999999999999 112.342 0.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -128.08 -91.96 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.099999999999994 110.895 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -130.67 160.61 33.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 72.530000000000001 110.924 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.0 t -89.94 119.46 30.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 73.219999999999999 110.843 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.541 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -141.11 138.87 18.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.56 0.695 . . . . 72.340000000000003 111.184 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.69 169.29 63.77 Favored 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.678 -1.801 . . . . 64.319999999999993 112.354 -0.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.09 22.73 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.637 2.225 . . . . 74.329999999999998 112.346 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.42 ' C ' HD12 ' A' ' 26' ' ' ILE . 68.1 mt -114.73 80.29 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 62.109999999999999 111.127 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.469 HG23 ' NZ ' ' A' ' 7' ' ' LYS . 5.3 mp 60.97 101.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 65.329999999999998 111.104 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.79 -145.75 4.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 72.099999999999994 112.467 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -130.14 137.97 50.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.946 0.403 . . . . 75.310000000000002 110.865 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.13 129.3 35.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 54.399999999999999 110.879 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 62.399999999999999 110.935 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.812 0.339 . . . . 64.040000000000006 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 7' ' ' LYS . 41.6 mm 63.37 110.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 111.175 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.59 7.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 74.010000000000005 111.108 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -50.85 120.29 4.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 72.420000000000002 110.896 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.81 35.59 19.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.9 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.63 166.0 23.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 72.030000000000001 112.532 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.27 152.03 44.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 63.219999999999999 110.928 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.23 149.77 40.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 73.510000000000005 110.84 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -74.48 -34.9 63.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 73.400000000000006 110.848 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.42 -70.19 0.37 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 71.129999999999995 112.525 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.43 -25.43 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 75.400000000000006 111.185 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 mt -94.1 93.26 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.123 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -88.0 8.99 23.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.409999999999997 110.908 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -80.94 69.52 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 72.439999999999998 110.92 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 t -100.57 104.75 16.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 74.030000000000001 110.84 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 m -54.98 -64.43 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 110.848 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -131.54 161.37 62.59 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 55.119999999999997 110.862 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.78 -49.74 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.225 0 C-N-CA 122.674 -1.803 . . . . 72.120000000000005 112.307 0.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -128.97 -92.56 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.882 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -131.0 160.45 34.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 74.230000000000004 110.908 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.82 125.3 35.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 62.350000000000001 110.893 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.522 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -144.2 136.36 13.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.574 0.702 . . . . 64.340000000000003 111.159 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.83 170.99 56.09 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.648 -1.813 . . . . 75.129999999999995 112.346 -0.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -5.68 16.74 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 75.120000000000005 112.362 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 1.055 HG22 HD12 ' A' ' 26' ' ' ILE . 14.4 mt -93.68 -69.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 73.439999999999998 111.157 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.055 HD12 HG22 ' A' ' 25' ' ' ILE . 2.5 mp -153.09 115.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 74.129999999999995 111.098 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.1 -143.08 3.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 53.109999999999999 112.466 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -130.68 141.59 50.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.877 0.37 . . . . 74.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.2 t -73.99 128.22 34.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 73.239999999999995 110.864 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 62.229999999999997 110.953 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 13.6 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 73.209999999999994 110.878 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.5 mm 62.5 109.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 72.450000000000003 111.155 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.31 160.05 11.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 61.350000000000001 111.052 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.66 120.92 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 72.120000000000005 110.85 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 61.12 36.15 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 71.140000000000001 110.893 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.25 169.63 29.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.783 -0.723 . . . . 72.310000000000002 112.462 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 154.93 41.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.342 . . . . 73.549999999999997 110.884 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -116.06 149.75 38.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 43.530000000000001 110.89 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.55 -32.27 69.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.837 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.22 -79.38 0.29 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.737 -0.744 . . . . 75.510000000000005 112.483 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -25.11 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 70.019999999999996 111.075 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.71 101.0 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 53.140000000000001 111.145 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -86.01 9.51 16.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 73.439999999999998 110.864 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -79.83 69.56 6.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 110.925 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.12 105.44 17.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 64.230000000000004 110.841 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -50.7 -72.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 71.510000000000005 110.887 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -135.31 159.5 71.54 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.578 0.704 . . . . 74.030000000000001 110.896 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.78 -49.43 0.23 Allowed 'Cis proline' 0 C--O 1.232 0.179 0 C-N-CA 122.717 -1.784 . . . . 74.409999999999997 112.33 0.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -130.42 -91.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.879 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.59 160.27 34.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 74.239999999999995 110.935 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 23.7 p -95.42 126.44 40.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 63.5 110.848 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.543 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -136.87 140.89 33.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.569 0.7 . . . . 64.349999999999994 111.109 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.74 170.41 58.53 Favored 'Cis proline' 0 C--N 1.342 0.199 0 C-N-CA 122.694 -1.794 . . . . 63.020000000000003 112.35 -0.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -5.14 15.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.652 2.235 . . . . 64.530000000000001 112.382 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.473 ' C ' HD12 ' A' ' 26' ' ' ILE . 33.7 mt -108.52 73.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 53.130000000000003 111.131 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.473 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.4 mp 62.13 98.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 61.450000000000003 111.167 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.05 -143.63 3.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 63.229999999999997 112.54 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -130.77 139.52 50.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.377 . . . . 64.5 110.846 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -76.27 128.71 35.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 53.210000000000001 110.887 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 61.240000000000002 110.895 179.963 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.808 0.337 . . . . 72.150000000000006 110.876 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.445 HD12 ' O ' ' A' ' 7' ' ' LYS . 43.3 mm 63.43 110.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 71.340000000000003 111.162 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.65 160.92 6.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 111.109 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.58 120.23 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 110.857 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.75 35.44 19.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 110.91 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.09 164.71 23.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 72.430000000000007 112.47 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.3 152.33 44.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.341 . . . . 72.310000000000002 110.925 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 149.84 40.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 31.34 110.882 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -74.6 -35.16 62.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 72.299999999999997 110.864 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.35 -69.36 0.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 73.319999999999993 112.446 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.86 -25.92 30.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.784 0.326 . . . . 74.430000000000007 111.091 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -96.85 93.58 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.13 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -88.22 9.44 22.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 63.299999999999997 110.903 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -80.29 69.6 6.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 71.019999999999996 110.909 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.6 t -100.39 104.82 16.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 61.350000000000001 110.871 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.3 m -54.44 -64.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 110.875 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -130.53 161.74 58.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.602 0.715 . . . . 44.32 110.879 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.71 -49.53 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.15 0 C-N-CA 122.737 -1.776 . . . . 62.329999999999998 112.34 -0.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.49 -93.04 0.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.540000000000006 110.925 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -131.63 160.14 36.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 70.439999999999998 110.883 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.77 126.1 35.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 63.109999999999999 110.866 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 23' ' ' PRO . 94.4 m -146.07 135.79 11.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.608 0.718 . . . . 75.200000000000003 111.132 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.586 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.73 170.44 58.33 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.684 -1.799 . . . . 72.25 112.345 -0.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -7.62 21.52 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 75.140000000000001 112.329 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.637 HG22 HG13 ' A' ' 26' ' ' ILE . 18.5 mt -93.4 -58.89 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 74.439999999999998 111.164 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.637 HG13 HG22 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -163.22 130.67 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 52.119999999999997 111.102 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.71 -139.33 4.99 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.751 -0.738 . . . . 34.409999999999997 112.508 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -131.33 140.72 49.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 74.150000000000006 110.88 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.1 t -75.29 128.51 35.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 62.119999999999997 110.875 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 71.239999999999995 110.914 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.772 0.32 . . . . 70.310000000000002 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.2 mm 63.36 110.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 73.519999999999996 111.106 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.66 160.69 6.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.409999999999997 111.059 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -50.62 120.42 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 75.329999999999998 110.82 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.83 35.6 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 54.409999999999997 110.922 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.27 165.23 23.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 64.439999999999998 112.498 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 152.47 44.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 74.349999999999994 110.899 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.87 149.89 40.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.888 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.12 -33.92 38.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.867 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.51 -69.26 0.39 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 43.420000000000002 112.433 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -25.88 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 71.129999999999995 111.126 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.55 90.44 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 53.020000000000003 111.127 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -88.03 9.4 22.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.040000000000006 110.881 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -80.33 69.61 6.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 110.942 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.9 t -99.92 104.67 16.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.857 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -54.49 -64.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 110.863 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -129.94 161.63 58.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 61.140000000000001 110.87 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.67 -49.54 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.671 -1.804 . . . . 71.349999999999994 112.373 -0.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -129.16 -91.88 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.937 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -130.83 160.23 35.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 63.229999999999997 110.934 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 m -91.94 125.54 36.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.9 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.527 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -142.41 137.35 15.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.612 0.72 . . . . 41.240000000000002 111.122 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.71 171.02 55.4 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.712 -1.786 . . . . 43.43 112.369 -0.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -7.02 20.01 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.695 2.264 . . . . 71.409999999999997 112.353 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.634 HG22 HG13 ' A' ' 26' ' ' ILE . 21.6 mt -94.89 -56.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 72.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.634 HG13 HG22 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -164.93 129.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 70.409999999999997 111.144 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.97 -140.76 5.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 71.230000000000004 112.485 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -131.15 140.98 50.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 71.209999999999994 110.878 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -74.56 128.95 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 52.030000000000001 110.861 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 73.040000000000006 110.956 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.83 0.348 . . . . 73.450000000000003 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 7' ' ' LYS . 45.7 mm 63.26 109.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 45.409999999999997 111.122 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 161.07 11.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 61.32 111.089 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -50.13 120.46 4.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 71.540000000000006 110.871 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 60.8 36.01 19.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 71.310000000000002 110.906 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.07 164.64 20.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 74.109999999999999 112.49 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.524 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -66.86 154.35 41.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 65.209999999999994 110.874 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.37 149.57 39.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 110.886 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.43 -22.25 51.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.319999999999993 110.877 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.07 -77.33 0.22 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 73.340000000000003 112.509 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -25.08 29.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 63.450000000000003 111.107 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 39.4 mt -89.59 97.53 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 65.430000000000007 111.117 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -86.93 7.48 27.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 60.030000000000001 110.886 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -80.02 69.35 6.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 72.310000000000002 110.899 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.37 106.62 18.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 63.140000000000001 110.893 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -49.67 -72.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 62.530000000000001 110.865 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.497 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -135.27 160.7 67.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 63.049999999999997 110.878 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.73 -49.8 0.21 Allowed 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.716 -1.785 . . . . 73.430000000000007 112.352 -0.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -130.51 -91.53 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 75.140000000000001 110.917 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.9 160.65 33.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 72.310000000000002 110.983 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 24.4 p -94.4 126.81 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.87 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.542 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -136.34 140.96 34.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.605 0.717 . . . . 64.209999999999994 111.107 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.0 Cg_endo -69.82 170.61 57.91 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 -1.802 . . . . 71.219999999999999 112.291 -0.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -3.75 12.61 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.667 2.245 . . . . 53.409999999999997 112.365 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 26' ' ' ILE . 32.3 mt -109.85 72.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 75.109999999999999 111.139 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.2 mp 62.65 99.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 61.43 111.116 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.46 -143.21 3.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.702 -0.761 . . . . 52.140000000000001 112.458 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -130.52 139.74 50.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.928 0.394 . . . . 73.510000000000005 110.886 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -76.1 129.05 36.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.86 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 63.219999999999999 110.978 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.863 0.363 . . . . 43.119999999999997 110.924 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.2 mm 63.52 111.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 111.087 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.73 160.48 7.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 72.329999999999998 111.061 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -50.98 120.26 4.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.813 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.71 35.6 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.510000000000005 110.909 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.52 166.37 24.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 71.430000000000007 112.518 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 152.41 44.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 64.140000000000001 110.915 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 149.96 40.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.857 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.62 -22.75 66.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 75.019999999999996 110.836 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.24 -87.84 0.42 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.671 -0.776 . . . . 71.450000000000003 112.48 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -25.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 63.350000000000001 111.12 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.54 93.52 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 70.450000000000003 111.18 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -100.51 19.69 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 70.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.27 70.38 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 73.239999999999995 110.9 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 p -107.53 111.0 23.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 52.240000000000002 110.865 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.2 m -39.58 -63.56 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 72.340000000000003 110.879 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.2 m-20 -128.1 162.56 49.34 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.623 0.725 . . . . 74.310000000000002 110.803 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.5 Cg_endo -69.78 -50.92 0.17 OUTLIER 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.712 -1.787 . . . . 73.0 112.312 0.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -130.47 -93.8 0.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.923 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -126.88 161.34 28.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 73.319999999999993 110.897 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.1 m -85.63 125.97 33.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 50.43 110.891 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.535 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -153.2 138.23 11.35 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.586 0.707 . . . . 72.200000000000003 111.18 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.72 169.38 63.47 Favored 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 -1.79 . . . . 53.200000000000003 112.331 -0.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -8.4 23.52 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 54.329999999999998 112.34 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.18 92.18 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 75.540000000000006 111.132 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 50.19 85.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 65.530000000000001 111.109 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.51 -152.24 5.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.741 -0.742 . . . . 75.409999999999997 112.481 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -130.88 140.72 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 73.519999999999996 110.861 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 4.1 t -74.1 126.47 30.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 74.310000000000002 110.876 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 30' ' ' LEU . 1.6 pt? . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 110.904 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.852 0.358 . . . . 44.119999999999997 110.935 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 7' ' ' LYS . 39.8 mm 63.45 110.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 60.310000000000002 111.153 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.59 7.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 72.439999999999998 111.081 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -50.93 120.28 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 65.430000000000007 110.843 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.85 35.69 19.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.914 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.18 166.58 23.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 31.239999999999998 112.492 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.684 ' NZ ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -70.11 151.92 44.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.773 0.32 . . . . 64.439999999999998 110.918 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 149.71 40.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 60.039999999999999 110.857 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -74.02 -35.42 64.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.0 110.87 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.02 -69.38 0.34 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 60.200000000000003 112.478 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -25.86 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 72.420000000000002 111.168 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.67 94.78 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 65.329999999999998 111.108 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -88.16 9.45 22.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 51.340000000000003 110.899 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -80.4 69.56 6.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 62.539999999999999 110.888 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.5 t -101.2 104.82 15.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 73.340000000000003 110.884 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.9 m -53.39 -64.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 62.119999999999997 110.845 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -131.89 161.71 60.93 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.602 0.715 . . . . 73.140000000000001 110.867 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.84 -49.52 0.23 Allowed 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 -1.805 . . . . 62.219999999999999 112.331 0.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -128.23 -92.93 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 75.299999999999997 110.884 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -131.51 160.45 35.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 71.549999999999997 110.863 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.4 m -90.13 125.18 35.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 65.409999999999997 110.877 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -143.33 136.64 14.03 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.594 0.712 . . . . 54.229999999999997 111.128 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.8 170.63 57.71 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.617 -1.826 . . . . 63.340000000000003 112.352 -0.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 2.32 3.66 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.703 2.269 . . . . 72.430000000000007 112.314 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.608 ' HB ' HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -107.65 -65.56 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 34.109999999999999 111.099 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.684 HG23 ' NZ ' ' A' ' 7' ' ' LYS . 4.2 mp -148.36 123.93 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 111.141 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 23' ' ' PRO . . . 176.93 -147.08 8.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 72.230000000000004 112.487 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.493 ' O ' HD12 ' A' ' 30' ' ' LEU . 81.0 m-85 -130.94 142.19 50.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 73.200000000000003 110.922 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.8 t -73.15 128.27 34.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 55.210000000000001 110.909 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 63.100000000000001 110.88 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.845 0.355 . . . . 72.209999999999994 110.883 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 7' ' ' LYS . 35.2 mm 65.01 115.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 111.075 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.73 7.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 74.219999999999999 111.071 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.81 120.3 4.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 55.43 110.86 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.74 35.26 19.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.914 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.42 170.19 24.28 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 63.030000000000001 112.508 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.563 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -69.92 152.85 44.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 72.530000000000001 110.924 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.1 156.73 28.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 62.450000000000003 110.888 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.24 -28.55 38.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 64.409999999999997 110.894 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.19 -69.58 0.21 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 74.409999999999997 112.487 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -26.09 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 62.340000000000003 111.156 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.89 99.97 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 61.210000000000001 111.148 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -89.01 9.65 24.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 63.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -80.24 69.83 6.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 73.140000000000001 110.947 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.0 t -103.97 103.51 13.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 61.340000000000003 110.862 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 p -49.75 -62.17 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 71.349999999999994 110.841 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.507 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -136.34 160.94 64.94 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.573 0.701 . . . . 51.030000000000001 110.893 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.77 -50.23 0.2 OUTLIER 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.662 -1.807 . . . . 74.049999999999997 112.388 0.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -130.6 -93.81 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.952 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.84 160.94 35.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 72.439999999999998 110.926 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.8 m -84.0 125.65 32.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 50.140000000000001 110.861 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 23' ' ' PRO . 95.9 m -145.94 136.86 12.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.573 0.701 . . . . 64.200000000000003 111.131 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.625 ' HA ' HG23 ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.72 162.31 84.27 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.792 . . . . 64.349999999999994 112.337 -0.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.634 ' O ' HG23 ' A' ' 25' ' ' ILE . 53.8 Cg_endo -69.76 54.59 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.241 . . . . 55.329999999999998 112.351 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -172.39 86.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 73.209999999999994 111.127 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp 50.34 83.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 73.5 111.125 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -145.7 -140.22 3.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 73.010000000000005 112.487 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -130.82 137.59 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 62.219999999999999 110.867 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 t -77.29 128.43 34.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 74.510000000000005 110.876 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 71.239999999999995 110.895 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.756 0.312 . . . . 74.230000000000004 110.868 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.5 mm 64.62 114.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 74.310000000000002 111.157 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.84 160.51 7.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 41.030000000000001 111.107 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -50.79 120.48 4.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 75.230000000000004 110.835 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.85 35.63 19.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 63.420000000000002 110.905 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.53 167.1 24.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 54.32 112.45 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 152.01 44.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 70.430000000000007 110.877 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 149.9 40.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 71.340000000000003 110.827 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -72.59 -35.17 67.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 64.510000000000005 110.885 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.32 -69.88 0.37 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 74.230000000000004 112.505 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -26.67 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.78 0.324 . . . . 62.030000000000001 111.145 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.1 mt -94.71 92.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 61.109999999999999 111.135 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -88.1 8.83 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 110.874 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.84 69.55 7.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 75.450000000000003 110.925 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.5 t -99.25 103.48 15.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 64.450000000000003 110.878 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 p -50.09 -61.49 2.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 71.310000000000002 110.895 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -135.75 161.26 63.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.57 0.7 . . . . 71.400000000000006 110.911 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.76 -49.66 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.193 0 C-N-CA 122.676 -1.802 . . . . 73.129999999999995 112.35 0.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.9 -93.0 0.45 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 73.200000000000003 110.909 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -131.51 160.72 34.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 70.510000000000005 110.923 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.5 m -90.06 125.01 35.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 71.519999999999996 110.893 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.521 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -142.94 136.09 13.94 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.591 0.71 . . . . 71.319999999999993 111.116 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.78 171.08 55.46 Favored 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.689 -1.796 . . . . 64.5 112.324 -0.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -5.56 16.46 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.681 2.254 . . . . 54.0 112.337 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 1.057 HG22 HD12 ' A' ' 26' ' ' ILE . 14.0 mt -93.8 -69.37 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 53.210000000000001 111.169 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 1.057 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -153.05 115.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 111.14 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.27 -142.85 3.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 61.020000000000003 112.495 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.587 ' O ' HD12 ' A' ' 30' ' ' LEU . 83.2 m-85 -130.57 141.66 50.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 74.340000000000003 110.858 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.9 t -74.32 128.98 36.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 110.898 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 28' ' ' PHE . 3.5 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.918 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.813 0.34 . . . . 75.409999999999997 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm 63.83 112.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 50.520000000000003 111.155 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.49 160.78 6.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 73.129999999999995 111.088 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.62 120.24 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 73.010000000000005 110.831 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.73 35.37 19.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.904 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.63 162.92 25.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 71.319999999999993 112.473 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 151.0 45.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 72.150000000000006 110.838 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.32 149.93 40.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 65.209999999999994 110.892 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.28 -27.69 56.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 75.239999999999995 110.884 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.45 -74.65 0.37 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.739 . . . . 63.409999999999997 112.515 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -13.91 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 65.430000000000007 111.149 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 12' ' ' ILE . 6.4 tt -88.5 85.69 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 111.086 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -85.6 6.71 26.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 110.898 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.06 69.27 9.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 110.907 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.8 t -106.96 103.41 12.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 50.439999999999998 110.89 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.8 m -56.03 -64.31 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 52.32 110.872 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.497 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -131.37 160.94 64.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.559 0.695 . . . . 63.140000000000001 110.878 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.71 -49.47 0.23 Allowed 'Cis proline' 0 C--O 1.231 0.155 0 C-N-CA 122.696 -1.793 . . . . 63.149999999999999 112.354 0.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.65 -93.8 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 74.129999999999995 110.937 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -132.18 160.73 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.030000000000001 110.885 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -87.32 125.3 34.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 74.209999999999994 110.861 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.521 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -143.41 137.29 14.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.581 0.705 . . . . 74.409999999999997 111.123 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.79 171.18 55.04 Favored 'Cis proline' 0 C--O 1.232 0.195 0 C-N-CA 122.691 -1.795 . . . . 73.150000000000006 112.362 -0.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -6.47 18.68 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.651 2.234 . . . . 54.25 112.33 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.63 HG22 HG13 ' A' ' 26' ' ' ILE . 20.1 mt -95.37 -56.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 55.43 111.123 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.63 HG13 HG22 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -165.47 131.03 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 73.540000000000006 111.115 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.26 -139.09 4.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.752 -0.737 . . . . 74.140000000000001 112.531 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -131.64 141.39 49.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 74.519999999999996 110.851 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.3 t -74.11 128.57 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 70.439999999999998 110.863 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.541 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.9 pp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.477 . . . . 74.109999999999999 110.936 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.815 0.341 . . . . 73.329999999999998 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 7' ' ' LYS . 40.8 mm 63.54 110.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 51.140000000000001 111.1 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.72 160.62 7.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 111.099 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -50.83 120.34 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 65.120000000000005 110.857 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.79 35.63 19.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.941 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.2 166.21 23.14 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.78 -0.724 . . . . 31.550000000000001 112.466 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.21 152.31 44.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 74.329999999999998 110.91 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 149.74 40.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.310000000000002 110.911 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -73.01 -35.38 66.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 74.409999999999997 110.875 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.14 -69.37 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 51.299999999999997 112.481 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -25.96 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.337 . . . . 60.140000000000001 111.118 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.27 95.04 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 70.109999999999999 111.125 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -88.32 9.51 23.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 74.430000000000007 110.848 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.3 69.61 6.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 34.119999999999997 110.947 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.5 t -99.46 104.75 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 54.119999999999997 110.882 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -53.24 -64.61 0.77 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 60.43 110.853 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -131.86 161.83 60.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.723 . . . . 73.319999999999993 110.845 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.78 -49.55 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.213 0 C-N-CA 122.653 -1.811 . . . . 71.140000000000001 112.364 0.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -127.85 -92.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 72.230000000000004 110.927 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.47 160.36 35.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 72.030000000000001 110.936 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -88.83 126.04 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 64.340000000000003 110.891 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.568 HG23 ' HA ' ' A' ' 23' ' ' PRO . 94.5 m -145.99 135.31 11.39 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 64.400000000000006 111.136 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.79 170.41 58.74 Favored 'Cis proline' 0 C--N 1.341 0.147 0 C-N-CA 122.758 -1.767 . . . . 74.239999999999995 112.313 0.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -6.47 18.68 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.702 2.268 . . . . 61.439999999999998 112.32 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 1.042 HG22 HD12 ' A' ' 26' ' ' ILE . 14.7 mt -92.98 -69.58 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 51.409999999999997 111.1 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.042 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -152.92 119.67 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.129999999999995 111.172 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.63 -141.85 3.8 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 72.329999999999998 112.468 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -130.69 141.19 50.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 73.439999999999998 110.893 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.9 t -74.52 128.85 36.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 72.209999999999994 110.893 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.5 pp . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.109999999999999 110.9 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.796 0.331 . . . . 73.409999999999997 110.901 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 7' ' ' LYS . 44.5 mm 63.45 109.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 52.25 111.136 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.49 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 70.140000000000001 111.124 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -50.85 120.34 4.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 71.129999999999995 110.862 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.85 35.63 19.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 74.099999999999994 110.949 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.44 166.79 23.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 54.130000000000003 112.478 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.1 152.1 44.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.352 . . . . 65.299999999999997 110.893 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 149.67 40.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 71.049999999999997 110.889 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.09 -34.57 68.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 52.439999999999998 110.869 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.66 -69.68 0.31 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 73.040000000000006 112.493 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -25.97 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 72.120000000000005 111.147 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -96.35 97.32 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 63.5 111.105 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -89.29 9.97 24.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 64.439999999999998 110.879 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.13 69.94 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.109999999999999 110.937 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.6 t -101.71 105.24 16.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 62.119999999999997 110.884 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.2 m -54.15 -64.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 54.030000000000001 110.903 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -129.98 161.79 57.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.589 0.709 . . . . 52.140000000000001 110.875 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.74 -49.64 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 -1.788 . . . . 74.129999999999995 112.306 0.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.88 -91.6 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 65.140000000000001 110.907 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -130.45 160.24 34.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 54.030000000000001 110.884 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -88.48 125.12 34.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 64.239999999999995 110.874 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.585 HG23 ' HA ' ' A' ' 23' ' ' PRO . 94.8 m -147.96 136.24 11.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.572 0.701 . . . . 70.140000000000001 111.113 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.585 ' HA ' HG23 ' A' ' 22' ' ' THR . 54.6 Cg_endo -69.71 168.08 68.6 Favored 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.691 -1.796 . . . . 74.219999999999999 112.334 -0.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.29 23.21 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.628 2.218 . . . . 74.319999999999993 112.355 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 26' ' ' ILE . 3.3 pt -116.56 83.72 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 64.329999999999998 111.106 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.3 mp 61.07 103.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 111.097 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.01 -151.99 7.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 64.340000000000003 112.446 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.542 ' O ' HD12 ' A' ' 30' ' ' LEU . 88.5 m-85 -124.05 137.55 54.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 75.400000000000006 110.893 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.0 t -77.54 129.72 36.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 53.219999999999999 110.906 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 28' ' ' PHE . 4.6 mp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 72.310000000000002 110.912 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.819 0.343 . . . . 72.209999999999994 110.881 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 7' ' ' LYS . 41.5 mm 63.42 109.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 111.129 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.84 160.64 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 74.530000000000001 111.07 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -50.92 120.43 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 73.150000000000006 110.824 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.76 35.49 19.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 74.0 110.932 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.32 166.73 23.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.686 -0.769 . . . . 73.310000000000002 112.468 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.17 152.2 44.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 74.420000000000002 110.873 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 149.85 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 65.049999999999997 110.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.25 -28.96 61.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 110.913 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 -69.41 0.22 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 71.239999999999995 112.439 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.05 -25.46 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 63.409999999999997 111.142 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.26 96.43 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 71.129999999999995 111.126 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -88.82 9.86 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 60.020000000000003 110.855 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -80.21 69.67 6.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 74.109999999999999 110.903 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -101.56 104.98 15.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.94 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.8 m -54.6 -64.62 0.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.420000000000002 110.884 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -129.95 161.79 57.63 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 74.510000000000005 110.861 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.76 -49.44 0.23 Allowed 'Cis proline' 0 C--N 1.341 0.157 0 C-N-CA 122.695 -1.794 . . . . 63.240000000000002 112.349 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -127.72 -91.7 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 71.530000000000001 110.947 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -130.59 160.37 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.319999999999993 110.92 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.2 m -87.73 125.27 34.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 54.530000000000001 110.908 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.6 HG23 ' HA ' ' A' ' 23' ' ' PRO . 96.0 m -148.85 136.48 11.1 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.543 0.687 . . . . 63.43 111.133 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.6 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.74 167.6 70.4 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 -1.798 . . . . 74.409999999999997 112.342 -0.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -9.45 26.14 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.676 2.251 . . . . 54.119999999999997 112.375 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.458 ' C ' HD12 ' A' ' 26' ' ' ILE . 4.3 pt -112.91 79.71 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 75.510000000000005 111.14 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.3 mp 61.42 104.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 72.329999999999998 111.122 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -164.72 -146.51 4.79 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 61.140000000000001 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.21 137.49 52.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 75.209999999999994 110.843 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.4 t -77.45 129.56 35.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 74.209999999999994 110.88 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 74.099999999999994 110.969 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.793 0.33 . . . . 72.329999999999998 110.881 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 7' ' ' LYS . 47.0 mm 63.47 110.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 63.439999999999998 111.138 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.69 160.65 7.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 51.409999999999997 111.103 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -50.77 120.46 4.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 63.340000000000003 110.82 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.87 35.68 19.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.540000000000006 110.958 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.46 165.03 23.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 42.229999999999997 112.438 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.16 152.23 44.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.343 . . . . 64.450000000000003 110.92 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 150.4 39.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 74.230000000000004 110.86 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' HB3' HD12 ' A' ' 12' ' ' ILE . 26.1 t0 -73.64 -29.92 62.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.144 -0.48 . . . . 71.230000000000004 110.871 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.82 -69.68 0.25 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 70.420000000000002 112.511 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.64 -26.04 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 71.340000000000003 111.132 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.499 HD12 ' HB3' ' A' ' 9' ' ' ASP . 2.5 mp -95.82 95.12 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 111.16 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -89.34 9.77 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 71.310000000000002 110.879 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -80.24 69.91 6.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 73.530000000000001 110.899 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.6 t -101.57 105.37 16.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.909 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.4 m -53.83 -64.76 0.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 64.329999999999998 110.848 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.1 m-20 -131.0 161.82 59.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.581 0.705 . . . . 64.340000000000003 110.866 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.69 -49.75 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.694 -1.794 . . . . 52.119999999999997 112.397 -0.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.57 -92.19 0.49 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 71.099999999999994 110.961 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -130.61 160.35 34.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 71.329999999999998 110.871 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.79 117.46 29.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 74.519999999999996 110.871 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.539 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -139.74 139.24 21.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.608 0.718 . . . . 71.340000000000003 111.122 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.73 169.47 63.05 Favored 'Cis proline' 0 C--O 1.232 0.185 0 C-N-CA 122.66 -1.808 . . . . 72.439999999999998 112.377 -0.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -7.98 22.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.655 2.237 . . . . 71.439999999999998 112.35 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.403 ' C ' HD12 ' A' ' 26' ' ' ILE . 66.3 mt -115.05 80.98 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 61.109999999999999 111.13 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.2 mp 60.6 100.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 71.219999999999999 111.1 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.74 -146.2 4.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 71.239999999999995 112.502 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -130.39 138.4 50.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.379 . . . . 65.420000000000002 110.85 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 t -76.8 128.97 35.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 72.310000000000002 110.879 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 51.200000000000003 110.905 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.813 0.339 . . . . 75.439999999999998 110.901 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.2 mm 63.77 118.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.239999999999995 111.131 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.38 159.82 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 64.310000000000002 111.064 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -51.28 118.24 3.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 74.219999999999999 110.866 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 60.44 35.83 20.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 75.400000000000006 110.941 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.72 167.06 31.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 32.310000000000002 112.489 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 152.64 43.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 71.549999999999997 110.943 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.07 154.88 31.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 70.140000000000001 110.865 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -72.91 -35.12 67.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.13 -69.57 0.29 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.759 -0.734 . . . . 72.25 112.514 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -26.04 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.759 0.314 . . . . 54.299999999999997 111.14 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mt -97.16 98.51 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 63.119999999999997 111.174 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -89.59 9.83 25.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 63.229999999999997 110.89 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.11 69.94 6.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 73.340000000000003 110.916 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.9 t -100.0 106.29 18.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 61.130000000000003 110.909 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.7 m -52.62 -64.91 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.120000000000005 110.873 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.504 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -132.66 161.43 63.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.565 0.697 . . . . 72.310000000000002 110.904 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.77 -49.83 0.21 Allowed 'Cis proline' 0 C--N 1.341 0.166 0 C-N-CA 122.685 -1.798 . . . . 63.439999999999998 112.365 0.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.31 -92.07 0.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 73.049999999999997 110.954 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -130.45 160.37 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 110.873 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -90.26 118.64 29.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 70.439999999999998 110.859 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -140.35 138.96 19.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 64.239999999999995 111.121 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.78 169.42 63.52 Favored 'Cis proline' 0 C--N 1.342 0.22 0 C-N-CA 122.665 -1.806 . . . . 65.0 112.356 -0.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -7.83 22.05 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.676 2.251 . . . . 43.409999999999997 112.351 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -115.14 80.93 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 73.400000000000006 111.145 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 60.4 100.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.040000000000006 111.108 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.69 -146.29 4.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 73.219999999999999 112.486 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -130.16 137.93 50.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 70.439999999999998 110.875 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.21 131.78 38.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 75.519999999999996 110.89 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 30' ' ' LEU . 2.8 pp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 61.43 110.911 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.79 0.329 . . . . 72.239999999999995 110.871 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 7' ' ' LYS . 40.5 mm 63.37 109.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 73.510000000000005 111.104 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.67 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 74.239999999999995 111.085 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -50.78 120.35 4.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 54.43 110.847 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.88 35.62 19.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 73.450000000000003 110.863 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.09 165.94 23.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 43.310000000000002 112.499 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.26 152.39 44.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.861 0.362 . . . . 73.219999999999999 110.893 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.92 149.89 40.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 60.119999999999997 110.852 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -76.39 -35.41 58.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 74.019999999999996 110.845 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.04 -69.22 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 65.540000000000006 112.531 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.72 -25.88 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.34 . . . . 63.219999999999999 111.129 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.9 mp -97.3 93.33 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 74.409999999999997 111.16 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -88.16 9.5 22.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 70.239999999999995 110.926 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -80.29 69.6 6.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 71.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.5 t -99.53 104.74 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 43.140000000000001 110.871 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.0 m -54.69 -64.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 60.539999999999999 110.897 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -130.64 161.63 59.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 72.150000000000006 110.848 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.76 -49.52 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.673 -1.803 . . . . 62.25 112.314 0.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.64 -92.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 75.299999999999997 110.887 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.09 160.12 35.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.340000000000003 110.882 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.57 126.16 35.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 64.230000000000004 110.892 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 23' ' ' PRO . 96.0 m -145.48 135.39 11.72 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.713 . . . . 72.129999999999995 111.147 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.575 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.79 170.34 59.09 Favored 'Cis proline' 0 C--N 1.341 0.153 0 C-N-CA 122.648 -1.813 . . . . 74.409999999999997 112.354 -0.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -6.67 19.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 50.409999999999997 112.333 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 1.066 HG22 HD12 ' A' ' 26' ' ' ILE . 12.9 mt -92.95 -69.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 73.140000000000001 111.147 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.066 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -152.87 120.09 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 41.299999999999997 111.145 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.13 -141.91 3.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 65.349999999999994 112.462 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -130.73 141.24 50.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.391 . . . . 62.210000000000001 110.865 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.7 t -74.4 128.66 36.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 73.230000000000004 110.9 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 64.120000000000005 110.896 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.845 0.355 . . . . 63.310000000000002 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 7' ' ' LYS . 39.6 mm 63.43 109.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 62.420000000000002 111.11 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.93 160.51 7.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 61.409999999999997 111.093 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -50.8 120.4 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 73.0 110.862 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.79 35.58 19.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 74.120000000000005 110.961 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.21 166.69 23.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.732 -0.747 . . . . 70.120000000000005 112.451 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.27 152.19 44.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.795 0.331 . . . . 74.400000000000006 110.925 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.17 149.85 40.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 110.898 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.479 ' OD2' HD12 ' A' ' 12' ' ' ILE . 7.2 m-20 -75.27 -35.16 61.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 74.120000000000005 110.84 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.2 -70.01 0.37 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 75.209999999999994 112.502 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -25.36 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 73.120000000000005 111.117 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.479 HD12 ' OD2' ' A' ' 9' ' ' ASP . 8.3 mt -94.66 93.75 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 65.219999999999999 111.105 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.16 9.08 24.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 75.209999999999994 110.845 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -80.86 69.46 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 71.409999999999997 110.929 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 t -99.56 104.6 16.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 72.319999999999993 110.904 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.8 m -54.62 -64.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 70.209999999999994 110.882 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -131.81 161.72 60.78 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.601 0.715 . . . . 72.319999999999993 110.888 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.79 -49.64 0.22 Allowed 'Cis proline' 0 C--O 1.232 0.179 0 C-N-CA 122.695 -1.794 . . . . 72.340000000000003 112.28 0.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.64 -92.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 71.319999999999993 110.945 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.02 160.22 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 54.420000000000002 110.902 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.49 126.28 35.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.400000000000006 110.872 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 23' ' ' PRO . 95.5 m -145.4 135.48 11.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.561 0.696 . . . . 73.310000000000002 111.182 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.73 170.23 59.33 Favored 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.685 -1.798 . . . . 74.219999999999999 112.359 -0.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.83 19.53 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.705 2.27 . . . . 54.539999999999999 112.323 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 1.07 HG22 HD12 ' A' ' 26' ' ' ILE . 11.9 mt -92.68 -69.34 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 74.219999999999999 111.133 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.07 HD12 HG22 ' A' ' 25' ' ' ILE . 2.7 mp -152.8 119.58 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 61.030000000000001 111.113 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.68 -142.2 3.94 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.775 -0.726 . . . . 74.040000000000006 112.501 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -130.79 141.4 50.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 70.219999999999999 110.867 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.5 t -74.06 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 73.310000000000002 110.902 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 30' ' ' LEU . 1.7 pt? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 75.209999999999994 110.879 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.776 0.322 . . . . 63.229999999999997 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 7' ' ' LYS . 48.0 mm 63.67 110.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 73.25 111.112 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.72 160.7 7.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 71.299999999999997 111.095 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -50.81 120.35 4.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 73.049999999999997 110.879 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 60.81 35.6 19.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.241 -0.436 . . . . 72.340000000000003 110.946 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.51 165.78 23.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.738 -0.744 . . . . 73.349999999999994 112.466 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.22 152.22 44.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 62.329999999999998 110.931 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 149.82 40.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 42.329999999999998 110.878 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.42 -33.49 67.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 70.420000000000002 110.868 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.37 -73.19 0.33 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.738 -0.744 . . . . 75.120000000000005 112.506 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -25.93 32.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.833 0.349 . . . . 64.450000000000003 111.134 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.2 mt -90.7 93.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 62.43 111.159 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -88.06 9.12 23.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 64.209999999999994 110.847 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.79 69.71 7.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.340000000000003 110.947 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -102.03 104.8 15.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.209999999999994 110.868 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.9 m -54.81 -64.54 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 51.420000000000002 110.855 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -131.21 160.97 64.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.601 0.715 . . . . 63.340000000000003 110.882 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.8 -49.72 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.701 -1.791 . . . . 72.109999999999999 112.327 0.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -128.53 -93.02 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 73.510000000000005 110.909 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.4 160.35 35.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 72.400000000000006 110.907 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.8 m -88.28 125.96 34.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.877 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 23' ' ' PRO . 93.9 m -146.15 135.38 11.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.575 0.703 . . . . 73.319999999999993 111.144 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.564 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.79 170.34 59.08 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.687 -1.797 . . . . 70.430000000000007 112.331 -0.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -6.64 19.11 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.704 2.269 . . . . 72.230000000000004 112.32 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 1.044 HG22 HD12 ' A' ' 26' ' ' ILE . 14.5 mt -92.58 -69.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 71.219999999999999 111.108 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.044 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -153.04 119.72 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.146 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.99 -141.93 3.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.773 -0.727 . . . . 32.299999999999997 112.479 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -130.65 141.52 50.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 71.219999999999999 110.883 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.0 t -74.17 128.33 35.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 74.239999999999995 110.874 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 71.450000000000003 110.896 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.788 0.327 . . . . 70.0 110.869 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 7' ' ' LYS . 51.9 mm 63.57 112.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 70.040000000000006 111.109 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.35 161.31 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 52.109999999999999 111.147 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -50.14 120.41 4.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 43.130000000000003 110.852 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.8 35.25 19.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 73.340000000000003 110.981 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.68 155.55 19.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.697 -0.763 . . . . 74.120000000000005 112.499 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' NZ ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -70.36 150.26 46.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 70.140000000000001 110.849 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.28 161.79 19.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.299999999999997 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.579 ' HB3' HD12 ' A' ' 12' ' ' ILE . 26.9 t70 -67.72 -32.68 73.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.409999999999997 110.856 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.13 -69.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 73.420000000000002 112.486 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -25.82 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 72.120000000000005 111.121 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 9' ' ' ASP . 2.7 mp -89.95 97.13 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.430000000000007 111.149 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -88.84 9.85 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 50.329999999999998 110.866 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -80.14 69.73 6.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 71.310000000000002 110.857 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.2 t -102.22 104.85 15.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.439999999999998 110.846 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.2 m -53.98 -64.78 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 71.409999999999997 110.871 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -131.63 161.63 61.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 63.32 110.837 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.85 -49.57 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.713 -1.786 . . . . 64.340000000000003 112.328 0.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -129.67 -91.39 0.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 72.239999999999995 110.925 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.18 160.2 34.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 61.5 110.946 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.19 119.81 32.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 61.420000000000002 110.854 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -139.25 139.56 23.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.576 0.703 . . . . 63.409999999999997 111.166 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.79 169.71 62.15 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.793 . . . . 70.450000000000003 112.359 -0.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -7.87 22.16 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 64.109999999999999 112.369 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.412 ' C ' HD12 ' A' ' 26' ' ' ILE . 6.1 pt -114.91 83.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 71.400000000000006 111.125 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.487 HG23 ' NZ ' ' A' ' 7' ' ' LYS . 5.3 mp 61.28 86.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 51.450000000000003 111.114 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.39 -157.48 7.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 53.340000000000003 112.525 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.23 138.36 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.395 . . . . 64.340000000000003 110.817 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.04 129.4 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 75.25 110.874 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.885 -180.0 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.826 0.346 . . . . 71.200000000000003 110.889 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 7' ' ' LYS . 49.3 mm 63.79 111.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 75.409999999999997 111.127 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.87 161.01 6.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 74.430000000000007 111.097 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -50.71 120.46 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 75.140000000000001 110.873 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.84 35.11 19.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 64.439999999999998 110.913 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.41 161.69 18.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 44.439999999999998 112.488 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.3 150.3 46.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.851 0.358 . . . . 64.219999999999999 110.899 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -119.53 160.84 21.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 52.210000000000001 110.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -69.06 -34.96 76.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 60.32 110.866 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.79 -69.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.71 -0.757 . . . . 64.109999999999999 112.493 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -25.72 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 70.099999999999994 111.19 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.5 mt -90.12 100.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 72.129999999999995 111.144 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.41 9.13 21.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 73.319999999999993 110.924 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -80.63 69.66 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 75.340000000000003 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.1 t -102.82 104.78 15.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 52.219999999999999 110.813 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.0 m -55.32 -64.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.109999999999999 110.86 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -132.83 161.46 63.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 73.219999999999999 110.864 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.75 -49.68 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 -1.805 . . . . 64.219999999999999 112.342 0.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -128.08 -91.96 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.099999999999994 110.895 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -130.67 160.61 33.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 72.530000000000001 110.924 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.0 t -89.94 119.46 30.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 73.219999999999999 110.843 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.541 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -141.11 138.87 18.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.56 0.695 . . . . 72.340000000000003 111.184 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.69 169.29 63.77 Favored 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.678 -1.801 . . . . 64.319999999999993 112.354 -0.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.09 22.73 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.637 2.225 . . . . 74.329999999999998 112.346 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.42 ' C ' HD12 ' A' ' 26' ' ' ILE . 68.1 mt -114.73 80.29 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 62.109999999999999 111.127 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.469 HG23 ' NZ ' ' A' ' 7' ' ' LYS . 5.3 mp 60.97 101.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 65.329999999999998 111.104 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.79 -145.75 4.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 72.099999999999994 112.467 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -130.14 137.97 50.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.946 0.403 . . . . 75.310000000000002 110.865 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.13 129.3 35.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 54.399999999999999 110.879 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 62.399999999999999 110.935 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.812 0.339 . . . . 64.040000000000006 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 7' ' ' LYS . 41.6 mm 63.37 110.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 111.175 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.59 7.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 74.010000000000005 111.108 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -50.85 120.29 4.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 72.420000000000002 110.896 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.81 35.59 19.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.9 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.63 166.0 23.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 72.030000000000001 112.532 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.27 152.03 44.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 63.219999999999999 110.928 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.23 149.77 40.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 73.510000000000005 110.84 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -74.48 -34.9 63.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 73.400000000000006 110.848 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.42 -70.19 0.37 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 71.129999999999995 112.525 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.43 -25.43 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 75.400000000000006 111.185 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 mt -94.1 93.26 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.123 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -88.0 8.99 23.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.409999999999997 110.908 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -80.94 69.52 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 72.439999999999998 110.92 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 t -100.57 104.75 16.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 74.030000000000001 110.84 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 m -54.98 -64.43 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 110.848 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -131.54 161.37 62.59 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 55.119999999999997 110.862 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.78 -49.74 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.225 0 C-N-CA 122.674 -1.803 . . . . 72.120000000000005 112.307 0.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -128.97 -92.56 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.882 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -131.0 160.45 34.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 74.230000000000004 110.908 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.82 125.3 35.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 62.350000000000001 110.893 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.522 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -144.2 136.36 13.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.574 0.702 . . . . 64.340000000000003 111.159 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.83 170.99 56.09 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.648 -1.813 . . . . 75.129999999999995 112.346 -0.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -5.68 16.74 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 75.120000000000005 112.362 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 1.055 HG22 HD12 ' A' ' 26' ' ' ILE . 14.4 mt -93.68 -69.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 73.439999999999998 111.157 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.055 HD12 HG22 ' A' ' 25' ' ' ILE . 2.5 mp -153.09 115.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 74.129999999999995 111.098 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.1 -143.08 3.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 53.109999999999999 112.466 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -130.68 141.59 50.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.877 0.37 . . . . 74.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.2 t -73.99 128.22 34.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 73.239999999999995 110.864 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 62.229999999999997 110.953 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 13.6 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 73.209999999999994 110.878 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.5 mm 62.5 109.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 72.450000000000003 111.155 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.31 160.05 11.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 61.350000000000001 111.052 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.66 120.92 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 72.120000000000005 110.85 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 61.12 36.15 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 71.140000000000001 110.893 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.25 169.63 29.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.783 -0.723 . . . . 72.310000000000002 112.462 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 154.93 41.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.342 . . . . 73.549999999999997 110.884 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -116.06 149.75 38.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 43.530000000000001 110.89 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.55 -32.27 69.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 64.120000000000005 110.837 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.22 -79.38 0.29 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.737 -0.744 . . . . 75.510000000000005 112.483 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -25.11 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 70.019999999999996 111.075 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.71 101.0 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 53.140000000000001 111.145 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -86.01 9.51 16.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 73.439999999999998 110.864 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -79.83 69.56 6.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 110.925 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.12 105.44 17.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 64.230000000000004 110.841 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -50.7 -72.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 71.510000000000005 110.887 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -135.31 159.5 71.54 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.578 0.704 . . . . 74.030000000000001 110.896 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.78 -49.43 0.23 Allowed 'Cis proline' 0 C--O 1.232 0.179 0 C-N-CA 122.717 -1.784 . . . . 74.409999999999997 112.33 0.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -130.42 -91.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.879 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.59 160.27 34.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 74.239999999999995 110.935 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 23.7 p -95.42 126.44 40.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 63.5 110.848 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.543 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -136.87 140.89 33.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.569 0.7 . . . . 64.349999999999994 111.109 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.74 170.41 58.53 Favored 'Cis proline' 0 C--N 1.342 0.199 0 C-N-CA 122.694 -1.794 . . . . 63.020000000000003 112.35 -0.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -5.14 15.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.652 2.235 . . . . 64.530000000000001 112.382 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.473 ' C ' HD12 ' A' ' 26' ' ' ILE . 33.7 mt -108.52 73.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 53.130000000000003 111.131 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.473 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.4 mp 62.13 98.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 61.450000000000003 111.167 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.05 -143.63 3.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 63.229999999999997 112.54 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -130.77 139.52 50.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.377 . . . . 64.5 110.846 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -76.27 128.71 35.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 53.210000000000001 110.887 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 61.240000000000002 110.895 179.963 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.808 0.337 . . . . 72.150000000000006 110.876 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.445 HD12 ' O ' ' A' ' 7' ' ' LYS . 43.3 mm 63.43 110.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 71.340000000000003 111.162 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.65 160.92 6.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 111.109 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.58 120.23 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 74.239999999999995 110.857 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.75 35.44 19.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.319999999999993 110.91 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.09 164.71 23.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 72.430000000000007 112.47 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.3 152.33 44.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.341 . . . . 72.310000000000002 110.925 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 149.84 40.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 31.34 110.882 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -74.6 -35.16 62.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 72.299999999999997 110.864 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.35 -69.36 0.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 73.319999999999993 112.446 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.86 -25.92 30.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.784 0.326 . . . . 74.430000000000007 111.091 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -96.85 93.58 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.13 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -88.22 9.44 22.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 63.299999999999997 110.903 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -80.29 69.6 6.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 71.019999999999996 110.909 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.6 t -100.39 104.82 16.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 61.350000000000001 110.871 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.3 m -54.44 -64.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 74.319999999999993 110.875 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -130.53 161.74 58.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.602 0.715 . . . . 44.32 110.879 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.71 -49.53 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.15 0 C-N-CA 122.737 -1.776 . . . . 62.329999999999998 112.34 -0.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.49 -93.04 0.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.540000000000006 110.925 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -131.63 160.14 36.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 70.439999999999998 110.883 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.77 126.1 35.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 63.109999999999999 110.866 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 23' ' ' PRO . 94.4 m -146.07 135.79 11.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.608 0.718 . . . . 75.200000000000003 111.132 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.586 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.73 170.44 58.33 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.684 -1.799 . . . . 72.25 112.345 -0.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -7.62 21.52 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 75.140000000000001 112.329 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.637 HG22 HG13 ' A' ' 26' ' ' ILE . 18.5 mt -93.4 -58.89 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 74.439999999999998 111.164 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.637 HG13 HG22 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -163.22 130.67 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 52.119999999999997 111.102 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.71 -139.33 4.99 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.751 -0.738 . . . . 34.409999999999997 112.508 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -131.33 140.72 49.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 74.150000000000006 110.88 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.1 t -75.29 128.51 35.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 62.119999999999997 110.875 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 71.239999999999995 110.914 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.772 0.32 . . . . 70.310000000000002 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.2 mm 63.36 110.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 73.519999999999996 111.106 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.66 160.69 6.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.409999999999997 111.059 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -50.62 120.42 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 75.329999999999998 110.82 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.83 35.6 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 54.409999999999997 110.922 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.27 165.23 23.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 64.439999999999998 112.498 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 152.47 44.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 74.349999999999994 110.899 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.87 149.89 40.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.888 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.12 -33.92 38.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.867 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.51 -69.26 0.39 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 43.420000000000002 112.433 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -25.88 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 71.129999999999995 111.126 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.55 90.44 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 53.020000000000003 111.127 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -88.03 9.4 22.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.040000000000006 110.881 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -80.33 69.61 6.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 110.942 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.9 t -99.92 104.67 16.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.857 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -54.49 -64.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 75.329999999999998 110.863 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -129.94 161.63 58.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 61.140000000000001 110.87 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.67 -49.54 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.671 -1.804 . . . . 71.349999999999994 112.373 -0.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -129.16 -91.88 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.937 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -130.83 160.23 35.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 63.229999999999997 110.934 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 m -91.94 125.54 36.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.9 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.527 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -142.41 137.35 15.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.612 0.72 . . . . 41.240000000000002 111.122 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.71 171.02 55.4 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.712 -1.786 . . . . 43.43 112.369 -0.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -7.02 20.01 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.695 2.264 . . . . 71.409999999999997 112.353 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.634 HG22 HG13 ' A' ' 26' ' ' ILE . 21.6 mt -94.89 -56.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 72.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.634 HG13 HG22 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -164.93 129.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 70.409999999999997 111.144 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.97 -140.76 5.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 71.230000000000004 112.485 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -131.15 140.98 50.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 71.209999999999994 110.878 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -74.56 128.95 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 52.030000000000001 110.861 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 73.040000000000006 110.956 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.83 0.348 . . . . 73.450000000000003 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 7' ' ' LYS . 45.7 mm 63.26 109.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 45.409999999999997 111.122 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 161.07 11.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 61.32 111.089 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -50.13 120.46 4.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 71.540000000000006 110.871 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 60.8 36.01 19.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 71.310000000000002 110.906 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.07 164.64 20.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 74.109999999999999 112.49 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.524 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -66.86 154.35 41.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 65.209999999999994 110.874 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.37 149.57 39.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 110.886 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.43 -22.25 51.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.319999999999993 110.877 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.07 -77.33 0.22 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 73.340000000000003 112.509 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -25.08 29.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 63.450000000000003 111.107 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 39.4 mt -89.59 97.53 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 65.430000000000007 111.117 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -86.93 7.48 27.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 60.030000000000001 110.886 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -80.02 69.35 6.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 72.310000000000002 110.899 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.37 106.62 18.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 63.140000000000001 110.893 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -49.67 -72.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 62.530000000000001 110.865 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.497 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -135.27 160.7 67.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 63.049999999999997 110.878 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.73 -49.8 0.21 Allowed 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.716 -1.785 . . . . 73.430000000000007 112.352 -0.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -130.51 -91.53 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 75.140000000000001 110.917 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.9 160.65 33.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 72.310000000000002 110.983 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 24.4 p -94.4 126.81 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.87 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.542 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -136.34 140.96 34.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.605 0.717 . . . . 64.209999999999994 111.107 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.0 Cg_endo -69.82 170.61 57.91 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 -1.802 . . . . 71.219999999999999 112.291 -0.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -3.75 12.61 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.667 2.245 . . . . 53.409999999999997 112.365 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 26' ' ' ILE . 32.3 mt -109.85 72.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 75.109999999999999 111.139 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.2 mp 62.65 99.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 61.43 111.116 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.46 -143.21 3.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.702 -0.761 . . . . 52.140000000000001 112.458 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -130.52 139.74 50.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.928 0.394 . . . . 73.510000000000005 110.886 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -76.1 129.05 36.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.86 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 63.219999999999999 110.978 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.863 0.363 . . . . 43.119999999999997 110.924 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.2 mm 63.52 111.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 72.239999999999995 111.087 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.73 160.48 7.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 72.329999999999998 111.061 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -50.98 120.26 4.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.813 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.71 35.6 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.510000000000005 110.909 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.52 166.37 24.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 71.430000000000007 112.518 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 152.41 44.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 64.140000000000001 110.915 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 149.96 40.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 75.310000000000002 110.857 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.62 -22.75 66.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 75.019999999999996 110.836 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.24 -87.84 0.42 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.671 -0.776 . . . . 71.450000000000003 112.48 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -25.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 63.350000000000001 111.12 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.54 93.52 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 70.450000000000003 111.18 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -100.51 19.69 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 70.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.27 70.38 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 73.239999999999995 110.9 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 p -107.53 111.0 23.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 52.240000000000002 110.865 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.2 m -39.58 -63.56 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 72.340000000000003 110.879 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.2 m-20 -128.1 162.56 49.34 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.623 0.725 . . . . 74.310000000000002 110.803 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.5 Cg_endo -69.78 -50.92 0.17 OUTLIER 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.712 -1.787 . . . . 73.0 112.312 0.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -130.47 -93.8 0.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.923 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.45 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -126.88 161.34 28.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 73.319999999999993 110.897 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.1 m -85.63 125.97 33.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 50.43 110.891 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.535 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -153.2 138.23 11.35 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.586 0.707 . . . . 72.200000000000003 111.18 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.72 169.38 63.47 Favored 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 -1.79 . . . . 53.200000000000003 112.331 -0.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -8.4 23.52 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 54.329999999999998 112.34 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.18 92.18 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 75.540000000000006 111.132 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 50.19 85.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 65.530000000000001 111.109 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.51 -152.24 5.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.741 -0.742 . . . . 75.409999999999997 112.481 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -130.88 140.72 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 73.519999999999996 110.861 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 4.1 t -74.1 126.47 30.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 74.310000000000002 110.876 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 30' ' ' LEU . 1.6 pt? . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 72.129999999999995 110.904 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.852 0.358 . . . . 44.119999999999997 110.935 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 7' ' ' LYS . 39.8 mm 63.45 110.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 60.310000000000002 111.153 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.59 7.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 72.439999999999998 111.081 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -50.93 120.28 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 65.430000000000007 110.843 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.85 35.69 19.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.914 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.18 166.58 23.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 31.239999999999998 112.492 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.684 ' NZ ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -70.11 151.92 44.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.773 0.32 . . . . 64.439999999999998 110.918 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 149.71 40.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 60.039999999999999 110.857 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -74.02 -35.42 64.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.0 110.87 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.02 -69.38 0.34 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 60.200000000000003 112.478 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -25.86 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 72.420000000000002 111.168 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.67 94.78 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 65.329999999999998 111.108 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -88.16 9.45 22.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 51.340000000000003 110.899 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -80.4 69.56 6.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 62.539999999999999 110.888 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.5 t -101.2 104.82 15.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 73.340000000000003 110.884 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.9 m -53.39 -64.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 62.119999999999997 110.845 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -131.89 161.71 60.93 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.602 0.715 . . . . 73.140000000000001 110.867 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.84 -49.52 0.23 Allowed 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 -1.805 . . . . 62.219999999999999 112.331 0.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -128.23 -92.93 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 75.299999999999997 110.884 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -131.51 160.45 35.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 71.549999999999997 110.863 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.4 m -90.13 125.18 35.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 65.409999999999997 110.877 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -143.33 136.64 14.03 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.594 0.712 . . . . 54.229999999999997 111.128 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.8 170.63 57.71 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.617 -1.826 . . . . 63.340000000000003 112.352 -0.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 2.32 3.66 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.703 2.269 . . . . 72.430000000000007 112.314 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.608 ' HB ' HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -107.65 -65.56 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 34.109999999999999 111.099 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.684 HG23 ' NZ ' ' A' ' 7' ' ' LYS . 4.2 mp -148.36 123.93 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 111.141 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 23' ' ' PRO . . . 176.93 -147.08 8.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 72.230000000000004 112.487 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.493 ' O ' HD12 ' A' ' 30' ' ' LEU . 81.0 m-85 -130.94 142.19 50.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 73.200000000000003 110.922 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.8 t -73.15 128.27 34.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 55.210000000000001 110.909 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 63.100000000000001 110.88 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.845 0.355 . . . . 72.209999999999994 110.883 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 7' ' ' LYS . 35.2 mm 65.01 115.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 111.075 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.73 7.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 74.219999999999999 111.071 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.81 120.3 4.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 55.43 110.86 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.74 35.26 19.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 74.239999999999995 110.914 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.42 170.19 24.28 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 63.030000000000001 112.508 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.563 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -69.92 152.85 44.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 72.530000000000001 110.924 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.1 156.73 28.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 62.450000000000003 110.888 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.24 -28.55 38.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 64.409999999999997 110.894 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.19 -69.58 0.21 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 74.409999999999997 112.487 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -26.09 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 62.340000000000003 111.156 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.89 99.97 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 61.210000000000001 111.148 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -89.01 9.65 24.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 63.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -80.24 69.83 6.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 73.140000000000001 110.947 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.0 t -103.97 103.51 13.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 61.340000000000003 110.862 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 p -49.75 -62.17 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 71.349999999999994 110.841 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.507 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -136.34 160.94 64.94 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.573 0.701 . . . . 51.030000000000001 110.893 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.77 -50.23 0.2 OUTLIER 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.662 -1.807 . . . . 74.049999999999997 112.388 0.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -130.6 -93.81 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 110.952 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.84 160.94 35.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 72.439999999999998 110.926 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.8 m -84.0 125.65 32.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 50.140000000000001 110.861 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 23' ' ' PRO . 95.9 m -145.94 136.86 12.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.573 0.701 . . . . 64.200000000000003 111.131 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.625 ' HA ' HG23 ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.72 162.31 84.27 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.792 . . . . 64.349999999999994 112.337 -0.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.634 ' O ' HG23 ' A' ' 25' ' ' ILE . 53.8 Cg_endo -69.76 54.59 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.241 . . . . 55.329999999999998 112.351 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -172.39 86.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 73.209999999999994 111.127 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp 50.34 83.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 73.5 111.125 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -145.7 -140.22 3.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 73.010000000000005 112.487 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -130.82 137.59 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 62.219999999999999 110.867 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 t -77.29 128.43 34.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 74.510000000000005 110.876 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 71.239999999999995 110.895 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.756 0.312 . . . . 74.230000000000004 110.868 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.5 mm 64.62 114.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 74.310000000000002 111.157 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.84 160.51 7.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 41.030000000000001 111.107 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -50.79 120.48 4.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 75.230000000000004 110.835 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.85 35.63 19.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 63.420000000000002 110.905 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.53 167.1 24.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 54.32 112.45 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 152.01 44.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 70.430000000000007 110.877 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 149.9 40.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 71.340000000000003 110.827 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -72.59 -35.17 67.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 64.510000000000005 110.885 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.32 -69.88 0.37 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 74.230000000000004 112.505 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -26.67 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.78 0.324 . . . . 62.030000000000001 111.145 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.1 mt -94.71 92.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 61.109999999999999 111.135 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -88.1 8.83 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 110.874 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.84 69.55 7.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 75.450000000000003 110.925 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.5 t -99.25 103.48 15.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 64.450000000000003 110.878 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 p -50.09 -61.49 2.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 71.310000000000002 110.895 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -135.75 161.26 63.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.57 0.7 . . . . 71.400000000000006 110.911 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.76 -49.66 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.193 0 C-N-CA 122.676 -1.802 . . . . 73.129999999999995 112.35 0.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.9 -93.0 0.45 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 73.200000000000003 110.909 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -131.51 160.72 34.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 70.510000000000005 110.923 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.5 m -90.06 125.01 35.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 71.519999999999996 110.893 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.521 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -142.94 136.09 13.94 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.591 0.71 . . . . 71.319999999999993 111.116 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.78 171.08 55.46 Favored 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.689 -1.796 . . . . 64.5 112.324 -0.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -5.56 16.46 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.681 2.254 . . . . 54.0 112.337 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 1.057 HG22 HD12 ' A' ' 26' ' ' ILE . 14.0 mt -93.8 -69.37 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 53.210000000000001 111.169 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 1.057 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -153.05 115.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.519999999999996 111.14 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.27 -142.85 3.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 61.020000000000003 112.495 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.587 ' O ' HD12 ' A' ' 30' ' ' LEU . 83.2 m-85 -130.57 141.66 50.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 74.340000000000003 110.858 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.9 t -74.32 128.98 36.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 73.329999999999998 110.898 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 28' ' ' PHE . 3.5 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.918 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.813 0.34 . . . . 75.409999999999997 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm 63.83 112.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 50.520000000000003 111.155 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.49 160.78 6.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 73.129999999999995 111.088 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.62 120.24 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 73.010000000000005 110.831 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.73 35.37 19.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.340000000000003 110.904 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.63 162.92 25.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 71.319999999999993 112.473 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 151.0 45.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 72.150000000000006 110.838 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.32 149.93 40.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 65.209999999999994 110.892 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.28 -27.69 56.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 75.239999999999995 110.884 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.45 -74.65 0.37 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.739 . . . . 63.409999999999997 112.515 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -13.91 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 65.430000000000007 111.149 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 12' ' ' ILE . 6.4 tt -88.5 85.69 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 111.086 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -85.6 6.71 26.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 110.898 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.06 69.27 9.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 110.907 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.8 t -106.96 103.41 12.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 50.439999999999998 110.89 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.8 m -56.03 -64.31 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 52.32 110.872 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.497 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -131.37 160.94 64.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.559 0.695 . . . . 63.140000000000001 110.878 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.71 -49.47 0.23 Allowed 'Cis proline' 0 C--O 1.231 0.155 0 C-N-CA 122.696 -1.793 . . . . 63.149999999999999 112.354 0.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.65 -93.8 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 74.129999999999995 110.937 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -132.18 160.73 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.030000000000001 110.885 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -87.32 125.3 34.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 74.209999999999994 110.861 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.521 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -143.41 137.29 14.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.581 0.705 . . . . 74.409999999999997 111.123 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.79 171.18 55.04 Favored 'Cis proline' 0 C--O 1.232 0.195 0 C-N-CA 122.691 -1.795 . . . . 73.150000000000006 112.362 -0.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -6.47 18.68 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.651 2.234 . . . . 54.25 112.33 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.63 HG22 HG13 ' A' ' 26' ' ' ILE . 20.1 mt -95.37 -56.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 55.43 111.123 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.63 HG13 HG22 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -165.47 131.03 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 73.540000000000006 111.115 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.26 -139.09 4.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.752 -0.737 . . . . 74.140000000000001 112.531 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -131.64 141.39 49.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 74.519999999999996 110.851 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.3 t -74.11 128.57 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 70.439999999999998 110.863 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.541 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.9 pp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.477 . . . . 74.109999999999999 110.936 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.815 0.341 . . . . 73.33 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 7' ' ' LYS . 40.8 mm 63.54 110.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 51.14 111.1 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.72 160.62 7.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 74.22 111.099 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -50.83 120.34 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 65.12 110.857 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.79 35.63 19.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 75.22 110.941 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.2 166.21 23.14 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.78 -0.724 . . . . 31.55 112.466 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.468 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.21 152.31 44.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 74.33 110.91 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 149.74 40.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.911 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -73.01 -35.38 66.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 74.41 110.875 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.14 -69.37 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 51.3 112.481 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -25.96 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.337 . . . . 60.14 111.118 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.27 95.04 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 70.11 111.125 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -88.32 9.51 23.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 74.43 110.848 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.3 69.61 6.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 34.12 110.947 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.5 t -99.46 104.75 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 54.12 110.882 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -53.24 -64.61 0.77 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 60.43 110.853 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -131.86 161.83 60.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.723 . . . . 73.32 110.845 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.78 -49.55 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.213 0 C-N-CA 122.653 -1.811 . . . . 71.14 112.364 0.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -127.85 -92.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 72.23 110.927 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.442 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.47 160.36 35.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 72.03 110.936 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -88.83 126.04 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 64.34 110.891 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.568 HG23 ' HA ' ' A' ' 23' ' ' PRO . 94.5 m -145.99 135.31 11.39 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 64.4 111.136 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.79 170.41 58.74 Favored 'Cis proline' 0 C--N 1.341 0.147 0 C-N-CA 122.758 -1.767 . . . . 74.24 112.313 0.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -6.47 18.68 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.702 2.268 . . . . 61.44 112.32 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 1.042 HG22 HD12 ' A' ' 26' ' ' ILE . 14.7 mt -92.98 -69.58 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 51.41 111.1 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.042 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -152.92 119.67 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.13 111.172 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.63 -141.85 3.8 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 72.33 112.468 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -130.69 141.19 50.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 73.44 110.893 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.9 t -74.52 128.85 36.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 72.21 110.893 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.5 pp . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.9 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.796 0.331 . . . . 73.41 110.901 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 7' ' ' LYS . 44.5 mm 63.45 109.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 52.25 111.136 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.49 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 70.14 111.124 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -50.85 120.34 4.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 71.13 110.862 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.85 35.63 19.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 74.1 110.949 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.44 166.79 23.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 54.13 112.478 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.1 152.1 44.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.352 . . . . 65.3 110.893 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 149.67 40.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 71.05 110.889 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.09 -34.57 68.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 52.44 110.869 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.66 -69.68 0.31 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 73.04 112.493 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -25.97 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 72.12 111.147 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -96.35 97.32 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 63.5 111.105 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -89.29 9.97 24.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 64.44 110.879 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.13 69.94 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.937 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.6 t -101.71 105.24 16.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 62.12 110.884 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.2 m -54.15 -64.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 54.03 110.903 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -129.98 161.79 57.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.589 0.709 . . . . 52.14 110.875 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.74 -49.64 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 -1.788 . . . . 74.13 112.306 0.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.88 -91.6 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 65.14 110.907 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -130.45 160.24 34.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 54.03 110.884 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -88.48 125.12 34.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 64.24 110.874 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.585 HG23 ' HA ' ' A' ' 23' ' ' PRO . 94.8 m -147.96 136.24 11.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.572 0.701 . . . . 70.14 111.113 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.585 ' HA ' HG23 ' A' ' 22' ' ' THR . 54.6 Cg_endo -69.71 168.08 68.6 Favored 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.691 -1.796 . . . . 74.22 112.334 -0.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.29 23.21 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.628 2.218 . . . . 74.32 112.355 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 26' ' ' ILE . 3.3 pt -116.56 83.72 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 64.33 111.106 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.3 mp 61.07 103.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.097 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.01 -151.99 7.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 64.34 112.446 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.542 ' O ' HD12 ' A' ' 30' ' ' LEU . 88.5 m-85 -124.05 137.55 54.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 75.4 110.893 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.0 t -77.54 129.72 36.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 53.22 110.906 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 28' ' ' PHE . 4.6 mp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 72.31 110.912 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.819 0.343 . . . . 72.21 110.881 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 7' ' ' LYS . 41.5 mm 63.42 109.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 72.22 111.129 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.84 160.64 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 74.53 111.07 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -50.92 120.43 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 73.15 110.824 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.76 35.49 19.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 74.0 110.932 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.32 166.73 23.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.686 -0.769 . . . . 73.31 112.468 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.17 152.2 44.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 74.42 110.873 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 149.85 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 65.05 110.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.25 -28.96 61.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 72.41 110.913 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 -69.41 0.22 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 71.24 112.439 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.05 -25.46 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 63.41 111.142 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.26 96.43 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 71.13 111.126 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -88.82 9.86 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 60.02 110.855 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -80.21 69.67 6.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 74.11 110.903 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -101.56 104.98 15.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.94 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.8 m -54.6 -64.62 0.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.42 110.884 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -129.95 161.79 57.63 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 74.51 110.861 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.76 -49.44 0.23 Allowed 'Cis proline' 0 C--N 1.341 0.157 0 C-N-CA 122.695 -1.794 . . . . 63.24 112.349 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -127.72 -91.7 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 71.53 110.947 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -130.59 160.37 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.32 110.92 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.2 m -87.73 125.27 34.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 54.53 110.908 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.6 HG23 ' HA ' ' A' ' 23' ' ' PRO . 96.0 m -148.85 136.48 11.1 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.543 0.687 . . . . 63.43 111.133 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.6 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.74 167.6 70.4 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 -1.798 . . . . 74.41 112.342 -0.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -9.45 26.14 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.676 2.251 . . . . 54.12 112.375 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.458 ' C ' HD12 ' A' ' 26' ' ' ILE . 4.3 pt -112.91 79.71 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 75.51 111.14 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.3 mp 61.42 104.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 72.33 111.122 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -164.72 -146.51 4.79 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 61.14 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.21 137.49 52.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 75.21 110.843 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.4 t -77.45 129.56 35.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 74.21 110.88 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 74.1 110.969 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.793 0.33 . . . . 72.33 110.881 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 7' ' ' LYS . 47.0 mm 63.47 110.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 63.44 111.138 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.69 160.65 7.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 51.41 111.103 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -50.77 120.46 4.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 63.34 110.82 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.87 35.68 19.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.54 110.958 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.46 165.03 23.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 42.23 112.438 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.16 152.23 44.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.343 . . . . 64.45 110.92 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 150.4 39.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.86 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.499 ' HB3' HD12 ' A' ' 12' ' ' ILE . 26.1 t0 -73.64 -29.92 62.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.144 -0.48 . . . . 71.23 110.871 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.82 -69.68 0.25 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 70.42 112.511 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.64 -26.04 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 71.34 111.132 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.499 HD12 ' HB3' ' A' ' 9' ' ' ASP . 2.5 mp -95.82 95.12 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 73.22 111.16 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -89.34 9.77 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 71.31 110.879 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -80.24 69.91 6.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 73.53 110.899 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.6 t -101.57 105.37 16.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.909 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.4 m -53.83 -64.76 0.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 64.33 110.848 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.1 m-20 -131.0 161.82 59.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.581 0.705 . . . . 64.34 110.866 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.69 -49.75 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.694 -1.794 . . . . 52.12 112.397 -0.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.57 -92.19 0.49 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 71.1 110.961 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.444 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -130.61 160.35 34.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 71.33 110.871 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.79 117.46 29.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 74.52 110.871 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.539 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -139.74 139.24 21.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.608 0.718 . . . . 71.34 111.122 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.73 169.47 63.05 Favored 'Cis proline' 0 C--O 1.232 0.185 0 C-N-CA 122.66 -1.808 . . . . 72.44 112.377 -0.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -7.98 22.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.655 2.237 . . . . 71.44 112.35 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.403 ' C ' HD12 ' A' ' 26' ' ' ILE . 66.3 mt -115.05 80.98 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 61.11 111.13 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.2 mp 60.6 100.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 71.22 111.1 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.74 -146.2 4.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 71.24 112.502 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -130.39 138.4 50.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.379 . . . . 65.42 110.85 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 t -76.8 128.97 35.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 72.31 110.879 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 51.2 110.905 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.813 0.339 . . . . 75.44 110.901 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.2 mm 63.77 118.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.24 111.131 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.38 159.82 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 64.31 111.064 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -51.28 118.24 3.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 74.22 110.866 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 60.44 35.83 20.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 75.4 110.941 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.72 167.06 31.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 32.31 112.489 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 152.64 43.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 71.55 110.943 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.07 154.88 31.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 70.14 110.865 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -72.91 -35.12 67.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.31 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.13 -69.57 0.29 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.759 -0.734 . . . . 72.25 112.514 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -26.04 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.759 0.314 . . . . 54.3 111.14 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mt -97.16 98.51 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 63.12 111.174 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -89.59 9.83 25.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 63.23 110.89 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.11 69.94 6.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 73.34 110.916 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.9 t -100.0 106.29 18.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 61.13 110.909 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.7 m -52.62 -64.91 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.12 110.873 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.504 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -132.66 161.43 63.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.565 0.697 . . . . 72.31 110.904 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.77 -49.83 0.21 Allowed 'Cis proline' 0 C--N 1.341 0.166 0 C-N-CA 122.685 -1.798 . . . . 63.44 112.365 0.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.31 -92.07 0.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 73.05 110.954 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -130.45 160.37 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.873 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -90.26 118.64 29.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 70.44 110.859 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -140.35 138.96 19.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 64.24 111.121 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.78 169.42 63.52 Favored 'Cis proline' 0 C--N 1.342 0.22 0 C-N-CA 122.665 -1.806 . . . . 65.0 112.356 -0.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -7.83 22.05 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.676 2.251 . . . . 43.41 112.351 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -115.14 80.93 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 73.4 111.145 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 60.4 100.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.04 111.108 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.69 -146.29 4.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 73.22 112.486 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -130.16 137.93 50.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 70.44 110.875 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.21 131.78 38.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 75.52 110.89 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 30' ' ' LEU . 2.8 pp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 61.43 110.911 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.79 0.329 . . . . 72.24 110.871 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 7' ' ' LYS . 40.5 mm 63.37 109.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 73.51 111.104 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.67 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 74.24 111.085 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -50.78 120.35 4.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 54.43 110.847 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.88 35.62 19.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 73.45 110.863 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.09 165.94 23.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 43.31 112.499 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.26 152.39 44.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.861 0.362 . . . . 73.22 110.893 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.92 149.89 40.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 60.12 110.852 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -76.39 -35.41 58.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 74.02 110.845 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.04 -69.22 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 65.54 112.531 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.72 -25.88 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.34 . . . . 63.22 111.129 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.9 mp -97.3 93.33 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 74.41 111.16 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -88.16 9.5 22.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 70.24 110.926 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -80.29 69.6 6.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 71.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.5 t -99.53 104.74 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 43.14 110.871 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.0 m -54.69 -64.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 60.54 110.897 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -130.64 161.63 59.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 72.15 110.848 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.76 -49.52 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.673 -1.803 . . . . 62.25 112.314 0.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.64 -92.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 75.3 110.887 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.09 160.12 35.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.34 110.882 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.57 126.16 35.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 64.23 110.892 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 23' ' ' PRO . 96.0 m -145.48 135.39 11.72 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.713 . . . . 72.13 111.147 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.575 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.79 170.34 59.09 Favored 'Cis proline' 0 C--N 1.341 0.153 0 C-N-CA 122.648 -1.813 . . . . 74.41 112.354 -0.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -6.67 19.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 50.41 112.333 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 1.066 HG22 HD12 ' A' ' 26' ' ' ILE . 12.9 mt -92.95 -69.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 73.14 111.147 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.066 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -152.87 120.09 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 41.3 111.145 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.13 -141.91 3.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 65.35 112.462 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -130.73 141.24 50.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.391 . . . . 62.21 110.865 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.7 t -74.4 128.66 36.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 73.23 110.9 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 64.12 110.896 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.845 0.355 . . . . 63.31 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 7' ' ' LYS . 39.6 mm 63.43 109.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 62.42 111.11 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.93 160.51 7.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 61.41 111.093 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -50.8 120.4 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 73.0 110.862 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.79 35.58 19.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 74.12 110.961 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.21 166.69 23.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.732 -0.747 . . . . 70.12 112.451 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.27 152.19 44.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.795 0.331 . . . . 74.4 110.925 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.17 149.85 40.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 71.13 110.898 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.479 ' OD2' HD12 ' A' ' 12' ' ' ILE . 7.2 m-20 -75.27 -35.16 61.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 74.12 110.84 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.2 -70.01 0.37 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 75.21 112.502 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -25.36 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 73.12 111.117 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.479 HD12 ' OD2' ' A' ' 9' ' ' ASP . 8.3 mt -94.66 93.75 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 65.22 111.105 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.16 9.08 24.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 75.21 110.845 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -80.86 69.46 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 71.41 110.929 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 t -99.56 104.6 16.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 72.32 110.904 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.8 m -54.62 -64.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 70.21 110.882 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -131.81 161.72 60.78 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.601 0.715 . . . . 72.32 110.888 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.79 -49.64 0.22 Allowed 'Cis proline' 0 C--O 1.232 0.179 0 C-N-CA 122.695 -1.794 . . . . 72.34 112.28 0.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.64 -92.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 71.32 110.945 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.02 160.22 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 54.42 110.902 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.49 126.28 35.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.872 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 23' ' ' PRO . 95.5 m -145.4 135.48 11.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.561 0.696 . . . . 73.31 111.182 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.73 170.23 59.33 Favored 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.685 -1.798 . . . . 74.22 112.359 -0.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.83 19.53 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.705 2.27 . . . . 54.54 112.323 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 1.07 HG22 HD12 ' A' ' 26' ' ' ILE . 11.9 mt -92.68 -69.34 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 74.22 111.133 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.07 HD12 HG22 ' A' ' 25' ' ' ILE . 2.7 mp -152.8 119.58 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 61.03 111.113 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.68 -142.2 3.94 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.775 -0.726 . . . . 74.04 112.501 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -130.79 141.4 50.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 70.22 110.867 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.5 t -74.06 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 73.31 110.902 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 30' ' ' LEU . 1.7 pt? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 75.21 110.879 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.776 0.322 . . . . 63.23 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 7' ' ' LYS . 48.0 mm 63.67 110.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 73.25 111.112 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.72 160.7 7.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 71.3 111.095 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -50.81 120.35 4.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 73.05 110.879 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 60.81 35.6 19.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.946 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.51 165.78 23.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.738 -0.744 . . . . 73.35 112.466 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.403 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.22 152.22 44.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 62.33 110.931 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 149.82 40.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 42.33 110.878 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.42 -33.49 67.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 70.42 110.868 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.37 -73.19 0.33 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.738 -0.744 . . . . 75.12 112.506 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -25.93 32.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.833 0.349 . . . . 64.45 111.134 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.2 mt -90.7 93.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 62.43 111.159 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -88.06 9.12 23.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 64.21 110.847 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.79 69.71 7.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.947 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -102.03 104.8 15.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.868 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.9 m -54.81 -64.54 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 51.42 110.855 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -131.21 160.97 64.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.601 0.715 . . . . 63.34 110.882 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.8 -49.72 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.701 -1.791 . . . . 72.11 112.327 0.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -128.53 -93.02 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 73.51 110.909 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.4 160.35 35.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 72.4 110.907 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.8 m -88.28 125.96 34.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.877 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 23' ' ' PRO . 93.9 m -146.15 135.38 11.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.575 0.703 . . . . 73.32 111.144 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.564 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.79 170.34 59.08 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.687 -1.797 . . . . 70.43 112.331 -0.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -6.64 19.11 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.704 2.269 . . . . 72.23 112.32 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 1.044 HG22 HD12 ' A' ' 26' ' ' ILE . 14.5 mt -92.58 -69.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 71.22 111.108 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.044 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -153.04 119.72 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.41 111.146 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.99 -141.93 3.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.773 -0.727 . . . . 32.3 112.479 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -130.65 141.52 50.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 71.22 110.883 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.0 t -74.17 128.33 35.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 74.24 110.874 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 71.45 110.896 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.788 0.327 . . . . 70.0 110.869 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 7' ' ' LYS . 51.9 mm 63.57 112.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 70.04 111.109 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.35 161.31 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 52.11 111.147 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -50.14 120.41 4.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 43.13 110.852 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.8 35.25 19.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 73.34 110.981 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.68 155.55 19.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.697 -0.763 . . . . 74.12 112.499 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' NZ ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -70.36 150.26 46.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 70.14 110.849 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.28 161.79 19.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.3 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.579 ' HB3' HD12 ' A' ' 12' ' ' ILE . 26.9 t70 -67.72 -32.68 73.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.41 110.856 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.13 -69.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 73.42 112.486 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -25.82 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 72.12 111.121 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 9' ' ' ASP . 2.7 mp -89.95 97.13 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.43 111.149 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.84 9.85 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 50.33 110.866 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -80.14 69.73 6.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 71.31 110.857 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.2 t -102.22 104.85 15.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.44 110.846 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.2 m -53.98 -64.78 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 71.41 110.871 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -131.63 161.63 61.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 63.32 110.837 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.85 -49.57 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.713 -1.786 . . . . 64.34 112.328 0.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -129.67 -91.39 0.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 72.24 110.925 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.18 160.2 34.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 61.5 110.946 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.19 119.81 32.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 61.42 110.854 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -139.25 139.56 23.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.576 0.703 . . . . 63.41 111.166 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.79 169.71 62.15 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.793 . . . . 70.45 112.359 -0.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -7.87 22.16 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 64.11 112.369 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.412 ' C ' HD12 ' A' ' 26' ' ' ILE . 6.1 pt -114.91 83.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 71.4 111.125 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.487 HG23 ' NZ ' ' A' ' 7' ' ' LYS . 5.3 mp 61.28 86.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 51.45 111.114 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.39 -157.48 7.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 53.34 112.525 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.23 138.36 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.395 . . . . 64.34 110.817 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.04 129.4 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 75.25 110.874 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.885 -180.0 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.826 0.346 . . . . 71.2 110.889 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 7' ' ' LYS . 49.3 mm 63.79 111.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.127 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.87 161.01 6.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 74.43 111.097 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -50.71 120.46 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 75.14 110.873 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.84 35.11 19.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 64.44 110.913 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.41 161.69 18.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 44.44 112.488 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.3 150.3 46.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.851 0.358 . . . . 64.22 110.899 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -119.53 160.84 21.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 52.21 110.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -69.06 -34.96 76.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 60.32 110.866 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.79 -69.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.71 -0.757 . . . . 64.11 112.493 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -25.72 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 70.1 111.19 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.5 mt -90.12 100.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 72.13 111.144 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.41 9.13 21.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 73.32 110.924 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -80.63 69.66 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 75.34 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.1 t -102.82 104.78 15.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 52.22 110.813 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.0 m -55.32 -64.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.11 110.86 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -132.83 161.46 63.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 73.22 110.864 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.75 -49.68 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 -1.805 . . . . 64.22 112.342 0.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -128.08 -91.96 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.895 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -130.67 160.61 33.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 72.53 110.924 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.0 t -89.94 119.46 30.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 73.22 110.843 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.541 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -141.11 138.87 18.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.56 0.695 . . . . 72.34 111.184 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.69 169.29 63.77 Favored 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.678 -1.801 . . . . 64.32 112.354 -0.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.09 22.73 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.637 2.225 . . . . 74.33 112.346 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.42 ' C ' HD12 ' A' ' 26' ' ' ILE . 68.1 mt -114.73 80.29 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 62.11 111.127 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.469 HG23 ' NZ ' ' A' ' 7' ' ' LYS . 5.3 mp 60.97 101.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 65.33 111.104 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.79 -145.75 4.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 72.1 112.467 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -130.14 137.97 50.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.946 0.403 . . . . 75.31 110.865 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.13 129.3 35.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 54.4 110.879 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 62.4 110.935 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.812 0.339 . . . . 64.04 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 7' ' ' LYS . 41.6 mm 63.37 110.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.22 111.175 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.59 7.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 74.01 111.108 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -50.85 120.29 4.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 72.42 110.896 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.81 35.59 19.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 75.03 110.9 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.63 166.0 23.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 72.03 112.532 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.27 152.03 44.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 63.22 110.928 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.23 149.77 40.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 73.51 110.84 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -74.48 -34.9 63.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 73.4 110.848 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.42 -70.19 0.37 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 71.13 112.525 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.43 -25.43 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 75.4 111.185 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 mt -94.1 93.26 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 74.41 111.123 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -88.0 8.99 23.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.41 110.908 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -80.94 69.52 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 72.44 110.92 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 t -100.57 104.75 16.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 74.03 110.84 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 m -54.98 -64.43 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 74.3 110.848 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -131.54 161.37 62.59 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 55.12 110.862 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.78 -49.74 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.225 0 C-N-CA 122.674 -1.803 . . . . 72.12 112.307 0.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -128.97 -92.56 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 74.34 110.882 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -131.0 160.45 34.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 74.23 110.908 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.82 125.3 35.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 62.35 110.893 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.522 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -144.2 136.36 13.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.574 0.702 . . . . 64.34 111.159 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.83 170.99 56.09 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.648 -1.813 . . . . 75.13 112.346 -0.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -5.68 16.74 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 75.12 112.362 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 1.055 HG22 HD12 ' A' ' 26' ' ' ILE . 14.4 mt -93.68 -69.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 73.44 111.157 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.055 HD12 HG22 ' A' ' 25' ' ' ILE . 2.5 mp -153.09 115.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 74.13 111.098 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.1 -143.08 3.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 53.11 112.466 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -130.68 141.59 50.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.877 0.37 . . . . 74.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.2 t -73.99 128.22 34.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 73.24 110.864 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 62.23 110.953 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 13.6 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 73.21 110.878 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.5 mm 62.5 109.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 72.45 111.155 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.31 160.05 11.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 61.35 111.052 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.66 120.92 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 72.12 110.85 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 61.12 36.15 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 71.14 110.893 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.25 169.63 29.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.783 -0.723 . . . . 72.31 112.462 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 154.93 41.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.342 . . . . 73.55 110.884 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -116.06 149.75 38.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 43.53 110.89 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.55 -32.27 69.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 64.12 110.837 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.22 -79.38 0.29 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.737 -0.744 . . . . 75.51 112.483 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -25.11 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 70.02 111.075 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.71 101.0 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 53.14 111.145 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -86.01 9.51 16.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 73.44 110.864 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -79.83 69.56 6.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 75.43 110.925 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.12 105.44 17.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 64.23 110.841 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -50.7 -72.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 71.51 110.887 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -135.31 159.5 71.54 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.578 0.704 . . . . 74.03 110.896 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.78 -49.43 0.23 Allowed 'Cis proline' 0 C--O 1.232 0.179 0 C-N-CA 122.717 -1.784 . . . . 74.41 112.33 0.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -130.42 -91.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.879 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.59 160.27 34.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 74.24 110.935 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 23.7 p -95.42 126.44 40.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 63.5 110.848 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.543 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -136.87 140.89 33.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.569 0.7 . . . . 64.35 111.109 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.74 170.41 58.53 Favored 'Cis proline' 0 C--N 1.342 0.199 0 C-N-CA 122.694 -1.794 . . . . 63.02 112.35 -0.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -5.14 15.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.652 2.235 . . . . 64.53 112.382 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.473 ' C ' HD12 ' A' ' 26' ' ' ILE . 33.7 mt -108.52 73.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 53.13 111.131 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.473 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.4 mp 62.13 98.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 61.45 111.167 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.05 -143.63 3.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 63.23 112.54 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -130.77 139.52 50.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.377 . . . . 64.5 110.846 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -76.27 128.71 35.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 53.21 110.887 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 61.24 110.895 179.963 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.808 0.337 . . . . 72.15 110.876 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.445 HD12 ' O ' ' A' ' 7' ' ' LYS . 43.3 mm 63.43 110.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 71.34 111.162 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.65 160.92 6.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.32 111.109 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.58 120.23 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 74.24 110.857 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.75 35.44 19.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.32 110.91 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.09 164.71 23.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 72.43 112.47 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.3 152.33 44.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.341 . . . . 72.31 110.925 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 149.84 40.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 31.34 110.882 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -74.6 -35.16 62.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 72.3 110.864 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.35 -69.36 0.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 73.32 112.446 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.86 -25.92 30.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.784 0.326 . . . . 74.43 111.091 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -96.85 93.58 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.13 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -88.22 9.44 22.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 63.3 110.903 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -80.29 69.6 6.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 71.02 110.909 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.6 t -100.39 104.82 16.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 61.35 110.871 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.3 m -54.44 -64.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.875 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -130.53 161.74 58.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.602 0.715 . . . . 44.32 110.879 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.71 -49.53 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.15 0 C-N-CA 122.737 -1.776 . . . . 62.33 112.34 -0.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.49 -93.04 0.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.54 110.925 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.47 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -131.63 160.14 36.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 70.44 110.883 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.77 126.1 35.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 63.11 110.866 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 23' ' ' PRO . 94.4 m -146.07 135.79 11.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.608 0.718 . . . . 75.2 111.132 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.586 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.73 170.44 58.33 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.684 -1.799 . . . . 72.25 112.345 -0.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -7.62 21.52 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 75.14 112.329 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.637 HG22 HG13 ' A' ' 26' ' ' ILE . 18.5 mt -93.4 -58.89 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 74.44 111.164 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.637 HG13 HG22 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -163.22 130.67 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 52.12 111.102 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.71 -139.33 4.99 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.751 -0.738 . . . . 34.41 112.508 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -131.33 140.72 49.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 74.15 110.88 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.1 t -75.29 128.51 35.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 62.12 110.875 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 71.24 110.914 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.772 0.32 . . . . 70.31 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.2 mm 63.36 110.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 73.52 111.106 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.66 160.69 6.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.41 111.059 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -50.62 120.42 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 75.33 110.82 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.83 35.6 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 54.41 110.922 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.27 165.23 23.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 64.44 112.498 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 152.47 44.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 74.35 110.899 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.87 149.89 40.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.888 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.12 -33.92 38.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 72.42 110.867 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.51 -69.26 0.39 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 43.42 112.433 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -25.88 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 71.13 111.126 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.55 90.44 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 53.02 111.127 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -88.03 9.4 22.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.04 110.881 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -80.33 69.61 6.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.52 110.942 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.9 t -99.92 104.67 16.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.857 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -54.49 -64.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 75.33 110.863 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -129.94 161.63 58.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 61.14 110.87 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.67 -49.54 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.671 -1.804 . . . . 71.35 112.373 -0.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -129.16 -91.88 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.937 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -130.83 160.23 35.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 63.23 110.934 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 m -91.94 125.54 36.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.9 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.527 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -142.41 137.35 15.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.612 0.72 . . . . 41.24 111.122 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.71 171.02 55.4 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.712 -1.786 . . . . 43.43 112.369 -0.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -7.02 20.01 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.695 2.264 . . . . 71.41 112.353 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.634 HG22 HG13 ' A' ' 26' ' ' ILE . 21.6 mt -94.89 -56.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 72.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.634 HG13 HG22 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -164.93 129.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 70.41 111.144 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.97 -140.76 5.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 71.23 112.485 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -131.15 140.98 50.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 71.21 110.878 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -74.56 128.95 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 52.03 110.861 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 73.04 110.956 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.83 0.348 . . . . 73.45 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 7' ' ' LYS . 45.7 mm 63.26 109.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 45.41 111.122 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 161.07 11.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 61.32 111.089 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -50.13 120.46 4.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 71.54 110.871 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 60.8 36.01 19.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 71.31 110.906 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.07 164.64 20.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 74.11 112.49 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.524 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -66.86 154.35 41.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 65.21 110.874 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.37 149.57 39.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 73.34 110.886 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.43 -22.25 51.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.32 110.877 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.07 -77.33 0.22 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 73.34 112.509 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -25.08 29.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 63.45 111.107 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.448 HG23 HE21 ' A' ' 14' ' ' GLN . 39.4 mt -89.59 97.53 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 65.43 111.117 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.93 7.48 27.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 60.03 110.886 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.448 HE21 HG23 ' A' ' 12' ' ' ILE . 3.1 mp0 -80.02 69.35 6.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 72.31 110.899 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.37 106.62 18.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 63.14 110.893 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -49.67 -72.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 62.53 110.865 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.497 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -135.27 160.7 67.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 63.05 110.878 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.73 -49.8 0.21 Allowed 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.716 -1.785 . . . . 73.43 112.352 -0.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -130.51 -91.53 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 75.14 110.917 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.9 160.65 33.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 72.31 110.983 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 24.4 p -94.4 126.81 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.24 110.87 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.542 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -136.34 140.96 34.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.605 0.717 . . . . 64.21 111.107 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.0 Cg_endo -69.82 170.61 57.91 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 -1.802 . . . . 71.22 112.291 -0.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -3.75 12.61 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.667 2.245 . . . . 53.41 112.365 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 26' ' ' ILE . 32.3 mt -109.85 72.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 75.11 111.139 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.2 mp 62.65 99.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 61.43 111.116 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.46 -143.21 3.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.702 -0.761 . . . . 52.14 112.458 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -130.52 139.74 50.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.928 0.394 . . . . 73.51 110.886 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -76.1 129.05 36.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 73.44 110.86 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 63.22 110.978 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.863 0.363 . . . . 43.12 110.924 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.2 mm 63.52 111.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 72.24 111.087 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.73 160.48 7.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 72.33 111.061 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -50.98 120.26 4.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.813 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.71 35.6 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.51 110.909 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.52 166.37 24.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 71.43 112.518 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 152.41 44.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 64.14 110.915 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 149.96 40.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 75.31 110.857 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.62 -22.75 66.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 75.02 110.836 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.24 -87.84 0.42 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.671 -0.776 . . . . 71.45 112.48 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -25.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 63.35 111.12 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.54 93.52 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 70.45 111.18 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -100.51 19.69 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 70.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.27 70.38 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 73.24 110.9 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 p -107.53 111.0 23.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 52.24 110.865 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.2 m -39.58 -63.56 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 72.34 110.879 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.2 m-20 -128.1 162.56 49.34 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.623 0.725 . . . . 74.31 110.803 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.5 Cg_endo -69.78 -50.92 0.17 OUTLIER 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.712 -1.787 . . . . 73.0 112.312 0.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -130.47 -93.8 0.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 75.23 110.923 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -126.88 161.34 28.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 73.32 110.897 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.1 m -85.63 125.97 33.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 50.43 110.891 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.535 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -153.2 138.23 11.35 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.586 0.707 . . . . 72.2 111.18 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.72 169.38 63.47 Favored 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 -1.79 . . . . 53.2 112.331 -0.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -8.4 23.52 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 54.33 112.34 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.18 92.18 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 75.54 111.132 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 50.19 85.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 65.53 111.109 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.51 -152.24 5.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.741 -0.742 . . . . 75.41 112.481 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -130.88 140.72 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 73.52 110.861 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 4.1 t -74.1 126.47 30.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 74.31 110.876 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 30' ' ' LEU . 1.6 pt? . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 72.13 110.904 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.852 0.358 . . . . 44.12 110.935 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 7' ' ' LYS . 39.8 mm 63.45 110.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 60.31 111.153 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.59 7.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.081 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -50.93 120.28 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 65.43 110.843 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.85 35.69 19.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.914 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.18 166.58 23.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 31.24 112.492 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.684 ' NZ ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -70.11 151.92 44.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.773 0.32 . . . . 64.44 110.918 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 149.71 40.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 60.04 110.857 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -74.02 -35.42 64.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.0 110.87 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.02 -69.38 0.34 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 60.2 112.478 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -25.86 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 72.42 111.168 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.67 94.78 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 65.33 111.108 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -88.16 9.45 22.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 51.34 110.899 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -80.4 69.56 6.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 62.54 110.888 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.5 t -101.2 104.82 15.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 73.34 110.884 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.9 m -53.39 -64.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 62.12 110.845 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -131.89 161.71 60.93 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.602 0.715 . . . . 73.14 110.867 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.84 -49.52 0.23 Allowed 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 -1.805 . . . . 62.22 112.331 0.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -128.23 -92.93 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 75.3 110.884 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -131.51 160.45 35.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 71.55 110.863 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.4 m -90.13 125.18 35.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 65.41 110.877 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -143.33 136.64 14.03 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.594 0.712 . . . . 54.23 111.128 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.8 170.63 57.71 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.617 -1.826 . . . . 63.34 112.352 -0.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 2.32 3.66 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.703 2.269 . . . . 72.43 112.314 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.608 ' HB ' HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -107.65 -65.56 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 34.11 111.099 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.684 HG23 ' NZ ' ' A' ' 7' ' ' LYS . 4.2 mp -148.36 123.93 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.34 111.141 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 23' ' ' PRO . . . 176.93 -147.08 8.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 72.23 112.487 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.493 ' O ' HD12 ' A' ' 30' ' ' LEU . 81.0 m-85 -130.94 142.19 50.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 73.2 110.922 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.8 t -73.15 128.27 34.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 55.21 110.909 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 63.1 110.88 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.845 0.355 . . . . 72.21 110.883 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 7' ' ' LYS . 35.2 mm 65.01 115.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 75.32 111.075 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.73 7.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 74.22 111.071 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.81 120.3 4.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 55.43 110.86 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.74 35.26 19.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 74.24 110.914 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.42 170.19 24.28 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 63.03 112.508 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.563 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -69.92 152.85 44.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 72.53 110.924 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.1 156.73 28.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 62.45 110.888 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.24 -28.55 38.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 64.41 110.894 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.19 -69.58 0.21 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 74.41 112.487 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -26.09 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 62.34 111.156 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.89 99.97 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 61.21 111.148 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -89.01 9.65 24.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 63.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -80.24 69.83 6.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 73.14 110.947 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.0 t -103.97 103.51 13.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 61.34 110.862 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 p -49.75 -62.17 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 71.35 110.841 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.507 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -136.34 160.94 64.94 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.573 0.701 . . . . 51.03 110.893 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.77 -50.23 0.2 OUTLIER 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.662 -1.807 . . . . 74.05 112.388 0.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -130.6 -93.81 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 74.11 110.952 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.84 160.94 35.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.926 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.8 m -84.0 125.65 32.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 50.14 110.861 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 23' ' ' PRO . 95.9 m -145.94 136.86 12.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.573 0.701 . . . . 64.2 111.131 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.625 ' HA ' HG23 ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.72 162.31 84.27 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.792 . . . . 64.35 112.337 -0.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.634 ' O ' HG23 ' A' ' 25' ' ' ILE . 53.8 Cg_endo -69.76 54.59 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.241 . . . . 55.33 112.351 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -172.39 86.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 73.21 111.127 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp 50.34 83.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 73.5 111.125 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -145.7 -140.22 3.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 73.01 112.487 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -130.82 137.59 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 62.22 110.867 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 t -77.29 128.43 34.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 74.51 110.876 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 71.24 110.895 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.756 0.312 . . . . 74.23 110.868 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.5 mm 64.62 114.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 74.31 111.157 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.84 160.51 7.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 41.03 111.107 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -50.79 120.48 4.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 75.23 110.835 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.85 35.63 19.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 63.42 110.905 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.53 167.1 24.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 54.32 112.45 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 152.01 44.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 70.43 110.877 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 149.9 40.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 71.34 110.827 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -72.59 -35.17 67.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 64.51 110.885 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.32 -69.88 0.37 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 74.23 112.505 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -26.67 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.78 0.324 . . . . 62.03 111.145 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.1 mt -94.71 92.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 61.11 111.135 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -88.1 8.83 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 74.41 110.874 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.84 69.55 7.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.925 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.5 t -99.25 103.48 15.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 64.45 110.878 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 p -50.09 -61.49 2.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 71.31 110.895 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -135.75 161.26 63.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.57 0.7 . . . . 71.4 110.911 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.76 -49.66 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.193 0 C-N-CA 122.676 -1.802 . . . . 73.13 112.35 0.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.9 -93.0 0.45 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 73.2 110.909 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -131.51 160.72 34.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 70.51 110.923 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.5 m -90.06 125.01 35.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 71.52 110.893 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.521 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -142.94 136.09 13.94 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.591 0.71 . . . . 71.32 111.116 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.78 171.08 55.46 Favored 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.689 -1.796 . . . . 64.5 112.324 -0.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -5.56 16.46 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.681 2.254 . . . . 54.0 112.337 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 1.057 HG22 HD12 ' A' ' 26' ' ' ILE . 14.0 mt -93.8 -69.37 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 53.21 111.169 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 1.057 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -153.05 115.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.52 111.14 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.27 -142.85 3.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 61.02 112.495 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.587 ' O ' HD12 ' A' ' 30' ' ' LEU . 83.2 m-85 -130.57 141.66 50.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 74.34 110.858 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.9 t -74.32 128.98 36.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 73.33 110.898 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 28' ' ' PHE . 3.5 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.918 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.813 0.34 . . . . 75.41 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm 63.83 112.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 50.52 111.155 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.49 160.78 6.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 73.13 111.088 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.62 120.24 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 73.01 110.831 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.73 35.37 19.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.904 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.63 162.92 25.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 71.32 112.473 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 151.0 45.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 72.15 110.838 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.32 149.93 40.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 65.21 110.892 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.28 -27.69 56.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 75.24 110.884 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.45 -74.65 0.37 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.739 . . . . 63.41 112.515 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -13.91 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 65.43 111.149 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 12' ' ' ILE . 6.4 tt -88.5 85.69 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 72.14 111.086 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -85.6 6.71 26.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.33 110.898 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.06 69.27 9.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 72.43 110.907 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.8 t -106.96 103.41 12.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 50.44 110.89 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.8 m -56.03 -64.31 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 52.32 110.872 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.497 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -131.37 160.94 64.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.559 0.695 . . . . 63.14 110.878 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.71 -49.47 0.23 Allowed 'Cis proline' 0 C--O 1.231 0.155 0 C-N-CA 122.696 -1.793 . . . . 63.15 112.354 0.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.65 -93.8 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 74.13 110.937 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -132.18 160.73 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.03 110.885 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -87.32 125.3 34.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 74.21 110.861 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.521 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -143.41 137.29 14.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.581 0.705 . . . . 74.41 111.123 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.79 171.18 55.04 Favored 'Cis proline' 0 C--O 1.232 0.195 0 C-N-CA 122.691 -1.795 . . . . 73.15 112.362 -0.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -6.47 18.68 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.651 2.234 . . . . 54.25 112.33 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.63 HG22 HG13 ' A' ' 26' ' ' ILE . 20.1 mt -95.37 -56.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 55.43 111.123 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.63 HG13 HG22 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -165.47 131.03 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 73.54 111.115 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.26 -139.09 4.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.752 -0.737 . . . . 74.14 112.531 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -131.64 141.39 49.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 74.52 110.851 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.3 t -74.11 128.57 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 70.44 110.863 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.541 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.9 pp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.477 . . . . 74.11 110.936 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.815 0.341 . . . . 73.33 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 7' ' ' LYS . 40.8 mm 63.54 110.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 51.14 111.1 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.72 160.62 7.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 74.22 111.099 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -50.83 120.34 4.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 65.12 110.857 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.79 35.63 19.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 75.22 110.941 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.2 166.21 23.14 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.78 -0.724 . . . . 31.55 112.466 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.21 152.31 44.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 74.33 110.91 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.08 149.74 40.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 74.31 110.911 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -73.01 -35.38 66.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 74.41 110.875 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.14 -69.37 0.34 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 51.3 112.481 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.97 -25.96 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.807 0.337 . . . . 60.14 111.118 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.27 95.04 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 70.11 111.125 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -88.32 9.51 23.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 74.43 110.848 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.3 69.61 6.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 34.12 110.947 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.5 t -99.46 104.75 16.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 54.12 110.882 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -53.24 -64.61 0.77 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.164 -0.471 . . . . 60.43 110.853 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -131.86 161.83 60.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.617 0.723 . . . . 73.32 110.845 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.78 -49.55 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.213 0 C-N-CA 122.653 -1.811 . . . . 71.14 112.364 0.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -127.85 -92.91 0.47 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.444 . . . . 72.23 110.927 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.442 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.47 160.36 35.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 72.03 110.936 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.2 m -88.83 126.04 35.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 64.34 110.891 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.568 HG23 ' HA ' ' A' ' 23' ' ' PRO . 94.5 m -145.99 135.31 11.39 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.597 0.713 . . . . 64.4 111.136 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.79 170.41 58.74 Favored 'Cis proline' 0 C--N 1.341 0.147 0 C-N-CA 122.758 -1.767 . . . . 74.24 112.313 0.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -6.47 18.68 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.702 2.268 . . . . 61.44 112.32 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 1.042 HG22 HD12 ' A' ' 26' ' ' ILE . 14.7 mt -92.98 -69.58 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 51.41 111.1 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.042 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -152.92 119.67 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.13 111.172 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.63 -141.85 3.8 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.723 -0.751 . . . . 72.33 112.468 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -130.69 141.19 50.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 73.44 110.893 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.9 t -74.52 128.85 36.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 72.21 110.893 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.5 pp . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.11 110.9 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.796 0.331 . . . . 73.41 110.901 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 7' ' ' LYS . 44.5 mm 63.45 109.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.46 . . . . 52.25 111.136 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.49 7.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 70.14 111.124 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -50.85 120.34 4.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 71.13 110.862 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.85 35.63 19.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 74.1 110.949 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.44 166.79 23.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.751 -0.738 . . . . 54.13 112.478 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.463 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.1 152.1 44.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.838 0.352 . . . . 65.3 110.893 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 149.67 40.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 71.05 110.889 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -72.09 -34.57 68.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.147 -0.479 . . . . 52.44 110.869 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.66 -69.68 0.31 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.727 -0.749 . . . . 73.04 112.493 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.62 -25.97 33.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 72.12 111.147 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -96.35 97.32 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 63.5 111.105 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -89.29 9.97 24.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.137 -0.483 . . . . 64.44 110.879 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -80.13 69.94 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.937 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.6 t -101.71 105.24 16.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 62.12 110.884 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.2 m -54.15 -64.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 54.03 110.903 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -129.98 161.79 57.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.589 0.709 . . . . 52.14 110.875 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.74 -49.64 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.161 0 C-N-CA 122.709 -1.788 . . . . 74.13 112.306 0.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.88 -91.6 0.49 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 65.14 110.907 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -130.45 160.24 34.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 54.03 110.884 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -88.48 125.12 34.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 64.24 110.874 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.585 HG23 ' HA ' ' A' ' 23' ' ' PRO . 94.8 m -147.96 136.24 11.21 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.572 0.701 . . . . 70.14 111.113 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.585 ' HA ' HG23 ' A' ' 22' ' ' THR . 54.6 Cg_endo -69.71 168.08 68.6 Favored 'Cis proline' 0 C--N 1.341 0.16 0 C-N-CA 122.691 -1.796 . . . . 74.22 112.334 -0.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -8.29 23.21 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.628 2.218 . . . . 74.32 112.355 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.419 ' C ' HD12 ' A' ' 26' ' ' ILE . 3.3 pt -116.56 83.72 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 64.33 111.106 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.3 mp 61.07 103.15 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.097 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.01 -151.99 7.0 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 64.34 112.446 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.542 ' O ' HD12 ' A' ' 30' ' ' LEU . 88.5 m-85 -124.05 137.55 54.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 75.4 110.893 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.0 t -77.54 129.72 36.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 53.22 110.906 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.542 HD12 ' O ' ' A' ' 28' ' ' PHE . 4.6 mp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 72.31 110.912 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.819 0.343 . . . . 72.21 110.881 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.473 HD12 ' O ' ' A' ' 7' ' ' LYS . 41.5 mm 63.42 109.91 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 72.22 111.129 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.84 160.64 7.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 74.53 111.07 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -50.92 120.43 4.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 73.15 110.824 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.76 35.49 19.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 74.0 110.932 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.32 166.73 23.25 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.686 -0.769 . . . . 73.31 112.468 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.17 152.2 44.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 74.42 110.873 -179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 149.85 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 65.05 110.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -74.25 -28.96 61.47 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 72.41 110.913 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.62 -69.41 0.22 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.725 -0.75 . . . . 71.24 112.439 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.05 -25.46 29.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.831 0.348 . . . . 63.41 111.142 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.0 mt -97.26 96.43 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 71.13 111.126 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -88.82 9.86 23.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 60.02 110.855 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -80.21 69.67 6.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 74.11 110.903 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 t -101.56 104.98 15.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.94 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.8 m -54.6 -64.62 0.78 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.42 110.884 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -129.95 161.79 57.63 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 74.51 110.861 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.76 -49.44 0.23 Allowed 'Cis proline' 0 C--N 1.341 0.157 0 C-N-CA 122.695 -1.794 . . . . 63.24 112.349 0.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -127.72 -91.7 0.49 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 71.53 110.947 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -130.59 160.37 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.32 110.92 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.2 m -87.73 125.27 34.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 54.53 110.908 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.6 HG23 ' HA ' ' A' ' 23' ' ' PRO . 96.0 m -148.85 136.48 11.1 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.543 0.687 . . . . 63.43 111.133 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.6 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.74 167.6 70.4 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.686 -1.798 . . . . 74.41 112.342 -0.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -9.45 26.14 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.676 2.251 . . . . 54.12 112.375 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.458 ' C ' HD12 ' A' ' 26' ' ' ILE . 4.3 pt -112.91 79.71 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 75.51 111.14 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.3 mp 61.42 104.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 72.33 111.122 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -164.72 -146.51 4.79 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 61.14 112.471 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.21 137.49 52.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.939 0.4 . . . . 75.21 110.843 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.4 t -77.45 129.56 35.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 74.21 110.88 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 74.1 110.969 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.793 0.33 . . . . 72.33 110.881 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.419 HD12 ' O ' ' A' ' 7' ' ' LYS . 47.0 mm 63.47 110.58 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 63.44 111.138 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.69 160.65 7.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 51.41 111.103 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -50.77 120.46 4.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 63.34 110.82 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.87 35.68 19.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 72.54 110.958 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.46 165.03 23.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.708 -0.758 . . . . 42.23 112.438 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.16 152.23 44.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.819 0.343 . . . . 64.45 110.92 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 150.4 39.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 74.23 110.86 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' HB3' HD12 ' A' ' 12' ' ' ILE . 26.1 t0 -73.64 -29.92 62.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.144 -0.48 . . . . 71.23 110.871 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.82 -69.68 0.25 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 70.42 112.511 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.64 -26.04 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.776 0.322 . . . . 71.34 111.132 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.499 HD12 ' HB3' ' A' ' 9' ' ' ASP . 2.5 mp -95.82 95.12 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 73.22 111.16 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -89.34 9.77 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 71.31 110.879 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -80.24 69.91 6.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 73.53 110.899 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.6 t -101.57 105.37 16.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.909 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.4 m -53.83 -64.76 0.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 64.33 110.848 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.1 m-20 -131.0 161.82 59.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.581 0.705 . . . . 64.34 110.866 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.69 -49.75 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.694 -1.794 . . . . 52.12 112.397 -0.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.57 -92.19 0.49 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 71.1 110.961 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.444 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -130.61 160.35 34.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 71.33 110.871 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -90.79 117.46 29.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 74.52 110.871 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.539 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -139.74 139.24 21.44 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.608 0.718 . . . . 71.34 111.122 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.539 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.73 169.47 63.05 Favored 'Cis proline' 0 C--O 1.232 0.185 0 C-N-CA 122.66 -1.808 . . . . 72.44 112.377 -0.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -7.98 22.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.655 2.237 . . . . 71.44 112.35 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.403 ' C ' HD12 ' A' ' 26' ' ' ILE . 66.3 mt -115.05 80.98 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 61.11 111.13 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.403 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.2 mp 60.6 100.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 71.22 111.1 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.74 -146.2 4.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.731 -0.747 . . . . 71.24 112.502 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -130.39 138.4 50.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.895 0.379 . . . . 65.42 110.85 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.5 t -76.8 128.97 35.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.097 -0.502 . . . . 72.31 110.879 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 51.2 110.905 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.813 0.339 . . . . 75.44 110.901 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 41.2 mm 63.77 118.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 74.24 111.131 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.38 159.82 7.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.149 -0.478 . . . . 64.31 111.064 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -51.28 118.24 3.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 74.22 110.866 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 60.44 35.83 20.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 75.4 110.941 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.72 167.06 31.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 32.31 112.489 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.4 152.64 43.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 71.55 110.943 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.07 154.88 31.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 70.14 110.865 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -72.91 -35.12 67.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.31 110.866 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.13 -69.57 0.29 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.759 -0.734 . . . . 72.25 112.514 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -26.04 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.759 0.314 . . . . 54.3 111.14 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 mt -97.16 98.51 7.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 63.12 111.174 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -89.59 9.83 25.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 63.23 110.89 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.11 69.94 6.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 73.34 110.916 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.9 t -100.0 106.29 18.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 61.13 110.909 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.7 m -52.62 -64.91 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 73.12 110.873 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.504 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -132.66 161.43 63.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.565 0.697 . . . . 72.31 110.904 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.504 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.77 -49.83 0.21 Allowed 'Cis proline' 0 C--N 1.341 0.166 0 C-N-CA 122.685 -1.798 . . . . 63.44 112.365 0.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.31 -92.07 0.49 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 73.05 110.954 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -130.45 160.37 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 75.42 110.873 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -90.26 118.64 29.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 70.44 110.859 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -140.35 138.96 19.65 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.591 0.71 . . . . 64.24 111.121 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.78 169.42 63.52 Favored 'Cis proline' 0 C--N 1.342 0.22 0 C-N-CA 122.665 -1.806 . . . . 65.0 112.356 -0.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -7.83 22.05 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.676 2.251 . . . . 43.41 112.351 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 71.3 mt -115.14 80.93 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 73.4 111.145 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 60.4 100.4 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 73.04 111.108 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -158.69 -146.29 4.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 73.22 112.486 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -130.16 137.93 50.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.904 0.383 . . . . 70.44 110.875 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -77.21 131.78 38.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 75.52 110.89 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 30' ' ' LEU . 2.8 pp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 61.43 110.911 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.6 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.79 0.329 . . . . 72.24 110.871 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 7' ' ' LYS . 40.5 mm 63.37 109.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 73.51 111.104 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.67 7.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 74.24 111.085 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -50.78 120.35 4.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 54.43 110.847 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.88 35.62 19.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 73.45 110.863 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.09 165.94 23.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 43.31 112.499 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.26 152.39 44.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.861 0.362 . . . . 73.22 110.893 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.92 149.89 40.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 60.12 110.852 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -76.39 -35.41 58.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 74.02 110.845 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.04 -69.22 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 65.54 112.531 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.72 -25.88 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.34 . . . . 63.22 111.129 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.9 mp -97.3 93.33 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 74.41 111.16 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -88.16 9.5 22.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.155 -0.475 . . . . 70.24 110.926 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -80.29 69.6 6.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 71.0 110.904 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.5 t -99.53 104.74 16.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 43.14 110.871 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.0 m -54.69 -64.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 60.54 110.897 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -130.64 161.63 59.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 72.15 110.848 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.76 -49.52 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.673 -1.803 . . . . 62.25 112.314 0.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.64 -92.25 0.47 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 75.3 110.887 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.09 160.12 35.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 75.34 110.882 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.57 126.16 35.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 64.23 110.892 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 23' ' ' PRO . 96.0 m -145.48 135.39 11.72 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.598 0.713 . . . . 72.13 111.147 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.575 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.79 170.34 59.09 Favored 'Cis proline' 0 C--N 1.341 0.153 0 C-N-CA 122.648 -1.813 . . . . 74.41 112.354 -0.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -6.67 19.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 50.41 112.333 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 1.066 HG22 HD12 ' A' ' 26' ' ' ILE . 12.9 mt -92.95 -69.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 73.14 111.147 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.066 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -152.87 120.09 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 41.3 111.145 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -175.13 -141.91 3.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 65.35 112.462 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -130.73 141.24 50.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.922 0.391 . . . . 62.21 110.865 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.7 t -74.4 128.66 36.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.507 . . . . 73.23 110.9 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 64.12 110.896 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.845 0.355 . . . . 63.31 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.467 HD12 ' O ' ' A' ' 7' ' ' LYS . 39.6 mm 63.43 109.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 62.42 111.11 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.93 160.51 7.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 61.41 111.093 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -50.8 120.4 4.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 73.0 110.862 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.79 35.58 19.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 74.12 110.961 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.21 166.69 23.36 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.732 -0.747 . . . . 70.12 112.451 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.27 152.19 44.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.795 0.331 . . . . 74.4 110.925 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.17 149.85 40.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 71.13 110.898 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.479 ' OD2' HD12 ' A' ' 12' ' ' ILE . 7.2 m-20 -75.27 -35.16 61.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 74.12 110.84 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.2 -70.01 0.37 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 75.21 112.502 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -25.36 30.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 73.12 111.117 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.479 HD12 ' OD2' ' A' ' 9' ' ' ASP . 8.3 mt -94.66 93.75 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 65.22 111.105 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.16 9.08 24.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 75.21 110.845 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -80.86 69.46 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 71.41 110.929 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 t -99.56 104.6 16.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 72.32 110.904 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.8 m -54.62 -64.45 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 70.21 110.882 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -131.81 161.72 60.78 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.601 0.715 . . . . 72.32 110.888 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.79 -49.64 0.22 Allowed 'Cis proline' 0 C--O 1.232 0.179 0 C-N-CA 122.695 -1.794 . . . . 72.34 112.28 0.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.64 -92.05 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 71.32 110.945 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.429 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.02 160.22 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 54.42 110.902 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.49 126.28 35.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 71.4 110.872 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 23' ' ' PRO . 95.5 m -145.4 135.48 11.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.561 0.696 . . . . 73.31 111.182 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.576 ' HA ' HG23 ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.73 170.23 59.33 Favored 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.685 -1.798 . . . . 74.22 112.359 -0.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -6.83 19.53 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.705 2.27 . . . . 54.54 112.323 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 1.07 HG22 HD12 ' A' ' 26' ' ' ILE . 11.9 mt -92.68 -69.34 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 74.22 111.133 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.07 HD12 HG22 ' A' ' 25' ' ' ILE . 2.7 mp -152.8 119.58 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 61.03 111.113 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.68 -142.2 3.94 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.775 -0.726 . . . . 74.04 112.501 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -130.79 141.4 50.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 70.22 110.867 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.5 t -74.06 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 73.31 110.902 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 30' ' ' LEU . 1.7 pt? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 75.21 110.879 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.776 0.322 . . . . 63.23 110.839 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 7' ' ' LYS . 48.0 mm 63.67 110.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 73.25 111.112 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.72 160.7 7.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 71.3 111.095 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -50.81 120.35 4.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 73.05 110.879 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 60.81 35.6 19.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.946 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.51 165.78 23.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.738 -0.744 . . . . 73.35 112.466 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.403 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.22 152.22 44.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 62.33 110.931 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.18 149.82 40.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 42.33 110.878 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.42 -33.49 67.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 70.42 110.868 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.37 -73.19 0.33 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.738 -0.744 . . . . 75.12 112.506 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -25.93 32.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.833 0.349 . . . . 64.45 111.134 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.2 mt -90.7 93.35 4.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 62.43 111.159 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -88.06 9.12 23.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 64.21 110.847 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.79 69.71 7.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.947 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -102.03 104.8 15.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 74.21 110.868 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.9 m -54.81 -64.54 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 51.42 110.855 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -131.21 160.97 64.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.601 0.715 . . . . 63.34 110.882 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.8 -49.72 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.701 -1.791 . . . . 72.11 112.327 0.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -128.53 -93.02 0.45 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 73.51 110.909 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -131.4 160.35 35.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 72.4 110.907 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.8 m -88.28 125.96 34.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.877 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 23' ' ' PRO . 93.9 m -146.15 135.38 11.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.575 0.703 . . . . 73.32 111.144 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.564 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.79 170.34 59.08 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.687 -1.797 . . . . 70.43 112.331 -0.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -6.64 19.11 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.704 2.269 . . . . 72.23 112.32 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 1.044 HG22 HD12 ' A' ' 26' ' ' ILE . 14.5 mt -92.58 -69.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 71.22 111.108 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.044 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -153.04 119.72 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 74.41 111.146 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -174.99 -141.93 3.87 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.773 -0.727 . . . . 32.3 112.479 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -130.65 141.52 50.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 71.22 110.883 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.0 t -74.17 128.33 35.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 74.24 110.874 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 71.45 110.896 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.788 0.327 . . . . 70.0 110.869 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.439 HD12 ' O ' ' A' ' 7' ' ' LYS . 51.9 mm 63.57 112.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 70.04 111.109 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.35 161.31 5.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 52.11 111.147 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -50.14 120.41 4.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 43.13 110.852 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.8 35.25 19.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 73.34 110.981 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.68 155.55 19.34 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.697 -0.763 . . . . 74.12 112.499 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' NZ ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -70.36 150.26 46.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 70.14 110.849 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -119.28 161.79 19.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 75.3 110.884 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.579 ' HB3' HD12 ' A' ' 12' ' ' ILE . 26.9 t70 -67.72 -32.68 73.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 75.41 110.856 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.13 -69.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.751 -0.738 . . . . 73.42 112.486 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.09 -25.82 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 72.12 111.121 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 9' ' ' ASP . 2.7 mp -89.95 97.13 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.43 111.149 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.84 9.85 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 50.33 110.866 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -80.14 69.73 6.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 71.31 110.857 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.2 t -102.22 104.85 15.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.44 110.846 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.2 m -53.98 -64.78 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 71.41 110.871 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -131.63 161.63 61.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.625 0.726 . . . . 63.32 110.837 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.85 -49.57 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.168 0 C-N-CA 122.713 -1.786 . . . . 64.34 112.328 0.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -129.67 -91.39 0.46 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 72.24 110.925 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.18 160.2 34.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 61.5 110.946 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.19 119.81 32.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 61.42 110.854 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.537 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -139.25 139.56 23.37 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.576 0.703 . . . . 63.41 111.166 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.79 169.71 62.15 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.793 . . . . 70.45 112.359 -0.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -7.87 22.16 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.675 2.25 . . . . 64.11 112.369 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.412 ' C ' HD12 ' A' ' 26' ' ' ILE . 6.1 pt -114.91 83.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 71.4 111.125 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.487 HG23 ' NZ ' ' A' ' 7' ' ' LYS . 5.3 mp 61.28 86.57 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 51.45 111.114 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.39 -157.48 7.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 53.34 112.525 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.23 138.36 54.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.395 . . . . 64.34 110.817 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.04 129.4 36.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.109 -0.496 . . . . 75.25 110.874 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.885 -180.0 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.826 0.346 . . . . 71.2 110.889 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 7' ' ' LYS . 49.3 mm 63.79 111.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 75.41 111.127 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.87 161.01 6.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 74.43 111.097 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -50.71 120.46 4.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 75.14 110.873 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.84 35.11 19.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 64.44 110.913 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.41 161.69 18.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 44.44 112.488 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.49 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.3 150.3 46.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.851 0.358 . . . . 64.22 110.899 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.4 p -119.53 160.84 21.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 52.21 110.893 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -69.06 -34.96 76.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 60.32 110.866 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.79 -69.92 0.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.71 -0.757 . . . . 64.11 112.493 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.57 -25.72 32.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.827 0.346 . . . . 70.1 111.19 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.5 mt -90.12 100.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 72.13 111.144 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -87.41 9.13 21.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 73.32 110.924 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -80.63 69.66 7.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 75.34 110.912 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.1 t -102.82 104.78 15.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 52.22 110.813 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.0 m -55.32 -64.59 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.11 110.86 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -132.83 161.46 63.45 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.585 0.707 . . . . 73.22 110.864 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.75 -49.68 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.667 -1.805 . . . . 64.22 112.342 0.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -128.08 -91.96 0.48 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.895 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -130.67 160.61 33.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.431 . . . . 72.53 110.924 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.0 t -89.94 119.46 30.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 73.22 110.843 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.541 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.0 OUTLIER -141.11 138.87 18.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.56 0.695 . . . . 72.34 111.184 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.541 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.69 169.29 63.77 Favored 'Cis proline' 0 C--N 1.341 0.175 0 C-N-CA 122.678 -1.801 . . . . 64.32 112.354 -0.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -8.09 22.73 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.637 2.225 . . . . 74.33 112.346 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.42 ' C ' HD12 ' A' ' 26' ' ' ILE . 68.1 mt -114.73 80.29 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 62.11 111.127 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.469 HG23 ' NZ ' ' A' ' 7' ' ' LYS . 5.3 mp 60.97 101.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 65.33 111.104 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.79 -145.75 4.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 72.1 112.467 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -130.14 137.97 50.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.946 0.403 . . . . 75.31 110.865 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -77.13 129.3 35.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 54.4 110.879 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 62.4 110.935 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.812 0.339 . . . . 64.04 110.886 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.45 HD12 ' O ' ' A' ' 7' ' ' LYS . 41.6 mm 63.37 110.53 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 74.22 111.175 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.59 7.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.22 -0.445 . . . . 74.01 111.108 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -50.85 120.29 4.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 72.42 110.896 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.81 35.59 19.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 75.03 110.9 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.63 166.0 23.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.739 -0.743 . . . . 72.03 112.532 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.27 152.03 44.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.786 0.326 . . . . 63.22 110.928 -179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.23 149.77 40.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.245 -0.434 . . . . 73.51 110.84 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -74.48 -34.9 63.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 73.4 110.848 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.42 -70.19 0.37 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.785 -0.722 . . . . 71.13 112.525 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.43 -25.43 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 75.4 111.185 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.0 mt -94.1 93.26 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 74.41 111.123 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -88.0 8.99 23.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.41 110.908 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -80.94 69.52 7.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 72.44 110.92 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 t -100.57 104.75 16.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 74.03 110.84 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.2 m -54.98 -64.43 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 74.3 110.848 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -131.54 161.37 62.59 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.632 0.73 . . . . 55.12 110.862 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.78 -49.74 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.225 0 C-N-CA 122.674 -1.803 . . . . 72.12 112.307 0.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -128.97 -92.56 0.45 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.234 -0.439 . . . . 74.34 110.882 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -131.0 160.45 34.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 74.23 110.908 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.7 m -90.82 125.3 35.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 62.35 110.893 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.522 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -144.2 136.36 13.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.574 0.702 . . . . 64.34 111.159 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.83 170.99 56.09 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.648 -1.813 . . . . 75.13 112.346 -0.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.69 -5.68 16.74 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 75.12 112.362 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 1.055 HG22 HD12 ' A' ' 26' ' ' ILE . 14.4 mt -93.68 -69.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 73.44 111.157 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.055 HD12 HG22 ' A' ' 25' ' ' ILE . 2.5 mp -153.09 115.26 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 74.13 111.098 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.1 -143.08 3.72 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.731 -0.747 . . . . 53.11 112.466 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -130.68 141.59 50.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.877 0.37 . . . . 74.0 110.911 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.2 t -73.99 128.22 34.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 73.24 110.864 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.456 . . . . 62.23 110.953 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 13.6 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.846 0.355 . . . . 73.21 110.878 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.5 mm 62.5 109.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 72.45 111.155 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.31 160.05 11.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 61.35 111.052 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.66 120.92 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 72.12 110.85 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 61.12 36.15 18.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 71.14 110.893 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.25 169.63 29.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.783 -0.723 . . . . 72.31 112.462 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 154.93 41.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.342 . . . . 73.55 110.884 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -116.06 149.75 38.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 43.53 110.89 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.55 -32.27 69.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 64.12 110.837 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.22 -79.38 0.29 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.737 -0.744 . . . . 75.51 112.483 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.42 -25.11 30.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.77 0.319 . . . . 70.02 111.075 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.1 mt -89.71 101.0 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 53.14 111.145 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -86.01 9.51 16.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 73.44 110.864 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -79.83 69.56 6.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 75.43 110.925 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.12 105.44 17.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 64.23 110.841 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -50.7 -72.75 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 71.51 110.887 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -135.31 159.5 71.54 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.578 0.704 . . . . 74.03 110.896 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.78 -49.43 0.23 Allowed 'Cis proline' 0 C--O 1.232 0.179 0 C-N-CA 122.717 -1.784 . . . . 74.41 112.33 0.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -130.42 -91.27 0.45 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.879 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.59 160.27 34.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 74.24 110.935 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 1.309 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 23.7 p -95.42 126.44 40.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 63.5 110.848 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.543 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -136.87 140.89 33.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.569 0.7 . . . . 64.35 111.109 -179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.543 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.74 170.41 58.53 Favored 'Cis proline' 0 C--N 1.342 0.199 0 C-N-CA 122.694 -1.794 . . . . 63.02 112.35 -0.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -5.14 15.47 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.652 2.235 . . . . 64.53 112.382 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.473 ' C ' HD12 ' A' ' 26' ' ' ILE . 33.7 mt -108.52 73.21 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 53.13 111.131 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.473 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.4 mp 62.13 98.44 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 61.45 111.167 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.05 -143.63 3.74 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 63.23 112.54 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -130.77 139.52 50.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.891 0.377 . . . . 64.5 110.846 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.5 OUTLIER -76.27 128.71 35.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 53.21 110.887 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 61.24 110.895 179.963 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.808 0.337 . . . . 72.15 110.876 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.445 HD12 ' O ' ' A' ' 7' ' ' LYS . 43.3 mm 63.43 110.41 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 71.34 111.162 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.65 160.92 6.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.32 111.109 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -50.58 120.23 4.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 74.24 110.857 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.75 35.44 19.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 74.32 110.91 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.09 164.71 23.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 72.43 112.47 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -70.3 152.33 44.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.815 0.341 . . . . 72.31 110.925 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.8 149.84 40.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 31.34 110.882 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -74.6 -35.16 62.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 72.3 110.864 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.35 -69.36 0.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.732 . . . . 73.32 112.446 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.86 -25.92 30.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.784 0.326 . . . . 74.43 111.091 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -96.85 93.58 3.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 74.25 111.13 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -88.22 9.44 22.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 63.3 110.903 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -80.29 69.6 6.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.459 . . . . 71.02 110.909 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.6 t -100.39 104.82 16.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 61.35 110.871 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.3 m -54.44 -64.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 74.32 110.875 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -130.53 161.74 58.95 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.602 0.715 . . . . 44.32 110.879 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.71 -49.53 0.22 Allowed 'Cis proline' 0 C--O 1.231 0.15 0 C-N-CA 122.737 -1.776 . . . . 62.33 112.34 -0.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -127.49 -93.04 0.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 74.54 110.925 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.47 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -131.63 160.14 36.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 70.44 110.883 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.6 m -88.77 126.1 35.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 63.11 110.866 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 23' ' ' PRO . 94.4 m -146.07 135.79 11.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.608 0.718 . . . . 75.2 111.132 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.586 ' HA ' HG23 ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.73 170.44 58.33 Favored 'Cis proline' 0 C--O 1.231 0.163 0 C-N-CA 122.684 -1.799 . . . . 72.25 112.345 -0.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -7.62 21.52 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.702 2.268 . . . . 75.14 112.329 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.637 HG22 HG13 ' A' ' 26' ' ' ILE . 18.5 mt -93.4 -58.89 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 74.44 111.164 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.637 HG13 HG22 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -163.22 130.67 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 52.12 111.102 179.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.71 -139.33 4.99 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.751 -0.738 . . . . 34.41 112.508 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -131.33 140.72 49.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.881 0.372 . . . . 74.15 110.88 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.1 t -75.29 128.51 35.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 62.12 110.875 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 71.24 110.914 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.772 0.32 . . . . 70.31 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.2 mm 63.36 110.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 73.52 111.106 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.66 160.69 6.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 73.41 111.059 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -50.62 120.42 4.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 75.33 110.82 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.83 35.6 19.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.438 . . . . 54.41 110.922 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.27 165.23 23.8 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.72 -0.752 . . . . 64.44 112.498 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 152.47 44.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 74.35 110.899 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.87 149.89 40.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.888 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.12 -33.92 38.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 72.42 110.867 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.51 -69.26 0.39 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.745 -0.74 . . . . 43.42 112.433 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.71 -25.88 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.346 . . . . 71.13 111.126 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -97.55 90.44 2.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 53.02 111.127 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -88.03 9.4 22.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 64.04 110.881 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -80.33 69.61 6.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.52 110.942 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.9 t -99.92 104.67 16.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.857 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -54.49 -64.57 0.79 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 75.33 110.863 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.5 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.4 OUTLIER -129.94 161.63 58.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.599 0.714 . . . . 61.14 110.87 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.67 -49.54 0.22 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.671 -1.804 . . . . 71.35 112.373 -0.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -129.16 -91.88 0.46 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.937 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -130.83 160.23 35.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 63.23 110.934 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 m -91.94 125.54 36.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.9 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.527 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -142.41 137.35 15.44 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.612 0.72 . . . . 41.24 111.122 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.71 171.02 55.4 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.712 -1.786 . . . . 43.43 112.369 -0.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -7.02 20.01 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.695 2.264 . . . . 71.41 112.353 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.634 HG22 HG13 ' A' ' 26' ' ' ILE . 21.6 mt -94.89 -56.27 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 72.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.634 HG13 HG22 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -164.93 129.14 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 70.41 111.144 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 175.97 -140.76 5.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 71.23 112.485 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -131.15 140.98 50.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 71.21 110.878 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 t -74.56 128.95 36.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 52.03 110.861 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.606 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 73.04 110.956 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.83 0.348 . . . . 73.45 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.524 HD12 ' O ' ' A' ' 7' ' ' LYS . 45.7 mm 63.26 109.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 45.41 111.122 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 161.07 11.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 61.32 111.089 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -50.13 120.46 4.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 71.54 110.871 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 60.8 36.01 19.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 71.31 110.906 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.07 164.64 20.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.749 . . . . 74.11 112.49 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.524 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -66.86 154.35 41.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.83 0.348 . . . . 65.21 110.874 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -116.37 149.57 39.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 73.34 110.886 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -77.43 -22.25 51.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.32 110.877 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.07 -77.33 0.22 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 73.34 112.509 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -25.08 29.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 63.45 111.107 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.448 HG23 HE21 ' A' ' 14' ' ' GLN . 39.4 mt -89.59 97.53 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 65.43 111.117 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.93 7.48 27.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 60.03 110.886 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.448 HE21 HG23 ' A' ' 12' ' ' ILE . 3.1 mp0 -80.02 69.35 6.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 72.31 110.899 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.37 106.62 18.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 63.14 110.893 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -49.67 -72.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 62.53 110.865 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.497 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -135.27 160.7 67.12 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.594 0.711 . . . . 63.05 110.878 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.73 -49.8 0.21 Allowed 'Cis proline' 0 C--N 1.341 0.163 0 C-N-CA 122.716 -1.785 . . . . 73.43 112.352 -0.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -130.51 -91.53 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 75.14 110.917 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.9 160.65 33.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 72.31 110.983 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 24.4 p -94.4 126.81 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 74.24 110.87 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.542 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 0.9 OUTLIER -136.34 140.96 34.17 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.605 0.717 . . . . 64.21 111.107 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.0 Cg_endo -69.82 170.61 57.91 Favored 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 -1.802 . . . . 71.22 112.291 -0.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -3.75 12.61 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.667 2.245 . . . . 53.41 112.365 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 26' ' ' ILE . 32.3 mt -109.85 72.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 75.11 111.139 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.509 HD12 ' C ' ' A' ' 25' ' ' ILE . 5.2 mp 62.65 99.76 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 61.43 111.116 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.46 -143.21 3.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.702 -0.761 . . . . 52.14 112.458 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -130.52 139.74 50.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.928 0.394 . . . . 73.51 110.886 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 0.3 OUTLIER -76.1 129.05 36.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 73.44 110.86 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 63.22 110.978 179.896 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.863 0.363 . . . . 43.12 110.924 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.2 mm 63.52 111.26 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 72.24 111.087 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.73 160.48 7.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 72.33 111.061 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -50.98 120.26 4.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.32 110.813 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 60.71 35.6 19.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.51 110.909 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.52 166.37 24.04 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 71.43 112.518 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.24 152.41 44.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 64.14 110.915 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.31 149.96 40.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 75.31 110.857 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -66.62 -22.75 66.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 75.02 110.836 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.24 -87.84 0.42 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.671 -0.776 . . . . 71.45 112.48 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.97 -25.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 63.35 111.12 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.54 93.52 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 70.45 111.18 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -100.51 19.69 16.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 70.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.27 70.38 6.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 73.24 110.9 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 p -107.53 111.0 23.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 52.24 110.865 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.2 m -39.58 -63.56 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 72.34 110.879 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 1.2 m-20 -128.1 162.56 49.34 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.623 0.725 . . . . 74.31 110.803 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.5 Cg_endo -69.78 -50.92 0.17 OUTLIER 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.712 -1.787 . . . . 73.0 112.312 0.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -130.47 -93.8 0.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 75.23 110.923 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.7 OUTLIER -126.88 161.34 28.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 73.32 110.897 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 1.1 m -85.63 125.97 33.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 50.43 110.891 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.535 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -153.2 138.23 11.35 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.586 0.707 . . . . 72.2 111.18 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.535 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.72 169.38 63.47 Favored 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.704 -1.79 . . . . 53.2 112.331 -0.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.85 -8.4 23.52 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.664 2.243 . . . . 54.33 112.34 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 pt -113.18 92.18 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 75.54 111.132 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.3 mp 50.19 85.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 65.53 111.109 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -144.51 -152.24 5.6 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.741 -0.742 . . . . 75.41 112.481 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -130.88 140.72 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 73.52 110.861 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' CYS . 4.1 t -74.1 126.47 30.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 74.31 110.876 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 30' ' ' LEU . 1.6 pt? . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 72.13 110.904 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.852 0.358 . . . . 44.12 110.935 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.461 HD12 ' O ' ' A' ' 7' ' ' LYS . 39.8 mm 63.45 110.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 60.31 111.153 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.68 160.59 7.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 72.44 111.081 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -50.93 120.28 4.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 65.43 110.843 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.85 35.69 19.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.914 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.18 166.58 23.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 31.24 112.492 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.684 ' NZ ' HG23 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -70.11 151.92 44.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.773 0.32 . . . . 64.44 110.918 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 149.71 40.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.44 . . . . 60.04 110.857 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -74.02 -35.42 64.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.0 110.87 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.02 -69.38 0.34 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.741 -0.742 . . . . 60.2 112.478 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -25.86 30.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.347 . . . . 72.42 111.168 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.67 94.78 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 65.33 111.108 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -88.16 9.45 22.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 51.34 110.899 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -80.4 69.56 6.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 62.54 110.888 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.5 t -101.2 104.82 15.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 73.34 110.884 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.9 m -53.39 -64.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 62.12 110.845 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.9 OUTLIER -131.89 161.71 60.93 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.602 0.715 . . . . 73.14 110.867 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.84 -49.52 0.23 Allowed 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 -1.805 . . . . 62.22 112.331 0.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -128.23 -92.93 0.46 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 75.3 110.884 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -131.51 160.45 35.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 71.55 110.863 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.4 m -90.13 125.18 35.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 65.41 110.877 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -143.33 136.64 14.03 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.594 0.712 . . . . 54.23 111.128 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.8 170.63 57.71 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.617 -1.826 . . . . 63.34 112.352 -0.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.81 2.32 3.66 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.703 2.269 . . . . 72.43 112.314 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.608 ' HB ' HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -107.65 -65.56 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 34.11 111.099 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.684 HG23 ' NZ ' ' A' ' 7' ' ' LYS . 4.2 mp -148.36 123.93 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.34 111.141 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.429 ' HA3' ' HD2' ' A' ' 23' ' ' PRO . . . 176.93 -147.08 8.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 72.23 112.487 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.493 ' O ' HD12 ' A' ' 30' ' ' LEU . 81.0 m-85 -130.94 142.19 50.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.381 . . . . 73.2 110.922 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.8 t -73.15 128.27 34.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 55.21 110.909 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 28' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 63.1 110.88 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.845 0.355 . . . . 72.21 110.883 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 7' ' ' LYS . 35.2 mm 65.01 115.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 75.32 111.075 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.8 160.73 7.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 74.22 111.071 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.81 120.3 4.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 55.43 110.86 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.74 35.26 19.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 74.24 110.914 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.42 170.19 24.28 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 63.03 112.508 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.563 ' O ' HD12 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -69.92 152.85 44.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 72.53 110.924 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.1 156.73 28.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 62.45 110.888 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.24 -28.55 38.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 64.41 110.894 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.19 -69.58 0.21 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 74.41 112.487 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.32 -26.09 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 62.34 111.156 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.89 99.97 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 61.21 111.148 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -89.01 9.65 24.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 63.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -80.24 69.83 6.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 73.14 110.947 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 27.0 t -103.97 103.51 13.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 61.34 110.862 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 p -49.75 -62.17 1.71 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 71.35 110.841 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.507 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -136.34 160.94 64.94 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.573 0.701 . . . . 51.03 110.893 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.77 -50.23 0.2 OUTLIER 'Cis proline' 0 C--O 1.231 0.166 0 C-N-CA 122.662 -1.807 . . . . 74.05 112.388 0.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -130.6 -93.81 0.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 74.11 110.952 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.84 160.94 35.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 72.44 110.926 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.8 m -84.0 125.65 32.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 50.14 110.861 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.625 HG23 ' HA ' ' A' ' 23' ' ' PRO . 95.9 m -145.94 136.86 12.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.573 0.701 . . . . 64.2 111.131 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.625 ' HA ' HG23 ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.72 162.31 84.27 Favored 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.792 . . . . 64.35 112.337 -0.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.634 ' O ' HG23 ' A' ' 25' ' ' ILE . 53.8 Cg_endo -69.76 54.59 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.662 2.241 . . . . 55.33 112.351 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 24' ' ' PRO . 0.5 OUTLIER -172.39 86.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 73.21 111.127 179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mp 50.34 83.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.473 . . . . 73.5 111.125 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -145.7 -140.22 3.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.739 . . . . 73.01 112.487 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -130.82 137.59 49.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.849 0.357 . . . . 62.22 110.867 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 t -77.29 128.43 34.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 74.51 110.876 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 71.24 110.895 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.756 0.312 . . . . 74.23 110.868 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 43.5 mm 64.62 114.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 74.31 111.157 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.84 160.51 7.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 41.03 111.107 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -50.79 120.48 4.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 75.23 110.835 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.85 35.63 19.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 63.42 110.905 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.53 167.1 24.4 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 54.32 112.45 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 152.01 44.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.822 0.344 . . . . 70.43 110.877 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -118.4 149.9 40.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 71.34 110.827 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -72.59 -35.17 67.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 64.51 110.885 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.32 -69.88 0.37 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 74.23 112.505 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -26.67 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.78 0.324 . . . . 62.03 111.145 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 88.1 mt -94.71 92.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.46 . . . . 61.11 111.135 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -88.1 8.83 24.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 74.41 110.874 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.84 69.55 7.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.925 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.5 t -99.25 103.48 15.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 64.45 110.878 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 p -50.09 -61.49 2.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 71.31 110.895 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -135.75 161.26 63.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.57 0.7 . . . . 71.4 110.911 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.76 -49.66 0.22 Allowed 'Cis proline' 0 C--N 1.342 0.193 0 C-N-CA 122.676 -1.802 . . . . 73.13 112.35 0.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.9 -93.0 0.45 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.448 . . . . 73.2 110.909 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.436 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -131.51 160.72 34.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 70.51 110.923 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.5 m -90.06 125.01 35.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 71.52 110.893 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.521 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.2 m -142.94 136.09 13.94 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.591 0.71 . . . . 71.32 111.116 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.78 171.08 55.46 Favored 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.689 -1.796 . . . . 64.5 112.324 -0.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -5.56 16.46 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.681 2.254 . . . . 54.0 112.337 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 1.057 HG22 HD12 ' A' ' 26' ' ' ILE . 14.0 mt -93.8 -69.37 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 53.21 111.169 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 1.057 HD12 HG22 ' A' ' 25' ' ' ILE . 2.6 mp -153.05 115.39 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.52 111.14 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.27 -142.85 3.66 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 61.02 112.495 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.587 ' O ' HD12 ' A' ' 30' ' ' LEU . 83.2 m-85 -130.57 141.66 50.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.91 0.386 . . . . 74.34 110.858 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.9 t -74.32 128.98 36.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 73.33 110.898 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 28' ' ' PHE . 3.5 mp . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.918 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.813 0.34 . . . . 75.41 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 47.2 mm 63.83 112.96 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 50.52 111.155 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.49 160.78 6.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 73.13 111.088 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -50.62 120.24 4.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 73.01 110.831 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 60.73 35.37 19.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.34 110.904 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.63 162.92 25.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.753 -0.737 . . . . 71.32 112.473 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.32 151.0 45.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 72.15 110.838 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.32 149.93 40.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 65.21 110.892 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -76.28 -27.69 56.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 75.24 110.884 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.45 -74.65 0.37 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.749 -0.739 . . . . 63.41 112.515 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.27 -13.91 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.829 0.347 . . . . 65.43 111.149 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 12' ' ' ILE . 6.4 tt -88.5 85.69 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 72.14 111.086 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -85.6 6.71 26.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.33 110.898 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -83.06 69.27 9.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 72.43 110.907 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.8 t -106.96 103.41 12.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 50.44 110.89 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.8 m -56.03 -64.31 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 52.32 110.872 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.497 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -131.37 160.94 64.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.559 0.695 . . . . 63.14 110.878 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.71 -49.47 0.23 Allowed 'Cis proline' 0 C--O 1.231 0.155 0 C-N-CA 122.696 -1.793 . . . . 63.15 112.354 0.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -128.65 -93.8 0.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 74.13 110.937 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -132.18 160.73 35.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.03 110.885 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 m -87.32 125.3 34.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 74.21 110.861 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.521 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.1 m -143.41 137.29 14.47 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.581 0.705 . . . . 74.41 111.123 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.521 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.79 171.18 55.04 Favored 'Cis proline' 0 C--O 1.232 0.195 0 C-N-CA 122.691 -1.795 . . . . 73.15 112.362 -0.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -6.47 18.68 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.651 2.234 . . . . 54.25 112.33 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.63 HG22 HG13 ' A' ' 26' ' ' ILE . 20.1 mt -95.37 -56.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 55.43 111.123 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.63 HG13 HG22 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -165.47 131.03 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 73.54 111.115 179.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 173.26 -139.09 4.96 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.752 -0.737 . . . . 74.14 112.531 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -131.64 141.39 49.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.917 0.389 . . . . 74.52 110.851 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.3 t -74.11 128.57 35.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 70.44 110.863 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.541 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.9 pp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.477 . . . . 74.11 110.936 179.959 . . . . . . . . 1 1 . 1 stop_ save_